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Pyruvate dehydrogenase multi-enzyme complex (PDHc) is an assembly of multiple 
copies of four different proteins. Together they carry out the oxidative decarboxylation 
of pyruvate and generate acetyl-CoA and NADH, which are components of Krebs 
cycle, energy production and fatty acid biosynthesis in cells. Out of the four different 
subunits of PDHc, three are known to have distinct active sites and are found in PDHc 
from all organisms. The three catalytically important components are termed E1 
(pyruvate dehydrogenase), E2 (dihydrolipoamide acetyltransferase) and E3 
(dihydrolipoamide dehydrogenase). Exclusively in eukaryotic PDHc, an additional 
component, E3BP (E3 binding protein), is present whose role has been proposed to 
be for structural support of the PDHc assembly 
This enzyme complex, which has already been studied for half a century, is a textbook 
prototype for substrate channelling between remotely located active sites in a multi-
enzyme system. The individual active sites are spatially separated by at least few 
nanometers, and are coupled by highly flexible lipoyl arms of E2 and E3BP. The lipoyl 
arms consist of one or more lipoyl domains, each carrying covalently linked lipoamide 
groups. These lipoamide “swinging arms” need to visit all three active sites at E1, E2 
and E3 in a sequential manner in order to complete a reaction cycle of PDHc. By 
structural design, the E2 core in prokaryotes and E2/E3BP core in eukaryotes make 
24meric cube or 60meric pentagonal dodecahedron from which lipoyl arms and 
binding domains of E1 and E3 emanate outward.  
In this PhD thesis, we focussed our attention on human PDHc and could elucidate the 
structural architecture of the core in details not achieved before. Firstly, we were able 
to calculate structural models for human E2/E3BP (hE2/E3BP) core from the cryo-EM 
density map at a resolution of ~ 6 Å. Our data revealed that the published pseudo-
atomic model of human E2 was in part erroneous. By integrating crosslinking MS data 
in our E2/E3BP structural model, we predict a hitherto unknown mode of structural 
dynamics that act along the length of core subunits, at least for E3BP. This mode is 
different from the ‘breathing motion that acts at the inter-trimer bridges orthogonal to 
the length of the subunits. 
We proved that hE2/E3BP core most likely consists 40 hE2 and 20 E3BP subunits, 
which can bind to 20 human E3 dimers (hE3). Furthermore, only hE2 can bind to 
substrate coenzyme A (CoA). We observed that, unlike in prokaryotic PDHc, in 
hPDHc, only hE1 appear to form outer shell while hE3 can fluctuate between the outer 





trimer arrangements of core subunits in isolated hE2/E3BP core versus fully 
assembled hPDHc, namely 2 hE2 - 1 E3BP type and 1 hE2 – 2 E3BP type, 
respectively. All of these observations indicate that in hPDHc, hE2 and E3BP are not 
equally distributed in the core but rather with local patches. Wherever hE2-hE1 is in 
excess, E1/E2 reactions might be preferred. And at the patches where E3BP-hE3 is 
dominant, E3-catalyzed regeneration of the lipoamide cofactor mostly occur. 
Another key discovery made during this thesis work was the large conformational 
changes in the lipoyl arms when CoA binds to hE2. By quantifying crosslinks detected 
in crosslinking MS, we could show that when CoA substrate is bound, the preferred 
destination of lipoyl domains are the core surface and hE3. Together with increased 
crosstalk between lipoyl domain of E3BP and hE2, it appears that CoA binding primes 
the hPDHc for specifically E2 and E3 reactions. To our knowledge, this is the first 
instance where substrate binding in any PDHc could be shown to impact the 
conformational landscape of lipoyl arm dynamics.  In addition, the orientation of lipoyl 
domains while they come into proximity to each other seems to be conserved. This 
was an unexpected observation due to the very high flexibility of the lipoyl arms and 
the distances they have to travel in order to visit all the various active sites. These 
findings all indicate that movement of lipoyl arms to couple active sites in PDHc is not 
a multiple random coupling mechanism alone but is also impacted by substrate 
binding and catalysis synchronizing their movements for subsequent steps in the 
multi-step PDHc reaction. 
 
Keywords: pyruvate dehydrogenase complex, architecture, CoA, movement of 
lipoyl arms 






1.1. Multi-enzyme complexes 
To support life, two things are of utmost importance for a cell. First one is to contain 
important chemical compounds and biomolecules inside its protective space, thereby, 
enabling them to efficiently harness energy from sunlight and chemicals from its 
surroundings. Second one is to copy its genomic material and transfer to its daughter 
cells. To do both however, it needs to perform a myriad of chemical reactions, which 
could be catabolic or anabolic in nature. Evidence suggests that the responsibility of 
catalyzing these reactions have been delegated to proteins by ribonucleic acids (Cech 
2012). Nature might have found proteins to be versatile as they have more diverse 
functional groups than nucleic acids, which arm them to tackle wide array of 
biochemical reactions. 
These biocatalysts, which are known as ‘enzymes’, sometimes are part of a process, 
which needs several chemical transformations of a biomolecule (Reed 1966). Multiple 
enzymes activities are then required to finish the job, and occasionally they come 
together to associate into higher oligomers termed ‘multi-enzyme complex’. One well-
known example is fatty acid synthase (FAS) during biosynthesis of fatty acids. 
Depending on organisms, this whole process requires 7-8 completely different 
enzymatic steps. In prokaryotes and plants, a separate mono functional enzyme 
catalyzes each step, with their relative abundance directing the reaction (Anselmi, 
Grininger et al. 2010, Bukhari, Jakob et al. 2014). But in fungi, they are part of a large 
ensemble (fFAS), which is around 2.6 MDa in size. All the enzymatic activities are 
encoded in two peptide chains (α and β), 6 copies from each of them forming this 
colossal hetero-dodecameric enzyme machine. In metazoan, the idea remains the 
same for bringing active sites to close vicinity, but they are rather contained in, single 
peptide chain. Its homodimer (540 KDa) forms the fatty acid synthesizing scaffold 
(Leibundgut, Maier et al. 2008).   
One intriguing question that arises here is, what could be the relative advantage of 
such assembly? The more complex an organism, the more tendencies there is to find 
such aggregations. The first advantage could be that important chemical 
intermediates won’t diffuse into the cellular milieu till the final product is formed, 
making the whole pathway much more efficient (Reed 1966). This holds true even if 
the catalytic activity of the member enzymes is unaltered, since the active sites are 
optimally fixed in space. Other advantages could be the protection of intermediates 





Quite often, the active sites of multi-enzyme complexes are at considerable distance 
from each other’s. Use of extended appendages comprising flexible linkers, domains 
and prosthetic groups as means to couple distant active sties and channel substrates, 
seem to be a common feature in multi-enzyme complexes. In the FAS described 
above, the phosphopantetheine arm of acyl carrier protein does the job of carrying 
intermediates. In the pyruvate dehydrogenase complex (PDHc) which is the center of 
attention of this thesis, a lipoic acid covalently linked to lipoyl domain of a highly 
flexible swinging arm does the similar job (Reed and Hackert 1990). 
 
1.2. General overview of pyruvate dehydrogenase complex 
Pyruvate dehydrogenase complex (PDHc) is an enzyme complex dedicated to 
catalyze oxidative decarboxylation of pyruvate (Korkes, Delcampillo et al. 1951, Reed 
1966). This process involves several steps, which are catalyzed at the active sites of 
three enzymes namely, pyruvate dehydrogenase (E1), dihydrolipoamide 
acetyltransferase (E2) and dihydrolipoamide dehydrogenase (E3) (see Fig. 1). The 
final products of the overall reaction are acetyl-CoA and reduced nicotinamide 
adenine dinucleotide (NADH). The acetyl-CoA contains a high-energy thioester bond 
between acetyl group and thiol group of CoA, which makes it an excellent acetyl donor 
to other biomolecules (Tittmann 2009). It is also funneled to the Kreb’s cycle for 
complete combustion of acetyl group to produce further energy rich compounds like 
NADH and reduced flavin adenine dinucleotide (FADH2). These energy rich products 
are fed into the electron transport chain to maintain proton gradient across lipid 
membranes, which is a prerequisite for adenosine tri-phosphate (ATP) synthesis in a 
cell (Watt, Montgomery et al. 2010, Sazanov 2015). All in all, this complex channels 
the glycolytic end product i.e. pyruvate to cellular respiration.  
PDHc is present in all organisms, which depend on aerobic respiration. It is localized 
in the cytoplasm of prokaryotic cells whereas, in eukaryotes, it is localized in the 
mitochondria and plastids (Reed 1966, Reid, Lyttle et al. 1975). Another important 
difference between prokaryotic and eukaryotic PDHc is their regulation. While activity 
of both of them is affected by the metabolic state of a cell indicated by a redox state 
and CoA/acetyl-CoA ratio, only eukaryotic PDHc is regulated by posttranslational 
modifications (Patel and Korotchkina 2006). Site-specific phosphorylation and de-
phosphorylation of E1 component by pyruvate dehydrogenase kinase (PDK) and 





reactivate PDHc, is one classic example (Harris, Bowker-Kinley et al. 2002, Patel and 
Korotchkina 2006).   
 
 
Fig.1: Overall reaction scheme of PDHc. 
The pyruvate molecule is decarboxylated at E1 (green sphere) and the remaining two-carbon 
moiety is covalently attached to E1 bound ThDP. A highly mobile lipoyl group from E2 
(probably also E3BP) with a dithiolane ring, comes to the active site of E1 and takes away the 
acetyl group. Then, acetyl-lipoyl moves to the active site of E2 (grey sphere), which has an 
acetyl transferase activity. Here, acetyl-lipoyl donates the acetyl group to a CoA molecule. The 
product acetyl-CoA leaves PDHc while the reduced dihydrolipoyl has to go to active site of the 
E3 (yellow sphere) to get oxidized back to active lipoyl state. During this oxidation, the reducing 
equivalent moves from dihydrolipoyl to an intrinsic disulfide to the FAD cofactor and finally to 
NAD+ to yield NADH. This completes a cycle for the movement of lipoyl-group, and is ready 
for next round of reaction. 
 
Architecturally, the central component of PDHc is the E2 subunit, which oligomerizes 
into 24mer cube in gram-negative bacteria and plant and 60mer pentagonal 
dodecahedron in gram-positive bacteria (Reed and Hackert 1990). In mammals, 
nematodes and yeast, E2 also has a companion in the E3-binding protein (E3BP), 
together they form a dodecahedron, similar as in gram-positive bacteria (Stoops, 
Cheng et al. 1997, Vijayakrishnan, Kelly et al. 2010). There are however exceptions 
such as in the case of Thermoplasma acidophilum, where the E2s can arrange into 
42meric oligomer showing mixed characteristics of both the cubic and dodecahedral 
symmetries (Marrott, Marshall et al. 2014). These structures formed by E2 alone or 
with E3BP are called ‘cores’. Multiple copies of E1 and E3 proteins decorate these 
cores from outside by binding to their respective binding sites. In prokaryotes, E1 and 





is termed as subunit binding domain (SBD). In eukaryotes, E1 protein binds to the E1 
binding domain (E1BD) of E2 and E3 binds to the E3 binding domain (E3BD) of E3BP 
(Harris, BowkerKinley et al. 1997).  
Towards the N-terminus of E2 and E3BP, there are varying numbers of lipoyl 
domains, depending on source organism or organelle. In those lipoyl domains, a 
conserved lysine residue is covalently linked to lipoic acid to form a 14 Å long 
lipoamide. The rotational flexibility of the lipoyl group coupled with the flexibility of 
alanine and proline rich inter domain linkers; creates a highly flexible arm known as a 
‘lipoyl arm’ (Reed and Hackert 1990). These arms are the real work force behind 
substrate channeling as they act as spatial intermediate mover to connect the distant 
active sites of E1, E2 and E3, which are at least 5 nm away from each other 
(Wagenknecht, Grassucci et al. 1991, Zhou, McCarthy et al. 2001). 
 
Subunits Cofactors Substrates 
Pyruvate dehydrogenase (E1) Mg
2+
 and ThDP Pyruvate, lipoamide 
Dihydrolipoamide acetyl-
transferase (E2) 




binding protein (E3BP) 









Table 1: Subunits of PDHc with their respective cofactors and substrates.  
While E1, E2 and E3 are enzymatic components of all PDHc types, E3BP is regarded to have 
lost its acetyltransferase activity. However, it’s involvement in overall catalysis of human PDHc 
will be a subject of discussion in later chapters. Overall, PDHc utilizes magnesium ions and 
vitamin derived cofactors such as ThDP, lipoate and FAD in processing pyruvate to acetyl-
CoA, which also involves CoA and NAD+.  In addition to these subunits, the eukaryotic PDHc 
also consist of regulatory proteins PDK and PDP, which are lesser in copy number and are 








1.3. Peripheral subunits of human pyruvate dehydrogenase enzyme 
complex 
1.3.1. Human pyruvate dehydrogenase (hE1)  
Human pyruvate dehydrogenase (EC 1.2.4.1) is a decarboxylase consisting of loosely 
bound thiamine diphosphate (ThDP) and magnesium ion as cofactors. It is a heart 
shaped dimer of αβ hetero dimers (Ciszak, Korotchkina et al. 2003). In humans, the 
β chain is encoded by the PDHB gene (chromosome 3) while α chain has two isoforms 
expressed in somatic cells by PDHA1 (chromosome X) and in the testes by intron less 
PDHA2 (chromosome 4) (Brown, Brown et al. 1990, Dahl, Brown et al. 1990). 
 
 1.3.1.a. Structure and mechanism  
It catalyzes the decarboxylation of pyruvate and the reductive acetylation of lipoamide 
(see Fig. 1, step 1) (Reed 1966). It possesses two active sites, one at each αβ dimer. 
The active site consists of ThDP and Mg2+ bound via several hydrogen bonds and 
metal ligation. The α subunit is responsible for binding a Mg2+ and the diphosphate 
part of ThDP whereas the pyrimidine portion is bound to β chain, thereby forming a 
catalytic site between these two chains (Ciszak, Korotchkina et al. 2003).  
Similar to other ThDP dependent enzymes, the reaction starts with an interaction of 
conserved glutamate (Glu-89, β chain) with N1’ in the pyrimidine ring which increases 
the nucleophilicity of N4’ group promoting deprotonation of C2 carbon (Kern, Kern et 
al. 1997, Fang, Nixon et al. 1998). This generates a C2-carbanion called ylide that 
attacks the carbonyl group of pyruvate forming tetrahedral lactyl-ThDP (L-ThDP) 
intermediate. The decarboxylation of L-ThDP results in hydroxyethyl-ThDP 
intermediate (a protonated form of enamine/2-α-carbanion tautomer). At this point, 
the lipoyl group from E2 or/and E3BP with oxidized dithiolane ring arrives at the active 
site. The S-8 of the lipoyl group is attacked by HEThDP carbanion while S-6 is 
protonated. It’s been proposed that conserved histidine residues perform the role of 
general acid-base catalyst to protonate the lipoyl S-6 and deprotonate α-OH of the 
HEThDP intermediate.  The ThDP returns back into the ylide form, competent again 
for processing another pyruvate molecule, once the product from first round is cleared 






Fig. 2: Crystal structure of human E1 and its catalytic mechanism. 
A heart shaped hE1 molecule is a hetero dimer of αβ dimers. An active site pocket of one of 
the dimers (cyan-pink) is enlarged to show ThDP (PDB 1NI4). A C-2 ionization in a thiazolium 
ring of ThDP (1’-4’-imino-pyrimidine tautomer) is assisted by N4’ of pyrimidine resulting in a 
biologically active ylide moiety. The substrate ‘pyruvate’ enters the active site pocket where its 
carbonyl group is attacked by C-2 carbanion. A decarboxylation step produces HEThDP 
intermediate, whose carbanion attacks the dithiolane ring of incoming lipoyl-group, producing 
S-8-acetyldihydrolipoyl, completing the reaction at E1. The acetyldihydrolipoyl group then 





The first step of PDHc reaction, which is catalyzed by E1, is the rate-limiting step for 
PDHc. For example: the rate of reductive acetylation contributes to only 1 % of the 
rate of   E. coli PDHc overall reaction, while the second major step i.e. formation of 
acetyl-CoA contributes to around 70 %, and the final step of re-oxidizing dihydrolipoyl 
group is at least 7 times faster than the overall reaction (Reed 1966). Similarly, in 
reconstituted human PDHc, the kcat for overall reaction is ~ 50-70 s-1 per active site of 
E1 while the rate constants for the steps such as the C2-ThDP ionization, formation 
of L-ThDP and subsequent decarboxylation step are much slower, with rate constants 
of 51 s-1, 2.3 s-1 and 5.1 s-1 , respectively (Seifert, Golbik et al. 2006). It has been 
proposed that once E1 proteins are organized at the exterior of the E2 core 
(prokaryote) or E2/E3BP core (eukaryote), the 3-D arrangement would enhance E1 
activity probably by an increase in favorable interactions between lipoyl groups and 
HEThDP intermediates at the E1 active site, with an aid of lipoyl arm (Reed 1966).  
 
1.3.1.b. Binding of hE1 to its cognate binding site at hE2 
hE1 is bound to the E1BD of hE2 in a one to one fashion and shows tight association 
with a low KD of 9.47 nM. This involves a key electrostatic interaction between surficial 
hE1β-D289 residue and hE2-K276 (Patel, Korotchkina et al. 2009). This pair is 
equivalent to a key interaction pair E1β-E285 with E2-R136 of the B. 
stearothermophilus PDDHc), for which the crystal structure of E1-SBD sub-complex 
has been published (Frank, Pratap et al. 2005). Two positively charged residues K137 
and R157 of bsPDHc E2 are involved in making salt bridges with C-terminal F324 
residue of bE1β chains. But unlike in bacterial counterpart, the C-terminal I329 
residue of hE1 β chain does not have any suitable partner at E1BD of hE2 to make 
salt bridges. The equivalent residues of these two positively charged residues of 
bsPDHc E2-SBD in E3BP protein of human PDHc, makes interactions with several 
residues of hE3 (Ciszak, Makal et al. 2006, Patel, Korotchkina et al. 2009). The 
absence of interaction of these residues with C-terminal residues of hE1 β chains is 
thought to confer monospecific binding between hE1 and hE2-E1BD. It is noteworthy 
to mention again that in mammalian PDHc, separate subunit binding domains are 
present in E2 and E3BP to bind E1 and E3, respectively. But in bacterial PDHc, the 
same subunit-binding domain of E2 can bind to E1 and E3 proteins in a mutually 
exclusive manner, possibly via common interaction partners K137 and R157 at 








Fig. 3: Binding of E1 β chains (magenta) with E2-SBD (cyan) in bsPDHc (PDB 1W85).  
The hE1 β chains (PDB 1NI4, yellow) are superimposed with the bsE1 β chains. The two C-
termini of hE1 β chains (I329) seem to be too far from making meaningful contact with hE2-
E1BD whereas the equivalent residues in bsE1β chains i.e. F324 can interact with K137 and 
R157 of bsE2-SBD. Adapted from (Patel, Korotchkina et al. 2009) 
 
 
1.3.2. Human dihydrolipoamide dehydrogenase (hE3)  
This enzyme is not only an exclusive partner to PDHc but also shares its utility with 
other related α-keto acid dehydrogenase complexes like α-ketoglutarate 
dehydrogenase complex and branched chain α-keto acid dehydrogenase complex, 
as well as glycine cleavage system (Carothers, Pons et al. 1989). It is encoded by 
DLD gene (chromosome 7) in human. Its primary function in all of those complexes is 
to oxidize dihydrolipoamide residue (see Fig. 1) and then, reduce NAD+ to NADH 
(Patel, Nemeria et al. 2014).  
1.3.2.a. Structure and mechanism  
hE3 (EC 1.8.1.4) is oxido-reductase with tightly bound FAD and a redox active C80-
C85 disulfide bridge, analogous to C45-C50 of E. coli E3. It is a homodimer with each 
monomer having one active site that consists of separate FAD and NAD binding 











Several works have been carried out to understand the reaction mechanism of E3 in 
detail. With series of steady and pre-steady state kinetic experiments in E3 and their 
variants (Koike, Shah et al. 1960, Argyrou and Blanchard 2001, Argyrou, Blanchard 
et al. 2002, Argyrou, Sun et al. 2003), important active site residues, intermediates 
and charge-transfer complexes (see Fig. 4) have been characterized. Earlier, JK 
Reed, and colleagues (Reed 1973), showed in rat E3 that the reaction involves ping 
pong mechanism, meaning the first substrate dihydrolipoamide residue leaves after 
its oxidation and only then second substrate NAD+ would get involved.  
In all E3 enzymes characterized so far, the reaction it catalyzes can be divided into 
reductive half and oxidative half reactions, which alternate between each other in 
every reaction cycle (Carothers, Pons et al. 1989). In the reductive half reaction, the 
reduced dihydrolipoyl-E2/E3BP binds to oxidized E3-FAD (Eox) and forms a mixed 
disulfide with the redox active disulfide bridge. The oxidized lipoyl-E2/E3BP residue 
moves away from E3, leaving two electrons reduced enzyme (EH2) whose disulfide 
is reduced but not the FAD. In an oxidative half reaction, NAD+ comes to its binding 
pocket and is thought to induce one of the thiol of disulfide to form a covalent link with 
C4 carbon of heterocyclic isoalloxazine ring of FAD (covalent C4a adduct), thereby 
reducing its N5 atom. The second thiol then attacks the first one regenerating 
disulfide, that breaks the covalent bond with FAD and in a process reduce N1 atom. 
The FADH2 thus formed, is rapidly oxidized by NAD+. The final output is an oxidized 








Fig. 4: Physiological reaction of E3.  
At the start, FAD cofactor (black, with N1 and N5 in pink and C4 in red) and intrinsic disulfide 
bridge (blue) are in the oxidized state. A reduced lipoyl group (purple) visits its active site after 
acetyl transfer to CoA in the E2 active site. The reaction proceeds with a thiolate being 
generated at the lipoyl group, which attacks an intrinsic disulfide bridge, producing a mixed 
disulfide intermediate. Next, the lipoyl moiety is reduced and leaves E3 while thiolate is 
generated at one of the cysteines of the intrinsic disulfide. Once the NAD+ substrate enters its 
binding pocket, the thiolate makes a covalent adduct at C4 with reduction of N5. Then, the 
intrinsic disulfide bridge is formed again followed by reduction of N1. The fully reduced FAD 
then reduces the NAD+ and the reaction cycle is complete with the clearance of NADH. As the 
enzyme now is in oxidized state, next reaction cycle can begin with another incoming reduced 
lipoyl moiety. 
 
In 2005, structures of hE3 in the presence of FAD and NAD+/NADH were solved 
(Brautigam, Chuang et al. 2005) (see Fig. 5).  It showed the nicotinamide base of 
NADH and not NAD+ facing the isoalloxazine ring of FAD, which was interesting 
because the hydride transfer from N5 of FADH2 to C4 atom of nicotinamide base of 
NAD+ would what produces NADH in the biological reaction. They explained that 
NAD+ would only adopt the conformation suiting to face FAD isoalloxazine ring once 
the negatively charged charge-transfer complex between C85 and FAD is formed 





(FAD and C80-C85), this possibly inclined the hydrophobic and neutral NAD binding 
pocket to better support neutral NADH. 
Fig. 5: Crystal structure of hE3 with bound FAD and NADH (PDB code 1ZMD). 
(A) The overall structure of hE3 has a sandwich topology with the active sites lying almost at 
the opposite ends. The two monomers are shown in cartoons of grey and magenta colors with 
carbon atoms of FAD in green and NADH in light blue respectively. (B) A large binding pocket 
could be seen from outside for NAD+ substrate. The nicotinamide ring of NADH is facing the 
isoalloxazine ring of FAD. (C) Opposite to the binding pocket of NAD+, a small space is 
available for dihydrolipoyl-E2 to enter, which would encounter C80-C85 disulfide (wheat) for 
electron transfer.  
 
 
1.3.2.b. Binding of hE3 to its cognate binding site at E3BP 
A crystal structure of hE3 bound to its binding site E3BD, a small domain belonging 
to E3BP, is available (Ciszak, Makal et al. 2006). E3BD makes contact with the hE3 
at the interface of its two subunits such that another E3BD cannot bind to hE3 due to 
steric hindrance. Much like bsE2-SBD (K137 and R157) interacting with the bsE1 (C-
terminal residues of β chains) (see Fig. 3), the equivalent residues in E3BD (N137 
and R155) have interacting partners at hE3, unlike in the case of hE1 where 
equivalent residues of E1BD seemed to be partnerless (Patel, Korotchkina et al. 







and combining with other hydrophobic interactions, give monospecificity of binding to 
E3BD. The hE2-E1BD lacks similar residues at equivalent positions, possibly 
disallowing it to bind hE3 (Ciszak, Makal et al. 2006, Patel, Korotchkina et al. 2009). 
The hE3-E3BD is different from the bsE3-SBD complex, as both helices (H1 and H2) 
of E3BD are involved in binding to hE3 with residues like K160 and E161 of H2. In 
bsE3-SBD however, H2 does not form any interactions with E3 protein (Mande, 




Fig. 6:  Crystal structure of hE3-E3BD complex (PDB code: 1zy8). 
A) An E3BD (pink) binds to an interface between two hE3 monomers, which is formed by C-
terminal interface domain of each monomer (brown). NAD, FAD and central domains of hE3 
are shown in cyan, green and red, respectively. (B) Some of the important interactions 
between residues of E3BD and hE3. The residues N137 and R155 of E3BD make several 
interactions with hE3 residues. The equivalent residues of E1BD are assumed not to play any 
role in binding to hE1 while they are important for bsE1 binding to bsE2-SBD. 
 
If two E3BD attempt to bind to hE3 at the same time, the rigid loop between H1 and 
H2 of E3BD is supposed to clash (Ciszak, Makal et al. 2006). However, they can bind 
to hE3 with two possible orientations at the interface between hE3 subunits. This 
supports one E3BP to one hE3 binding model from (Brautigam, Wynn et al. 2009) 
whereas other groups have reported 2:1 stoichiometry (Smolle, Prior et al. 2006, 
Vijayakrishnan, Callow et al. 2011).  Either way, the binding was shown to be very 
tight, with Kd of 0.78 nM calculated via isothermal titration calorimetry (Brautigam, 
Wynn et al. 2006) and 5.2 nM via surface plasmon resonance (Patel, Korotchkina et 








1.4. Core subunits of human pyruvate dehydrogenase enzyme complex 
1.4.1. Human dihydrolipoamide acetyltransferase (hE2)  
hE2 (EC 2.3.1.12) is an acetyl transferase which is encoded by DLAT gene located 
in the chromosome 11 in human. In all life forms, they cluster together to give rise to 
24meric cuboids or 60meric pentagonal dodecahedra (Reed 1966). Structurally it 
consists of two N-terminal lipoyl domains (LD) followed by one E1 binding domain 
(E1BD) and core forming C-terminal inner catalytic domain (IC), all interconnected via 
highly flexible linkers (see Fig. 7) (Perham 1991). The number of IC domain and E1BD 
is one in all characterized PDHc from various organisms. But the number of lipoyl 
domains can vary between species within same biological kingdom (Perham 1991, 
Yu, Du et al. 2012) (see table 2).   
Several groups have contributed in structural and functional characterization of 
domains and linkers of hE2 spanning several decades. The structure of these 
domains was solved mostly in isolation and not together as a functional unit. In the 
following sub-chapters, all the domains of hE2 are individually discussed with suitable 

















Fig. 7: Cartoon representation of modular architecture of human dihydrolipoamide 
acetyltransferase (hE2).  
The IC domains of several E2s together with similar IC domains of E3BPs form a central core 
of hPDHc. E1 protein binds to the E1BD, which is tethered to the exterior of the core by a fairly 
long linker. The lipoyl domains (LD1 and LD2) each carry a lipoyl group (green). A highly 
flexible Ala-Pro rich linker similar to that between E1BD and LD1 connects these lipoyl 
domains. (all linkers are in orange) 
 




















Table 2: Comparison of number of lipoyl domains in well-defined E2 subunits 
between different organisms.  
Although the number of lipoyl domains varies greatly between organisms, it appears that the 
trend does not follow hierarchy in taxonomy. The number of lipoyl domains does not correlate 
with the activity of E2. Furthermore, extra lipoyl domains could be deleted (genetically or 
proteolytically) without significantly reducing acetyl transferase activity of E2, suggesting 
functional redundancy. *Plant E2 mentioned in the table is mitochondrial in origin. Plastids also 


















1.4.1.a. Lipoyl domains 
hE2 has two lipoyl domains with similar primary sequences and structures (PDB 
2DNE and 1 FYC) (Howard, Fuller et al. 1998). The lipoyl domain situated at the N-
terminus part of hE2 is termed as lipoyl domain 1 (LD1) and the inner lipoyl domain 
situated between LD1 and E1BD is called lipoyl domain 2 (LD2). They are globular 
domains of around 75 amino acid residues with two sets of anti-parallel beta sheets 
each containing four β strands (PDB 2DNE and 1 FYC). They are roughly 35 Å long 
and 18 Å broad.  The conserved lysine residue, which is covalently linked to lipoic 
acid via amide linkage, lies at the loop region between β strand 4 and 5. These 
domains share structural similarity to lipoyl domains of E2 component of bacterial 
PDHc, even though the primary sequence differs by more than 50 % (Dardel, Davis 
et al. 1993, Green, Laue et al. 1995). Furthermore, the lipoyl domains of other related 
multi enzyme complexes such as alpha-ketoglutarate dehydrogenase complex and 
branched-chain alpha-ketoacid dehydrogenase complex also appear to share similar 
protein fold (Berg, Vervoort et al. 1996, Ricaud, Howard et al. 1996, Huang, Chang et 
al. 2002).  
 
 
Fig. 8:  Comparing structures of LD1 and LD2 of hE2.  
Both the primary sequences and structure of LD1 (green, PDB 2DNE) and LD2 (cyan, PDB 
1FYC) look similar. When their structures are superimposed, the lipoylation sites (K114 for 
LD1 and K241 for LD2) occupy similar space (represented as sticks at the top). The lipoamide 
group lies at the tip of lipoyl domain making it lot easier to enter the narrow active sites of hE1, 
hE2 and hE3.  
 
Lipoic acid is a derivative of octanoic acid, in which sulfur atoms are added to C-6 and 
C-8, with a possibility of ring closure giving rise to 1-2 dithiolane ring. The reduced 





chain. Deprotonation of any of the sulfur atom of dihydrolipoate forms highly 
nucleophilic thiolate ion. This can attack carbonyl carbons to form thioester bond. The 
pKa of thiols in dihydrolipoate is around 10.7 (Radda 1966) which suggests that at 
physiological pH, the generation of thiolate ion would be rare. But since lipoate group 
is covalently linked to protein, a suitable environment with strategically placed basic 
amino acid sidechain could accelerate the deprotonation of thiol to generate thiolate.  
In humans, lipoylation of proteins occur in two steps. First, an octanoyl transferase 
transfers the octanoyl group from ocatanoyl-acyl carrier protein to Ɛ-amino group of 
conserved lysine residue of lipoyl domain. In this process, an amide linkage is formed 
between lysine residue and octanoate. In the second step, lipoyl synthase enzyme 
replaces the hydrogen from C-6 and C-8 position of octanoyl group with sulfur atoms 
using two S-adenosyl methionine (SAM) molecules (Jordan and Cronan 1997, Zhao, 
Miller et al. 2003). In bacteria, there is also another pathway for lipoylation where free 
lipoic acid is added directly to lipoyl domain by lipoate protein ligase (Morris, Reed et 
al. 1994).  
One of the main advantages for an enzyme using lipoyl group as an acyl carrier in a 
multi-enzyme complex, beside its long reach of 14 Å, is its rotational flexibility. The 
lipoyl moiety was shown via electron paramagnetic resonance (EPR) spectroscopy to 
have a small rotational correlation time of 0.2 ns in E. coli PDHc (Ambrose and 
Perham 1976) and 0.18 ns in A. vinelandii PDHc (Ambrose and Perham 1976). It was 
proposed that it can rotate freely and rapidly in all direction from its anchoring point at 
peptide chain. Adding to that the flexible inter-domain linkers, we get extensions 
emanating from the core that are virtually free to move in all directions.  
Free lipoate and lipoamide easily can serve as a substrate for E2 and E3, which 
means the recognition of lipoyl group is enough for catalysis in those enzymes. But in 
the case of E1, these molecules are poor substrates with kcat/Km reduced by 20000 
fold in comparison to lipoylated lipoyl domain as a substrate (Graham, Packman et al. 
1989). This suggests lipoyl group is not the only entity, which is recognized at bacterial 
E1, but interactions between residues, possibly at the contact region between E1 and 
lipoyl domain, are also important.  
However, one thing that is yet to be explained is the mechanism of acetyl and electron 
pair transfer between lipoyl domains. In a study where 90% of E1 active sites in E. 
coli. PDHc were inactivated using thiamine thiazolone pyrophosphate (an analog of 
ThDP), all the lipoyl domains were still found to be acetylated (Collins and Reed 





increase suggesting the E1s are tightly bound and cannot possibly hop around to 
acetylate distant lipoyl domains. Similarly, in a theoretical model explaining 
experimental observations of change in activity vs E1:E2 molar ratio, it was found that 
one E1 protein must be serving at least 12 E2 chains in octahedral E. coli. PDHc 
(Bates, Danson et al. 1977). These studies confirmed that there must be an extensive 
inter lipoyl acetyl transfer network, as it’s physically impossible for single E1 to serve 
so many E2 chains at once. This networking is thought to aid in overall activity even 
when the PDHc core is not saturated with E1 and E3 proteins or when the pyruvate 
level is depleted. But the mechanism for such transfer is not explained in any detail. 
Also no data is available regarding the favorable orientation of such lipoyl domains 
coming into contact.  
This also brings us to another intriguing fact about lipoyl domain, which is its copy 
number in E2 from various organisms (see Table 2). It is still an open question why 
nature chose variable number of lipoyl domains when just a single copy can do the 
job. Genetic experiments carried out in E. coli PDHc demonstrated that the three lipoyl 
domains of its E2 could be mutated or deleted in any order, keeping at least one 
normal domain without altering the viability of the cell culture (Guest, Lewis et al. 1985, 
Allen, Perham et al. 1989). Prior to these comprehensive experiments, protease and 
lipoamidase were used to decrease active lipoyl content in E. coli PDHc, where it was 
shown that even when 50 % active lipoyl content is destroyed, it does not significantly 
reduce overall activity of PDHc and related α-ketoglutarate dehydrogenase complex. 
Computational models were built to best explain these observations, which again 
pointed toward extensive networking between lipoyl domains to transfer acetyl group 
or electron pairs. This mechanism was termed as multiple random coupling (MRC) 
and is assumed to be one of the bases of substrate channeling in all PDHc (Stepp, 
Bleile et al. 1981, Stepp, Pettit et al. 1981, Hackert, Oliver et al. 1983, Hackert, Oliver 
et al. 1983). Similar observations have also been made on mammalian PDHc, when 
a collagenase was used to selectively remove lipoyl domains from PDHc-E2 
(Rahmatullah, Radke et al. 1990). If at least one lipoyl domain was left for E2, it could 
support 100 % PDHc activity. But, if both lipoyl domains were removed, only < 20 % 
activity would remain, possibly due to the presence of lipoyl domain from E3BP. 
However, there are also E2s in nature with only one lipoyl domain and thus, MRC 
could also be a mere consequence of the presence of multiple lipoyl domains in a 







There are two linkers associated with lipoyl domains in human PDHc. An outer linker 
connects LD1 and LD2 whereas inner linker connects LD2 with E1BD. A relatively 
short linker connects E1BD to the core (see Fig. 9). The importance of such linkers 
was highlighted in a study of an engineered E. coli PDHc E2 with only one lipoyl 
domain. Shortening of the linker region between lipoyl domain and SBD reduced the 
overall activity, which was suggestive of the critical role of its length in helping lipoyl 
domain to reach active sites of E1, E2 and E3 (Miles, Guest et al. 1988).  What is 
characteristic regarding all these linkers are that they are extremely rich in proline and 
alanine residues (~ 40 % of total constituents). This gives them lots of flexibility, which 
is thought to be important for movement of lipoyl domains to all the catalytic sites. The 
direct proof for this came from the proton NMR experiment where a histidine residue 
was introduced via point mutation in the linker region between lipoyl domain and SBD 
of similar construct used in experiment mentioned above (Texter, Radford et al. 1988). 
The mutated version produced two sharp resonances in 1H NMR spectra at the 
aromatic region, which was absent for wild type PDHc. The chemical shifts of those 
sharp peaks (7.94 and 7.05 ppm) are characteristics of C-2 and C-4 protons of 
histidine residue. An apparent pKa of 6.4 was calculated for the side chain of this 
histidine. All in all, this made it clear that the newly added histidine is exposed to 




















Fig. 9: Comparing linker regions of hE2.  
All three linker regions constitute high number of alanine and proline residues. The peptide 
chains selected here are between globular domains (LD1, LD2 and IC domain from human 
PDHc and E1BD by comparing to SBD from bsPDHc).      
 
1.4.1.c. E1 binding domain (E1BD) 
It is a very small domain (35 amino acyl residues) making contact with E1 β chains 
(refer Section1.3.1.b.). The structure of E1BD has not been solved for human PDHc 
and thus comparative study with bacterial PDHc E2-SBD and E3BD from human 
E3BP is useful. Secondary structure prediction shows that they all might share similar 
structure (see Fig. 10). E1BD and E3BD diverged from SBD of prokaryotic PDHc 
during the course of evolution and lost ability to bind to E1 and E3 in a mutually 
exclusive manner. But instead they developed monospecificity towards these 
peripheral proteins. Albeit inconclusive, the orientation of E1BD could dictate where 
the two active sites of E1 proteins face, towards core or away from it. This may 
influence feasibility for lipoyl domains to visit those active sites (Zhou, McCarthy et al. 
2001). It is important to note that E1 proteins like many other ThDP dependent 
enzymes, show half of the sites reactivity meaning only one active site remain 









Outer linker:  168 GKPEDIEAFKNYTLDSSAAPTPQAAPAPTPAATASPPTPSAQAP
                   GSSYPPH 218 
Inner linker:  295 EKEADISAFADYRPTEVTDLKPQVPPPTPPPVAAVPPTPQPLAP 
                   TPSAPCPATPAGPKGRVFVS 358 
Linker between         







Fig. 10: Sequence alignment between E1BD and E3BD of human PDHc with SBD of 
B. stearothermophilus PDHc.  
Although the sequences have < 20 % identity, there are ~ 60 % of similar residues (Red-
identical, Blue-same in two sequence and Green-similar in all). The secondary structure 
prediction of E1BD by PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred) yields two helices with high 
confidence, which is comparable to crystal structures of hE2-E3BD and bsE2-SBD. They also 
have two helices (α1 and α2) joined by a long linker.  
 
1.4.1.d. Inner catalytic (IC) domain 
Also known as core forming domain, it is responsible for oligomerization of hE2 
proteins. In human PDHc, such aggregation provides a pentagonal dodecahedron 
framework onto which hE1 and hE3 proteins join in and altogether, form a huge 
assembly with molecular weight of ~ 10 MDa. This dodecahedral core is formed by 
twenty trimers made up of hE2 and E3BP, which share similar modular architecture 
of E2. Such trimers are located at the vertices of the dodecahedron resulting in twelve 
pentagonal empty openings.  
In all the available structural models of the PDHc core from various organisms, the 
internal interactions in the monomer are similar and the N-terminal arm makes several 
hydrophobic and hydrogen bond interactions with the body of another monomer within 
a trimer (Mattevi, Obmolova et al. 1992, Yu, Hiromasa et al. 2008, Wang, Nemeria et 
al. 2014). The C-terminal residues of monomers linking two trimers make contact with 
each other at their hydrophobic pockets, like a ‘ball and socket joint’ creating higher 
order structure from trimers. Furthermore, it was predicted that minor changes in the 
positioning of amino acid residues at the contact point should suffice in changing the 
symmetry of PDHc cores between cuboidal in gm-negative bacteria and 





Yu, Hiromasa et al. 2008). Following Euclidean geometric principle, a dodecahedral 
core could be constructed from cubic one, by first increasing the distance between 
centers of the core to trimers, such that the edges of cube and dodecahedron become 
same and then rotating the trimer to make monomeric components face the edges of 
the dodecahedron. This concept was validated using examples from crystal structures 
of cubic core of PDHc of A. vinelandii and dodecahedral one from 
B. stearothermophilus (Izard, Aevarsson et al. 1999). 
Irrespective of the symmetry though, each monomeric unit possess one catalytic site 
where an acetyl group is transferred from S8-acetyldehydrolipoyl group to CoA. This 
catalytic site is a long tunnel (~ 30 Å), at the interface between two monomers of a 
trimer unit. The CoA substrate first enters inside region of this tunnel probably via 
pentagonal openings, whereas the S8-acetyldehydrolipoyl group arrives from outside 
the core (Mattevi, Obmolova et al. 1992, Wang, Nemeria et al. 2014).  
While comparing crystal structures of binary complexes of A. vinelandii PDHc core 
with CoA (IN conformation) and dihydrolipoamide, the thiols from both molecules, 
were shown to be at close proximity to catalytic histidine residue (Mattevi, Obmolova 
et al. 1993). This residue is part of a conserved DHRXXDG motif present in all acetyl 
transferases and is thought to play a role of general acid-base catalyst in 
deprotonation of CoA thiol to form thiolate anion that attacks carbonyl in S8-
acetyldehydrolipoyl group. However, in a same study, a crystal structure of a tertiary 
complex between A. vinelandii PDHc core, CoA and dihydrolipoamide was also 
determined, in which thiol of CoA (OUT conformation) was pushed to ~ 12 Å away 
from active site residues. In a separate study on dihydrolipoamide acetyl transferase 
(E2) from bovine branched chain α-ketoacid dehydrogenase complex (Kato, Wynn et 
al. 2006), it was shown that in the presence of CoA, the affinity of the core to the 
dihydrolipoamide or dihydrolipoamide-lipoyl domain is significantly increased from 
undetectable to 48 µM and 11 µM, respectively. Based on this, they proposed a gating 
mechanism in which, CoA binding triggers the opening of an entrance gate for acetyl-
dihydrolipoamide (see Fig. 11). After acetyl transfer, once the dihydrolipoamide 
leaves, the gate shifts back to its closed conformation. Conforming to this model, a 
residue (D228) proposed to be crucial for stabilizing open state was mutated.  
Afterwards, dihydrolipoamide could not bind to the core even in the presence of CoA. 
Similarly, when a residue (L293) important for stabilizing closed state was mutated; 






Fig. 11: A general model of gating mechanism for entry of acylated-lipoamide in a 
dihydrolipoamide acyltransferases (E2) of α-keto acid dehydrogenase complexes.  
In the absence of substrates, the gate remains closed (A). When CoA enters a long active site 
tunnel from inside of the core, the gate at the other end opens (B). The acylated lipoyl moiety 
can then enter the active site from outside the core (C). Upon acyl transfer, the dihydrolipoyl-
group leaves the active site, and the gate closes again (D). The conserved histidine residue 
(His´) is used as a general acid-base catalyst, which is contributed from another monomer of 
a same trimeric unit. Another well-conserved residue is a serine (Ser), which stabilizes 
tetrahedral intermediate formed after attack of thiolate of CoA on carbonyl of acyl-lipoyl group.   
 
1.4.2. Human dihydrolipoamide dehydrogenase binding protein (E3BP) 
E3BP, formerly known as protein X, is only present in eukaryotic PDHc (Demarcucci 
and Lindsay 1985, Jilka, Rahmatullah et al. 1986).  It is involved in forming the core 
with E2 and binding to E3 protein (Gopalakrishnan, Rahmatullah et al. 1989, 
Rahmatullah, Gopalakrishnan et al. 1989, Roche, Rahmatullah et al. 1989). It has 
similar modular architecture to hE2, with only one lipoyl domain (Neagle, Demarcucci 
et al. 1989) and E3 binding domain (E3BD) instead of E1BD. Although the structure 
of lipoyl domain of E3BP has not been solved, it should be similar to LD1 and LD2 of 
hE2, since they share high sequence similarity of ~ 45 % (Harris, BowkerKinley et al. 
1997). Flexible linkers much like in the case of hE2 connect domains in E3BP. The 







Fig. 12: Cartoon representation of modular architecture of human E3BP and 
sequences of associated inter domain linkers.   
Similar to hE2, E3BP possess core forming IC domain but is catalytically inactive. E3BD lies 
between IC domain and N-terminal lipoyl domain (LD). The inter domain linkers (orange) are 
rich in proline and alanine with an exception being the linker between LD and E3BD which 
does not have any alanine residues. Nevertheless, the high proline content means that it 
should still be flexible. 
 
The C-terminal part is a core-forming domain, which shares 50 % sequence identity 
with IC domain of hE2 (Harris, BowkerKinley et al. 1997). While hE2 can be 
recombinantly overexpressed and purified in the absence of E3BP, yielding 60meric 
dodecahedral core, successful overexpression of E3BP in the absence of hE2 has 
not been reported thus far. An artificial hE2 core however cannot form fully functional 
PDH complex, as it cannot bind to E3 proteins (Yang, Song et al. 1997).  
E3BP is not expected to have acetyltransferase activity as the conserved histidine in 
DGRXXDG motif present in all acetyl transferase, is mutated to serine residue (Harris, 
BowkerKinley et al. 1997). But it can still take part in the PDHc overall reaction since 
its lipoyl domain is shown to be lipoylated and also reductively acetylated in the 
presence of pyruvate (Demarcucci, Hodgson et al. 1986). Also, selective removal of 
lipoyl domain of E3BP did not abolish the overall PDH activity (~ 80 % remaining) in 
a bovine PDHc, which meant its function, can be easily overtaken by lipoyl domains 
of E2 (Neagle and Lindsay 1991). However, as mentioned in section 1.4.1.a, the role 
reversal for lipoyl domains of E3BP and E2 might not be fine for both ways, as when 
only lipoyl domains of E3BP were left functional, it could only sustain 10 % - 20 % 
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LD and E3BD:   133 EGEDWKHVEIPKDVGPPPPVSKPSEPRPSPEPQISIP 
                   VKKEHIPGTLRFRLS 185 
Linker between 
Core and E3BD: 223 KQTGKITESRPTPAPTATPTAPSPLQATAGPSYPRPV 





overall PDHc activity in mammalian PDHc. Thus, MRC mechanism (refer Section 
1.4.1.a.) explained for E2 might also be extended to the E3BP lipoyl domains. 
 
1.5. Organization of the human PDH complex 
Until the discovery of E3BP protein, it was imagined that eukaryotic PDHc core like in 
prokaryotic version, is also organized solely by E2 proteins. After electron microscopic 
investigation of eukaryotic PDHc (Hayakawa, Kanzaki et al. 1969, Reed 1974), it was 
established that the core of eukaryotic PDH complex has similar dodecahedral 
symmetry to that from gram-positive bacteria (Henderson, Perham et al. 1979). The 
copy number of E2 was assumed to be 60, with 20 trimers occupying 20 vertices of 
pentagonal dodecahedron.      
Once E3BP (Protein X) was proven to be an quintessential part of eukaryotic PDH 
complex, due to its affinity to aggregate with E2 component and also capacity to bind 
to E3 proteins, a discussion started for the localization of E3BP in PDH complex. The 
first model to emerge was 60+12 ‘addition model’ where 12 E3BP monomers were 
put at the 12 pentagonal openings of the 60meric E2 core (Gopalakrishnan, 
Rahmatullah et al. 1989, Maeng, Yazdi et al. 1994, Stoops, Cheng et al. 1997). Later, 
it was found mainly via sedimentation equilibrium studies that the E2/E3BP core was 
smaller in molecular weight than artificial E2 core lacking E3BP (Hiromasa, Fujisawa 
et al. 2004, Vijayakrishnan, Kelly et al. 2010). Also, the electron microscopic structure 
of human PDHc core lacked any density at the pentagonal openings supposed to be 
the location of E3BP (Vijayakrishnan, Kelly et al. 2010). This meant the native 
E2/E3BP core does not follow 60+12 model. Rather it appeared that E3BP proteins 
would substitute equivalent number of the E2 proteins in the core (‘substitution 
model’).  
Problem then arose in assigning the copy number of E3BP and E2 in the core, as 
several groups published conflicting results. Some studies show 12 E3BP proteins to 
be present in eukaryotic PDHc core along with 48 E2 proteins (48+12 substitution 
model) (Hiromasa, Fujisawa et al. 2004) while others have reported stoichiometry of 
40 E2 and 20 E3BP proteins (40+20 substitution model) (Brautigam, Wynn et al. 
2009). One study even demonstrated the discrepancy in the stoichiometry of E2 to 
E3BP between native mammalian PDHc core (48+12 model) and recombinantly 





The first reason why stoichiometry of the core components is important is that based 
on stoichiometry, location of E3BP could be better resolved. For example, if 40+20 
model is true, then, it can be imagined that all trimer elements are same, consisting 2 
E2 and 1 E3BP each. Second important reason why this is important is that the copy 
number of hE2 and E3BP also dictate number of hE1 and hE3 that can bind to the 
core.  
While there is a consensus in one hE2 binding to one hE1 via its E1BD (Brautigam, 
Wynn et al. 2009), E3BP binding to hE3 is not straightforward. Although in the crystal 
structure of E3BD-hE3 sub-complex, one E3BD is seen to bind with only one hE3 
protein (Ciszak, Makal et al. 2006), possibility of 2 E3BPs binding to one hE3 in 
solution has been proposed by other groups using small angle X-ray scattering 
(SAXS), isothermal titration calorimetry (ITC) and analytical ultracentrifugation (AUC) 
techniques (Smolle, Prior et al. 2006, Vijayakrishnan, Callow et al. 2011). However, 
using similar techniques, another group got different result, one that supports the 
crystal structure (Brautigam, Wynn et al. 2006, Brautigam, Wynn et al. 2009).  
From the electron microscopic studies, the E1 and E3 proteins have been localized 
at the periphery of the core in bacterial PDHc (Milne, Shi et al. 2002, Milne, Wu et al. 
2006) anchored by the linkers. However, for mammalian PDHc, only E1 have been 
observed at the periphery (Wagenknecht, Grassucci et al. 1991, Zhou, McCarthy et 
al. 2001) and E3’s position is in debate. Both, models for E3 proteins localized near 
the pentagonal openings of the core (Stoops, Cheng et al. 1997, Zhou, McCarthy et 
al. 2001) or distant from the core like E1 (Hiromasa, Fujisawa et al. 2004), are 
available in the literature.  
 
1.6. Conformational plasticity of PDHc core 
The functioning of a protein also depends in its dynamics. Very fast thermal fluctuation 
at pico-second scale, as well as domain movements and associated global 
conformational changes occurring at slower millisecond regime, all contribute to the 
flexibility of protein (Hammes 1964, Mccammon, Gelin et al. 1977, Hay and Scrutton 
2012). Just by looking at the reaction scheme of PDHc (see Fig. 1), it is self-
explanatory that the lipoyl arm must have certain reach and be extraordinarily flexible 
for lipoyl domains to visit three different active sites (details in section 1.4.1.b.).  
Another important dynamic feature of PDHc complex is the size variation of its core, 





et al. 2001). It was found that the size of yeast PDHc core could vary by ~ 4 nm 
between smallest and largest cores in a same population, which corresponds to 1.4 
nm changes in length of inter trimer bridges. It was proposed that such size variation 
is possible due to relaxation and stretching of inter trimer linkage (see Fig. 13). This 
phenomenon, which is termed as ‘breathing’, has also been observed in human PDHc 
cores (Yu, Hiromasa et al. 2008). Based on the size distribution and treating the cores 
as harmonic oscillator, the effective spring constant of such cores has been computed 
to be 0.015 N/m (Kong, Ming et al. 2003) which makes them roughly 10 times softer 
than other regular globular proteins (Zaccai 2000). This inherent softness allows the 
spontaneous expansion and contraction of the inter trimer linkage with small thermal 
energy. Although, speculations have been made on possible role of such dynamics 














Fig. 13: Breathing motion of PDHc core. 
Adapted from (Kong, Ming et al. 2003). A trimer of PDHc core component (black triangle) with 
S- shaped inter trimer bridge (blue) along the edges of a dodecahedron (dashed line) rotates 
spontaneously (orange triangle) such that the bridges are radially stretched following the 
trimer. It causes the global expansion of the core, which is as much as 20 % of the original 
size. In a reversible manner, it relaxes and the cycle of expansion and contraction continues 
which is assumed to be thermally driven process. 
 
1.7. Regulation of the activity of human PDH complex and health 
implications 
As PDH complex lies at the junction between glycolysis and Kreb’s cycle, almost 50 
% of the food source is broken down and passed through PDH complex in a respiring 
cell. Hence, it is imperative to check and balance its activity, as the demand for energy 
can dramatically change between dormant and active states of a cell and organism 
or their healthy and diseased states. Both prokaryotic and eukaryotic PDH complexes 
are prone to inactivation by its products NADH and acetyl CoA. These ensure that 
there is at least a metabolic check to decrease PDH activity when energy requirement 
is less.  
Another way to regulate the PDHc activity is reversible phosphorylation of pyruvate 
dehydrogenase (E1) component. The phosphorylation is done by pyruvate 
dehydrogenase kinase (PDK), which inhibits E1 while de-phosphorylation is 





inhibition (Harris, Bowker-Kinley et al. 2002, Patel and Korotchkina 2006). There are 
several organisms (both prokaryote and eukaryote), which possess PDK/PDP, and 
also putative phosphorylation sites at E1, yet, there are no evidences of E1 
phosphorylation. For example, among fungi, S. cerevisiae lacks this phosphorylation 
mechanism but is present in N. crassa (Patel and Korotchkina 2006). 
In humans, there are three phosphorylation sites at E1 alpha subunits, which are Ser-
264 (site 1), Ser-271 (site 2) and Ser-203 (site 3). There are four known isoforms of 
PDK (1, 2, 3 and 4) and two isoforms of PDP (1 and 2). Site 1 and site 2 can be 
phosphorylated by all the PDKs but site 3 is exclusively phosphorylated by PDK1 
(Korotchkina and Patel 2001). Phosphorylation of site 1 (most important one) or its 
mutation to glutamate and aspartate, severely impair pyruvate binding and reductive 
acetylation of lipoyl-E2 (Seifert, Ciszak et al. 2007, Kato, Wynn et al. 2008). The site 
1 is located near the substrate channel. As such, addition of negatively charged bulky 
group like phosphate would hinder the entry of pyruvate and lipoyl-hE2. The 
phosphorylation of other sites is supposed to affect ThDP binding to hE1 (Korotchkina 
and Patel 2001). PDP 1 and 2, when necessary relieve inactivation by 
dephosphorylating the phosphorylated sites. 
Adding to phosphorylation/dephosphorylation, which are known for decades, recent 
studies have revealed much more complexity in hPDHc regulation. Acetyl coenzyme-
A acetyl transferase 1 (ACAT1) and Sirtuin 3 (SIRT3) have been found to be involved 
in lysine acetylation/deacetylation of PDP and hE1, affecting the ability of PDP and 
PDK to stay bound to hPDHc (Fan, Shan et al. 2014). Sirtuin 4 (SIRT4) has been 
demonstrated to delipoylate the hE2-lipoyl domains of hPDHc, which is supposed to 
play role in glutamine metabolism (Mathias, Greco et al. 2014).     
Recent novel findings in regulatory pathways of hPDHc bear several health 
implications, especially in cancer biology. All of the negative regulations mentioned 
above are enhanced in tumor cells to stop carbon flow to cellular respiration. This, in 
turn, decrease production of reactive oxygen species, a side product of electron 
transport chain and an activator of apoptotic pathways (Chernyak 1997). Activation of 
PDP or deactivation of PDK was shown to maintain oncogene induced cell 
senescence, and also abolish established tumors (Kaplon, Zheng et al. 2013). Hence, 
engineering drugs that will target pathways of PDK/PDP inactivation/activation might 
provide a simpler treatment to cancer patients in the future. So far, few compounds 
like dichloroacetate (potent inhibitor of PDK) have been explored in pre-clinical in-vitro 





carried out yet, due to its neurotoxicity and other severe side effects (Michelakis, 








The first priority of this thesis work was to obtain high-resolution structure of the 
hPDHc core via cryo-EM.  The only such model published so far for hPDHc core was 
of truncated E2 core with cryo-EM map at mere 9 Å resolution. The core was shown 
to be dynamic as it undergoes rhythmic expansion and contraction and the motion 
termed as breathing. Although it was predicted that this motion has role in PDHc 
catalysis, especially in substrate channeling, no proof have ever been documented.  
One of its substrates, ‘coenzyme A', was used to see if its binding induces any change 
in the conformations of E2 and E3BP. The idea stemmed from our multiple 
observations during routine laboratory work that CoA stabilize the integrity of the 
hPDHc core and also E. coli PDHc. Various biophysical techniques such as atomic 
force microscopy (AFM), small angle X-ray scattering (SAXS) and direct stochastic 
optical reconstruction microscopy (dSTORM) were employed to see if size distribution 
of the core changes upon CoA binding.  
Cross-linking mass spectrometry was used to directly track movement of lipoyl 
domains in the functional hPDHc in CoA bound and unbound state. This would give 
snap shots of where and how lipoyl arm moves. Is the lipoyl arm movement stochastic 
as predicted by multiple random coupling mechanism or do key events in catalysis 
somehow dictate which active site lipoyl domain should preferentially visit? An answer 
for this might stimulate further discussion on its mode of function.  
Also, the stoichiometry between hE3 and E3BP in the sub-complex as well as 
between E2 and E3BP in a core needed further elucidation. An ITC method was used 
to discriminate between 40:20 model versus 48:12 model for the hE2 and E3BP 
stoichiometry in the core.  Also, 1 E3BP binding to 1 hE3 dimer versus a monomer 
models were evaluated. Neg-staining EM and native-MS were used to complement 
ITC in understanding the arrangement of core subunits and peripheral proteins.  
An ultimate goal for me during this thesis work was to model human PDH complex 
architecture and its inherent dynamics using multiple biophysical approaches and to 
probe their respective influence in its function.  
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Acetic acid Carl Roth, Karlsruhe 
Acrylamide (30 %) Carl Roth, Karlsruhe 
Agar AppliChem, Darmstadt 
Agarose AppliChem, Darmstadt 
Ammonium hydrogen carbonate Carl Roth, Karlsruhe 
Ammonium chloride AppliChem, Darmstadt 
Ammonium sulfate AppliChem, Darmstadt 
Antifoam 204 Sigma-Aldrich, Munich 
BisTris AppliChem, Darmstadt 
Bromophenol blue, sodium salt AppliChem, Darmstadt 
Carbenicillin, disodium salt AppliChem, Darmstadt 
Chloramphenicol AppliChem, Darmstadt 
Coenzyme A trilithium salt dihydrate AppliChem, Darmstadt 
Coomassie-Brilliant-Blue R-250 AppliChem, Darmstadt 
Dimethylsulfoxide Sigma-Aldrich, Munich 
Dithioerythritol (DTE) AppliChem, Darmstadt 
Dithiothreitol (DTT) AppliChem, Darmstadt 
2,6-Dichlorophenolindophenol (DCPIP) Merck KgaA 
Ethanol Nordhauser Spirituosen GmbH  
Ethidium bromide Carl Roth, Karlsruhe 
Ethylenediaminotetraacetic acid (EDTA) AppliChem, Darmstadt 
Ethanol Sigma-Aldrich, Munich 
Flavin adenine dinucleotide (FAD) 
disodium salt 2-hydrate 
Sigma-Aldrich, Munich 
Flavin adenine mononucleotide (FMN) 
monosodium salt 2-hydrate 
Sigma-Aldrich, Munich 
D-Glucose Carl Roth, Karlsruhe 
Glutaraldehyde Sigma-Aldrich, Munich 
Glycerol (anhydrous) AppliChem, Darmstadt 
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Glycerol (87 %) AppliChem, Darmstadt 
Glycine AppliChem, Darmstadt 
4-(2-hydroxyethyl)-1-piperazine 
ethanesulfonic acid  
AppliChem, Darmstadt 
Hydrochloric acid (37 %) Th.Geyer GmbH and CoKG  
Imidazole AppliChem, Darmstadt 
IPTG AppliChem, Darmstadt 
Isopropanol AppliChem, Darmstadt 
Kanamycin sulfate Carl Roth, Karlsruhe 
D-Lactose 1-hydrate AppliChem, Darmstadt 
 (+/- )-α-Lipoic acid Sigma-Aldrich, Munich 
Magnesium acetate tetrahydrate AppliChem, Darmstadt 
Magnesium chloride, hexahydrate Carl Roth, Karlsruhe 
Magnesium sulfate, hydrate Carl Roth, Karlsruhe 




Methanol Sigma-Aldrich, Munich 
Nicotineamide adenine dinucleotide 
(NAD+) 
AppliChem, Darmstadt 
Phenyl methane sulfonyl fluoride (PMSF) AppliChem, Darmstadt 
Phosphoric acid (85 %) Carl Roth, Karlsruhe 
Polyethylenglycol (PEG)-3350 Hampton Research Corp, CA  
Polyethylenglycol (PEG)-6000 CALBIOCHEM, San Diego  
Polyethylenglycol (PEG)-6000 Carl Roth, Karlsruhe 
Potassium chloride Carl Roth, Karlsruhe 
Potassium dihydrogen phosphate Carl Roth, Karlsruhe 
Potassium hydroxide AppliChem, Darmstadt 
Sodium dodecyl sulfate (SDS) AppliChem, Darmstadt 
Sodium chloride AppliChem, Darmstadt 
Sodium hydroxide AppliChem, Darmstadt 
D-Sucrose AppliChem, Darmstadt 
SYPRO Orange protein stain BioRad GmbH, Munich 
N,N,N´,N´- Tetramethylethylenediamine  Carl Roth, Karlsruhe 
Thiamine hydrochloride AppliChem, Darmstadt 
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Thiamine diphosphate Sigma-Aldrich, Munich 
Tris AppliChem, Darmstadt 
Trypton Carl Roth, Karlsruhe 
Yeast Extract Carl Roth, Karlsruhe 




E. coli culture  
Autoclave Zirbus, Bad Grund 
Biofermenter, Biostat C Sartorius AG, Göttingen 
Incubation shaker, Unitron Infors AG, Bottmingen 
Laminar flow Prettl-Telstar Bio-II-A Telstar, Terrasa, Spain 
  
Cell Disruption  
Microfluidizer, M-110S Microfluidics (Newton, MA, USA) 
Mortar Grinder RM 200 Retsch GmbH, Haan 
  
Centrifuge and its accessories  
AvantiTM HP-30I Beckmann Coulter GmbH, 
Krefeld 
Rotor JA-10 Beckmann Coulter GmbH, 
Krefeld 
Rotor JA-30.50 Ti Beckmann Coulter GmbH, 
Krefeld 
AvantiTM J-20 XPIJA-20 Beckmann Coulter GmbH, 
Krefeld 
Rotor JLA-8.1000 Beckmann Coulter GmbH, 
Krefeld 
Centrifuge bottle assemblies 
(polypropylene) 
Beckmann Coulter GmbH, 
Krefeld 
Eppendorf 5810 R Eppendorf AG, Wasseling-
Berzdorf 
Rotor A-4-81 Eppendorf AG, Wasseling-
Berzdorf 
Micro 200 Hettich GmbH & Co. KG  
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Rotor 2424B Hettich GmbH & Co. KG  
Qik spin Edwards Group Pty. Ltd., 
Australia 
OptimaTM L-90K ultracentrifuge Beckmann Coulter GmbH, 
Krefeld 
Rotor SW40 Ti Beckmann Coulter GmbH, 
Krefeld 
Rotor SW60 class GH Beckmann Coulter GmbH, 
Krefeld 
Centrifuge tubes for SW 40 and SW 60 Seton Scientific, Petaluma, USA 
Universal 320 R  Hettich GmbH & Co. KG  
Rotor 1420 A/B Hettich GmbH & Co. KG  
Rotor 1617 A Hettich GmbH & Co. KG 
Rotor 1620 A Hettich GmbH & Co. KG 
  
Liquid chromatography  
Äkta prime plus GE Healthcare Europe, Munich 
Äkta purifier GE Healthcare Europe, Munich 
HiPrepTM 26/10 desalting GE Healthcare Europe, Munich 
HisTrapTM FF 5 ml GE Healthcare Europe, Munich 
SuperdexTM 75 HiLoadTM 16/60 prep 
grade 
GE Healthcare Europe, Munich 
SuperdexTM 200 HiLoadTM 16/60 prep 
grade 
GE Healthcare Europe, Munich 
Superloop (50 ml, 150 ml) GE Healthcare Europe, Munich 
Frac-920 fraction collector GE Healthcare Europe, Munich 
  
UV-VIS spectroscopy  
NanoDrop Thermo Scientific, USA 
UV-Vis spectrometer, V-630 Jasco GmbH, Gross-Umstade 
UV-Vis spectrometer, V-650 Jasco GmbH, Gross-Umstade 
Precision cuvettes, suprasil Hellma GmbH & Co. KG, 
Mühlheim 
  
Isothermal Titration Calorimetry  
iTC200 Microcalorimeter MicroCal, Northampton, USA 
 




(Department of Structural Dynamics, 
Max Planck Institute for Biophysical 
Chemistry, Göttingen) 
 
TEM CM200 FEG Philips 
TEM Titan Krios FEI Company 
Vitrobot FEI Company 
Copper EM grids Plano 
  
Atomic Force Microscopy 
(Third Institute of Physics, Georg-
August-University Göttingen) 
 
Asylum MFP3D Oxford Instruments Asylum 
research, Wiesbaden 
Cypher S Oxford Instruments Asylum 
research, Wiesbaden 
Nanotec AFM Nanotec Electronica, 
Madrid,Spain 
BL-AC40TS-C2 micro cantilever Olympus 





Small Angle X-ray Scatterring (SAXS) 
(Research Group: Nanoscale Imaging 
of Cellular Dynamics, Georg-August-
University Göttingen ) 
 
Pilatus 100K detector Dectris, Baden, Switzerland 
Hecus S3-MICROpix camera system SWAXS version, Hecus X-ray 
Systems 
iMOXS X-ray source IfG - Institute for Scientific 
Instruments GmbH 
Glass capillaries Hilgenberg GmbH 




8-well imaging chamber Sarstedt, Nümbrecht 
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Mass spectrometry  
Orbitrap Fusion Tribrid Mass 
Spectrometer 
         Thermo Scientific 






DNase AppliChem, Darmstadt 
FastAP (Thermosensitive alkaline 
phosphatase) 
Thermo Fisher Scientific, 
Braunschweig 
Lysozyme AppliChem, Darmstadt 
Phusion® high fidelity DNA polymerase Thermo Fisher Scientific, 
Braunschweig 
Restriction endonucleases Thermo Fisher Scientific, 
Braunschweig 
T4-DNA-Ligase Thermo Fisher Scientific, 
Braunschweig 




Thermolysin  SigmaAldrich, Munich 
  
Bacterial strains  
E. coli BL21 (DE3) In-vitrogenTM, Karlsruhe 
E. coli BL21 StarTM (DE3) In-vitrogenTM, Karlsruhe 
E. coli DH5α In-vitrogenTM, Karlsruhe 
E. coli SoluBL21 (DE3) In-vitrogenTM, Karlsruhe 
E. coli Top 10 In-vitrogenTM, Karlsruhe 
XL1-Blue Stratagene, Heidelberg 
M15 QIAGEN 
  
Plasmids and vectors  
pET28a Novagen, Schwalbach/Ts. 
 
Materials and methods 
49 
 
pET28a-hE2 GeneArt, ThermoFisher 
Scientific  
pET28a-hE3 GeneArt, ThermoFisher 
Scientific, Braunschweig 
pET28a-His-eGFP-hE2 GeneArt, ThermoFisher 
Scientific, Braunschweig 
pET28a-KD-hE2 (catalytic domain) Dr. Kathrin S. Tittmann 
pET28a-SNAP-hE2 SNAP construct kindly received 
from Prof. Stefan Jakobs, 
MPIBPC 
pET28a-His-hE2 Sub-cloning by self 
pPDHE2/E3BP Prof. Mulchand Patel 
pQE-9-6HE1alphaE1beta Prof. Mulchand Patel 
  
Kits and solutions  
GC-buffer Thermo Fisher Scientific, 
Braunschweig 
HF-buffer Thermo Fisher Scientific, 
Braunschweig 
dNTP mix (10 mM) Thermo Fisher Scientific, 
Braunschweig 
NucleoSpinTM Plasmid kit Macherey Nagel, Düren 
NucleoSpinTM Gel and PCR clean up kit Macherey Nagel, Düren 
Bradford reagent (5x) SERVA Electrophoresis GmbH, 
Heidelberg 
  
Protein and DNA standards  
Gene RulerTM 1 kb DNA-Ladder Thermo Fisher Scientific, 
Braunschweig 
PageRuler Unstained Protein Ladder Thermo Fisher Scientific, 
Braunschweig 
Prestained Protein Molecular Weight 
Marker 
Thermo Fisher Scientific, 
Braunschweig 
Unstained Protein Molecular Weight 
Marker 




Balance Kern EW Kern, Balingen-Frommern 
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Balance Kern ABJ Kern, Balingen-Frommern 
C1000 thermal cycler BioRad laboratories GmbH, 
Munich 
CFX96TM Optical Reaction Module BioRad laboratories GmbH, 
Munich 
Filters (0.2 µm and 0.4 µM) Sartorius, Göttingen 
Gradient Master 108 BioComp, Canada 
Nitrocellulose membrane PROTRAN BA 83, Whatman 
GmbH 
pH meter FiveEasy Mettler-Toledo, Giessen 
SDS gel electrophoresis SE250 Hoefer, Holliston, USA 
Spin-X® UF concentrator, 20 mL and 5 
mL (MWCO 50 and 100 KDa) 
Corning GmbH, Kaiserslautern  
Vortex-Genie 2 Scientific Industries, USA 
ZelluTrans/Roth® dialysis membrane 
(MWCO 3.5 KDa) 
Carl Roth, Karlsruhe 
Water bath Isotemp 202 Thermo Scientific, Schwerte 
DNA loading dye (6 x) Fermentas 
 
2.1.4. Primers 
All the oligonucleotides were purchased from Sigma-Aldrich (Munich, Germany).  




RP_XhoI_polyHIS_hE2 GGTTACTCGAGTTACAGCAGCATGGTGAT CG 
FP_SNAPtag CGATGCTCTATAGCCATGGTGAGGTAGGGCG 
RP_SNAPtag CGCAGCATATGCTTGTACAGCTCGTCCATGC 
T7 promotor primer TAATACGACTCACTATAGGG 
T7 terminator primer GCTAGTTATTGCTCAGCGG 
 
2.1.5. Media compositions 
Lysogeny Broth (LB) Medium 
Modified from (Bertani 1951) 
Per 200 ml 
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Tryptone 2 g 
Yeast 1 g 
NaCl 1 g 
Auto Induction Medium Per 1 L 
Modified from (Studier 2005)  
50 x 52  
Glycerol 250 g 
D-Glucose 25 g 
D-Lactose 100 
20 x NPS  
(NH4)2SO4 66  g 
KH2SO4 136 g 
Na2HPO4 142 g 
TB medium  
Tryptone 10 g 
Yeast Extract 2 g 
SOC media  
Tryptone 2 % w/v 
Yeast extrat 0.5 % w/v 
NaCl 0.05 % w/v 
KCl 2.5 mM 
MgCl2 10 mM 
Glucose 2 % w/v 
 
LB-agar plates 
1.5 % agar was added to LB media and heated to dissolve agar. The solution was 
cooled down and supplemented with required antibiotics. The mix was poured to the 
petri dishes before it could solidify. 
Antibiotics concentration 
Kanamycin 25-50 µg/ml  
Carbenicillin 100 µg/ml 
Chloramphenicol 35 µg/ml  
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2.1.6. Software and web resources 
Adobe Photoshop CS6 Adobe 
ATSAS 2.6.0 https://www.embl-
hamburg.de/biosaxs/software.html 
UCSF Chimera  https://www.cgl.ucsf.edu/chimera/ 
Chromas 1.45 McCarthy, C., Griffith University, 
Australia 
Clustal Omega http://www.ebi.ac.uk/Tools/msa/clustalo/
CS ChemBioDraw Ultra 14.0 CambridgeSoft, UK 
ExPasy, ProtParam http://web.expasy.org/protparam/ 
Gene runner V.3.05 Hastings Software, Inc. 
MicroCal Analysis Malvern 
Microsoft Office 2013 Mocrosoft 
Origin 7 OriginLab 
Proteome-Discoverer 1.0.0 Thermo Fisher Scientific 
PSIPRED http://bioinf.cs.ucl.ac.uk/psipred/ 
PyMol v0.99 DeLano Scientific LLC 
Robetta http://robetta.bakerlab.org/ 
SigmaPlot 11 Systat Software, Inc 
SUMMIT_1_0 Taverner, Hernandez et al. 2008 
UNIPROT http://www.uniprot.org/ 












2.2.1. Molecular biology  
2.2.1.1. Determination of DNA concentration 
The concentration and purity of DNA samples were determined using NanoDrop 
instrument by simultaneously measuring the absorbance at 260 nm, 280 nm and 230 
nm.  The concentration of the double stranded (ds) DNA is calculated from the relation 
A260 = 1 = 50 µg/ml ds DNA. The significant absorbance at 280 nm and 230 nm 
indicate contaminations of RNA, protein and other reagents used during purification 
protocol. The isolated DNA was deemed to be free of such contaminant when the 
ratio between A260/A280 and A260/A230 were ~1.8 and 2.0-2.2, respectively.  
 
2.2.1.2. Polymerase chain reaction (PCR) 
A typical PCR mix had a total volume of 50 µL, which was equally divided into five 
Eppendorf tubes. The reaction was run with a temperature gradient such that the 
tubes will cover maximum, minimum and intermediate temperatures. After optimizing 
temperature and reagent concentration, the total volume was scaled up to 25 µL per 
aliquot. 






1 98 00:30 - - 
2 98 00:10 - - 
3 62-72 00:20 - - 
4 72 00:30 2 29 
5 72 05:00 - - 
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Following were the components of reaction mixture:  
Reagents Volume (µL) Cend 
H2O 31  
5 x HF buffer 10 1 x 
dNTPs (10 mM of each nucleotide-5’-
triphosphate) 
1 200 µM 
Forward primer (10 µM) 2.5 0.5 µM 
Reverse primer (10 µM) 2.5 0.5 µM 
Template DNA (10 ng/µL) 1 0.2 ng/µL 
DMSO 1.5 3 % w/v 
Phusion DNA Polymerase (2 U/ml) 0.5 0.02 U/ml 
Total 50  
 
2.2.1.3. Agarose gel electrophoresis (AGE) 
Agarose gel electrophoresis was performed with a 1 % agarose gel and TAE running 
buffer (40 mM Tris, 1 mM EDTA, 20 mM acetate, pH 8.5).  Sample aliquots were 
mixed with loading dye (6 x DNA loading dye, Fermentas) and pipetted onto the wells, 
alongside DNA ladder (Gene RulerTM 1 kb DNA-Ladder, Fermentas). The 
electrophoresis was carried out at 100 V, 60 mA and 150 W condition for 40 minutes. 
The region of interest in the gel were cut and soaked into ethidium bromide solution 
(2 mg/ml) for 10 min. The DNA bands were observed under UV light in a gel chamber 
(Department of Plant Biochemistry). The print out of the gel was made and if required, 
DNA bands of further interest were cut out before disposing the gel. 
 
2.2.1.4. Restriction digestion 
DNA was digested by appropriate restriction endonucleases as described 









AGE was performed after restriction digestion to isolate DNA bands of interest. Then, 
ligation reaction was performed using T4 DNA ligase according to manufacturer’s 
manual (Thermo Fisher Scientific).  
 
2.2.1.6. Bacterial transformation 
Post ligation mixtures were used to transform chemo-competent E. coli strains 
amenable for cloning purposes (DH5α, Top 10 or XL1-Blue). For expression of 
recombinant proteins, chemocompetent strains BL21 (DE3), BL21StarTM (DE3) or 
SoluBL21 (DE3) were prepared (Inoue, Nojima et al. 1990). 
Shortly, the chemo-competent cells were thawed from -80 °C freezer on ice for 10-20 
min. 10 ng plasmid DNA was added to 50 µL cells and incubated on ice for at least 5 
min. The mixture was incubated in a water bath at 42 °C for 45 sec. Subsequently, it 
was cooled down on ice for 2 min. SOC media (500 µL - 1 ml) pre-incubated at 37 °C 
was added to the transformed cell mix and allowed to grow at 37 °C and 750 RPM for 
30 min – 45 min in a thermomixer. 100 µL of this culture was spread onto one half of 
LB-agar plate (supplemented with desired antibiotics for screening). Rest of the 
culture was briefly centrifuged and most of the solution from the top was removed. 
The pelleted cells were re-suspended in remaining 50-100 µL liquid and spread onto 
another half of the LB-agar plate and incubated overnight at 37 °C (Froger and Hall 
2007).  
The colonies obtained were used in inoculating pre-culture (200 ml LB media) for 
protein over expression. However, for cloning purpose, they were picked to inoculate 
20 mL LB media and the grown cells were used to isolate plasmids according to 
manufacturer’s manual (NucleoSpinTM Plasmid kit).  
 
2.2.1.7. DNA sequencing 
For sequencing, 600-800 ng DNA were mixed with the corresponding sequencing 
primers (20 pM) and provided to Seqlab (Seqlab Sequence Labratories GmbH, 
Göttingen, Germany). The result of the sequencing was analyzed using Chromas 1.45 
to validate the insert sequences and their mutations. 
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2.2.2. Protein chemistry 
2.2.2.1. Determination of protein concentration 
A commercially available 5 x Bradford reagent (SERVA Electrophoresis GmbH, 
Heidelberg, Germany) was diluted in double distilled water to make 1 x solution. 10 
µL protein solution was added to 990 µL of 1 x Bradford reagent, incubated at room 
temperature for 5 min and absorbance at 595 nm was noted. Protocol was modified 
from (Bradford 1976).   
First, a standard curve of absorbance at 595 nm vs protein concentration was 
generated for BSA (0.1 mg/ml to 0.9 mg/ml). This curve was used to calculate the 
protein concentration in the query sample. A fresh 1 x Bradford reagent and the 
calibration curve was prepared every two days to ensure accuracy.  
 
2.2.2.2. Sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-
PAGE) 
SDS-PAGE was performed based on a modified protocol from Laemmli 1970, Weiner, 
Weber et al. 1972. The gels were casted such that ~ 1/4th part from the top will be 
stacking gel (5 % acrylamide/bis-acrylamide mix, 0.1 % w/v SDS, 125 mM Tris, pH 
6.8, polymerized with 0.03 % w/v APS and 0.2 % v/v TEMED) and remaining part will 
be separating gel (12 % acrylamide/bis-acrylamide mix, 0.1 % w/v SDS, 375 mM Tris, 
pH 8.8, polymerized with 0.03 % w/v APS and 0.1 % v/v TEMED). Protein samples 
were mixed with SDS loading buffer (100 mM Tris-HCl, pH 6.8, 0.02 % w/v 
bromophenol blue, 25 % w/v glycerol, 2 % w/v SDS and 2 % v/v β-mercaptoethanol) 
and heated at 95 °C for 5 min. The denatured samples were loaded into the wells. As 
a standard, a protein molecular weight marker was always co-electrophoresed. 
Electrophoresis was carried out in SDS running buffer (25 mM Tris, 200 mM glycine, 
0.1 % w/v SDS, pH 8.3) at 30 mA, 275 V and 150 W conditions for 40 min. After 
completion of electrophoresis, the gels were stained by an incubation step in 
Coomassie staining solution (0.25 % w/v Coomassie Brilliant Blue R-250, 30 % 
ethanol, 6 % acetic acid) for 20 min. The de-staining of the gels was done by shaking 
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2.2.2.3. Over expression of proteins 
2.2.2.3.1. High cell density fermentation for hE1 
E. coli (M15 strain) cells harboring pQE-9-6HE1α/E1β plasmid (Korotchkina, Tucker 
et al. 1995) were grown on a LB-agar plate containing 25 µg/mL kanamycin and 100 
µg/mL carbenicillin overnight at 37 °C. Single colonies were picked and inoculated 
into each of the two 1 L chicane flasks containing autoclaved LB medium (200 mL). 
These primary cultures were kept shaking at 200 RPM overnight at 30 °C. Next day, 
the cultures were pooled together and centrifuged at 5000 x g at 5 °C for 20 minutes. 
Thus obtained cell pellet was gently re-suspended in 50 ml fresh LB medium 
(autoclaved). 
Separately, 5.6 L of yeast extract [300 g yeast extract (Ohly, GmbH) + 3 g NH4Cl + 1 
mL anti-foam] was autoclaved in a BioStat C biofermenter (Sartorius AG, Göttingen). 
Using the feed tubes, 250 ml K2HPO4 (26.4 % w/v), 100 ml glucose (30 % w/v) and 
50 ml MgSO4 (8.16 % w/v) were added. From the septum, 6 ml each of kanamycin 
(25 mg/ml) and carbenicillin (100 mg/ml) were injected. The pH was kept constant at 
7 by connecting the fermentation chamber to 10 % w/v H3PO4 and 10 % w/v NaOH 
solutions. The temperature and partial oxygen pressure (pO2) were set at 37 °C and 
30 % respectively. 
Once the temperature and pO2 set conditions are reached, the re-suspended primary 
culture was added to the fermentation chamber via feed tube. The stirring speed of 
the culture (200 to 1500 RPM) and the airflow (5-25 L/min) were maintained to keep 
pO2 at 30 %. To ensure optimal growth of the bacteria every hour in the beginning and 
later every 30 min, optical density at 600 nm (OD600) was determined. At the same 
time, its glucose level was monitored by Midi Test Glucose strip (Macharey-Nagel). 
Once, it’s confirmed that glucose is completely consumed; feeding process was 
started with a flow rate of 15 %. The autoclaved feed contained 600 g of yeast extract 
(Ohly, GmbH) and 500 mL glycerol dissolved in 2 L deionized water. Additionally, 
corresponding antibiotics (2 ml kanamycin and 4 ml carbenicillin) were also added.  
When the OD600 reached 40, temperature was lowered to 25 °C (in small steps of 3 - 
5 °C). Once the temperature reached 25 °C, 8 ml thiamine hydrochloride (100 mg/ml) 
was added. Finally, protein over expression was induced by adding 1 mM IPTG. Next 
day, the culture was harvested by centrifugation step at 4800 RPM (JLA 8.1000 rotor), 
6 °C for 30 min. The cells were separated into 300 g portions and stored in a plastic 
bag at -80 °C. The samples for SDS-PAGE analysis were made from cells just before 
IPTG addition and post-harvest, to confirm successful hE1 over expression.    
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This protocol was adapted from the one developed in the lab by Dr. Kathrin S. 
Tittmann and described in a publication (Seifert, Golbik et al. 2006).  
 
2.2.2.3.2. Auto-induction of hE3, hE2, hE2/E3BP, KD-hE2, eGFP-hE2 and           
SNAP-hE2 (all in pET28a expression vector) 
A plasmid containing desired gene was transformed into E.coli strains designed for 
over expression purpose (refer Section 2.2.1.6). Single colonies were picked and 
inoculated into each of the two 1 L chicane flasks containing autoclaved LB medium 
(200 mL) and desired* antibiotics. These primary cultures were kept shaking at 200 
RPM overnight at 37 °C.  
Separately, a main culture, which is 465 ml of TB media, was added to 2 L chicane 
flask and autoclaved. Desired antibiotics*, 10 ml 50 x 5052 solution, 25 ml 20 x NPS 
solution and 500 µL MgSO4 (1 M) were added. For hE3 and hDPHc cores (except 
KD-hE2 core), 500 µL FMN (30 mg/ml) and 750 µL lipoic acid (0.25 M) were further 
supplemented, respectively. Then, respective primary cultures were added to main 
cultures to reach OD600 of ~ 0.1. It was then grown at 37 °C while shaking at 200 RPM. 
Once, the OD600 reached 0.6-0.8, the temperature was lowered to 16 °C and allowed 
to grow for at least two days. The cells were harvested by centrifuging at 9000 RPM 
(1620 A rotor, Hettich GmbH & Co. KG), 6 °C for 30 min and stored at -80 °C. The 
samples for SDS-PAGE analysis were made from cells just before temperature switch 
and post-harvest, to confirm successful protein over expression.      
*For overexpression from plasmids pET28a-hE3, pET28a-hE2, pET28a-KD-hE2, 
pET28a-SNAP-hE2 and pET28a-eGFP-hE2, 50 µg/ml kanamycin was added to the 
media. Whereas, for overexpression from pPDHE2/E3BP, 35 mg/ml chloramphenicol 
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2.2.2.4. Purification of proteins 
2.2.2.4.1. Purification of hE1  
100 g cell pellet was re-suspended in cold 400 ml lysis buffer (100 mM KH2PO4, pH 
7.0, 300 mM KCl, 20 mM Imidazole and 1 mM DTE) supplemented with 1 mM PMSF. 
Lysozyme (0.25 g) was added and the cell suspension was stirred in a cold room for 
minimum of 30 min or until the cells suspension became homogenous. Then, DNase 
I (5 mg) and MgCl2 (Cend of 3 mM) were added and the cell suspension was stirred in 
a cold room for another 30 min. This suspension was passed through fluidizer (2-3 
passages) at 70-80 psi for complete cell lysis. The lysed cell suspension was 
centrifuged at 45000 x g, 6 °C for 30 min and the clear supernatant was decanted in 
a beaker.  
A HisTrapTM FF column was equilibrated with 5 column volumes (cv) of lysis buffer 
and then, cell lysis supernatant was injected to the column. After this, the column was 
washed with 3 cv of lysis buffer. Now, the bound hE1 protein was selectively eluted 
by applying a gradient of 0 % - 100 % over 10 cv of elution buffer (100 mM KH2PO4, 
pH 7.0, 300 mM KCl, 300 mM Imidazole). SDS-PAGE was performed for elution 
fractions and the pure looking fractions were pooled and concentrated via 
centrifugation-based concentrator (MWCO 100 KDa) to reach volume < 1.5 ml.  
The concentrated protein was injected to the SuperdexTM 75 HiLoadTM 16/60 prep 
grade column pre-equilibrated with 3 cv of hE1-buffer (100 mM KH2PO4, pH 7.6, 300 
mM KCl). The eluted protein fractions were again subjected to SDS-PAGE analysis 
and the pure fractions were pooled together and concentrated like earlier. The protein 
concentration was estimated by Bradford assay (2.2.2.1.) The pure hE1 protein was 
stored on ice for further usage. 
This protocol was adapted from Seifert, Golbik et al. 2006.   
 
2.2.2.4.2. Purification of hE3 
5 g - 7.5 g of cell pellet was re-suspended in cold 20 ml lysis buffer (50 mM NaH2PO4, 
pH 8.0, 20 mM Imidazole, 200 mM NaCl) supplemented with 1 mM PMSF. Spatula 
tip lysozyme was added and the cell suspension was stirred in a cold room for 
minimum of 30 min. Then, spatula tip DNase I and MgCl2 (Cend of 3 mM) were added 
and the cell suspension was stirred in a cold room for another 30 min. The step for 
complete cell lysis using fluidizer is same as for hE1 protein (refer Section 2.2.2.3.1). 
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The purification step using His-trap column is same as for hE1 protein except the 
buffers. For lysis, 50 mM NaH2PO4, pH 8.0, 200 mM NaCl, 20 mM imidazole and for 
elution 50 mM NaH2PO4, pH 8.0, 200 mM NaCl, 100 mM imidazole were used. SDS-
PAGE was performed for elution fractions and the pure looking fractions were pooled 
and concentrated via centrifugation-based concentrator (MWCO 50 KDa) to reach 
volume of 2 ml. The protein concentration was estimated by Bradford assay (2.2.2.1.). 
FAD (5 times protein concentration) was added and the protein was kept overnight 
on ice.  
Next day, the concentrated protein supplemented with FAD was injected to the 
SuperdexTM 200 HiLoadTM 16/60 prep grade column pre-equilibrated with 3 cv of hE3-
buffer (50 mM NaH2PO4, pH 8, 200 mM NaCl). The eluted protein fractions were again 
subjected to SDS-PAGE analysis and the pure fractions were pooled together and 
concentrated like earlier. The pure hE3 protein was stored on ice for further usage.  
 
2.2.2.4.3. Purification of hE2, hE2/E3BP, KD- hE2, eGFP-hE2 and SNAP-hE2 
Cells (35 g – 45 g) were mixed with 100 g alumina and 20 ml of lysis buffer 
(supplemented with 1 mM PMSF) and grinded manually in a mortar using a pestle, to 
reach a dough like consistency. Then, the mortar and pestle was mounted to Mortar 
Grinder RM 200, Retsch GmbH and the cells were grinded for 45 min. Upon reaching 
35 min, lysozyme and DNAse I (both spatula tip) was added along with 80 ml of lysis 
buffer (supplemented with 1 mM PMSF).  
The cell suspension was centrifuged at 9000 RPM (1620 A rotor, Hettich GmbH & Co. 
KG), 6 °C for 30 min to remove alumina and cell debris partially. The supernatant was 
again centrifuged at 45000 x g, 6 °C for 30 min to remove all the cell debris. The 
supernatant was brought to room temperature and 0.1 % w/v protamine sulfate was 
added and stirred at room temperature for 30 min. Then, it was centrifuged at 15000 
x g, 20 °C for 20 min. The clear supernatant was incubated on ice for 10 min and cold 
PEG-6000 (50 % stock) was added to reach first cut off and stirred for 30 min in a 
cold room. It was centrifuged at 15000 x g, 4 °C for 20 min. PEG-6000 (50 % stock) 
was added to the supernatant to reach second cut off, stirred for 30 min in a cold room 
and centrifuged at 15000 x g, 4 °C for 20 min. The supernatant this time was slowly 
decanted and the pellet was washed with 5 ml of final buffer to remove excess PEG. 
The walls of centrifuge tube were dried with a tissue paper. Depending on the size of 
the pellet, 400 µL to 1 ml of final buffer was added and the pellet was re-suspended 
by gentle shaking. 
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When the protein is completely solubilized, it is added on the top of 10 % - 30 % linear 
sucrose gradient in a SW 40 rotor tubes and centrifuged at 20000 RPM - 25000 RPM, 
4 °C for 16 hr. The sucrose solutions were prepared in the *final buffer and the linear 
gradient was made by Gradient Master 108 according to the manufacturer’s manual 
(BioComp, Canada). Once the ultracentrifugation is finished, the gradient was 
fractionated from the top with 400 µL fraction size using micropipette. These fractions 
were subjected to SDS-PAGE analysis and the pure fractions were pooled together. 
PEG-6000 (50 % stock) was added to the pure protein pool until protein precipitation 
was visible (normally at 6 % - 8 %). It was centrifuged at 15000 x g, 4 °C for 20 min 
and the protein pellet was solubilized in final buffer. In order to remove the insoluble 
part, a further centrifugation step was performed at 15000 RPM (1420 B, Hettich 
GmbH & Co. KG), 4 °C for 15 min. The supernatant was transferred to fresh 
Eppendorf tube and kept on ice until further usage. 
*Lysis buffer for hE2, hE2/E3BP, eGFP-hE2 and SNAP-hE2 is 50 mM HEPES, pH 
7.5, 150 mM KCl, 20 mM Mg(OAc)2, 30 mM NH4Cl and 1 mM DTE whereas for KD-
hE2 is 50 mM MES, pH 6, 300 mM KCl, 20 mM Mg(OAc)2, 30 mM NH4Cl and 5 mM 
DTE. Final buffer here means lysis buffer without Mg(OAc)2 and NH4Cl.   
*The first and second PEG cut off were 4 % and 6 %, respectively for hE2, hE2/E3BP, 
eGFP-hE2 and SNAP-hE2 whereas for KD-hE2, they are 2 % and 4 %, respectively.  
 
2.2.2.5. Proteolysis of hE2 and hE2/E3BP core 
Thermolysin protease was added to hE2 and hE2/E3BP to a mass ratio of 1:400 and 
1:100, respectively. They were then incubated at 20 °C for 60 min in a thermomixer 
with shaking at 700 RPM. 5 mM EDTA was added to quench the reaction and the 
protein mix was loaded on top of 10 % - 30 % linear sucrose gradient. The sucrose 
gradient ultracentrifugation and protein precipitation part is same as in section 
2.2.2.3.3. Exception being the final buffer used which is 50 mM MES, pH 6, 150 mM 
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2.2.2.6. In-vitro reconstitution of hPDHc, hE1-hE2/E3BP sub-complex and 
hE3-hE2/E3BP sub-complex 
Purified hE2/E3BP core was mixed with hE1 or hE3 or both, depending on target 
complex. Assuming each core consist 40 hE2 and 20 E3BP proteins, hE1 and hE3 
were added such that they would be in molar excess (3 - 5 times) compared to their 
binding sites at hE2 and E3BP, respectively. After incubating in a cold room for 15 
min, the protein mix was loaded onto 10 % - 30 % linear sucrose gradient. The 
gradient was prepared in a high salt buffer (50 mM HEPES pH 7.6, 300 mM KCl and 
1 mM DTE) if the target complex consists hE1. Else, low salt buffer was used which 
consists 150 mM KCl instead of 300 mM.To reconstitute holo-enzyme complex, 
cofactors and substrates such as CoA, ThDP, MgCl2 and NAD+ were added to the 
protein mix and buffers, with final concentrations of 2 mM, 0.1 mM, 1 mM and 0.2 mM. 
The sucrose gradient ultracentrifugation and protein precipitation part is same as in 
section 2.2.2.3.3. 
 
2.2.3. Activity assays 
2.2.3.1. DCPIP assay 
This assay was carried out to investigate enzymatic activity of hE1 protein. An artificial 
electron acceptor namely 2,6-dichlorophenolindophenol (DCPIP) which is dark blue 
in color was used to report the HEThDP intermediate formation. Once the DCPIP 
receives two electrons from this intermediate, it turns colorless. This process can thus 
be followed as depletion of absorbance at 600 nm (A600).  
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Where, 1 unit (U) = micromoles of DCPIP reduced/min, - ∆ Abs/min = slope of the 
progress curve (absorbance vs time), Ɛ600 = molar extinction coefficient of DCPIP at 
600 nm = 17700 M-1cm-1, Cenz = concentration of hE1 (stock) mg/ml, Venz = volume of 
hE1 added in µL and d = path length of the cuvette = 1 cm. 
The protocol was adapted from (Nemeria, Yan et al. 2001) and the experimental 
parameters were as follows: 
 
Stock solution Final concentration 
5 x hE1 buffer (0.5 M KH2PO4, 1.5 M 
KCl, pH 7.6) 
0.1 M KPP, 0.3 M KCl, pH 
7.6 
0.1 M pyruvate 10 mM 
0.01 M ThDP + 0.1 M MgCl2 0.2 mM ThDP + 2 mM 
MgCl2 
Enzyme (hE1) 0.4 mg/mL 
DCPIP (10 mM) 0.1 mM 
  
UV/Vis spectrophotometer V-650  
(Jasco GmbH) 
Parameters 
Wavelength 600 nm 
Data pitch 5 sec 
Temperature 30 °C 
Time 1000 sec 
 
890 µL pre-reaction mixture was made with 200 µL of 5 x hE1 buffer, 20 µL ThDP + 
MgCl2 mix, required volume of hE1 and water in a 1 ml cuvette. It was incubated on 
ice for 5 min. Then, 10 µL DCPIP was added, quickly mixed by pipetting and 
absorbance monitored at 600 nm for 600 sec. The reaction was started by adding 100 
µL pyruvate and absorbance monitored for further 400 sec. The slope from 620 sec - 
650 sec was noted down for calculating specific activity of hE1. 
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2.2.3.2. PDHc assay 
The overall activity of an in-vitro reconstituted human PDH complex (assumed to be 
40hE1:40hE2:20E3BP:20hE3) and its dependency on substrate concentrations were 
studied using this assay. The protocol was adapted from (Korotchkina and Patel 
2001), where basically reduction of NAD+, which represents the final step of PDH 
reaction, is monitored. The formation of NADH can be spectrophotometrically 
observed at 340 nm. The rate of increase in absorbance corresponds to specific 







Where, 1 unit (U) = micromoles of NADH produced/min, - ∆ Abs/min = slope of the 
progress curve (absorbance vs time, 0-25 sec), Ɛ600 = molar extinction coefficient of 
DCPIP at 600 nm = 6220 M-1cm-1, Cenz = concentration of hPDHc (stock) mg/ml, Venz 
= volume of hPDHc added in µL and d = path length of the cuvette = 1 cm. 






For only checking activity, 100 µL buffer, 705.05 µL H2O, 20 µL L-cysteine, 20 µL 
ThDP + Mg Cl2 mix, 31.2 µL CoA, 100 µL NAD+ and 3.75 µL hPDHc were added in a 
1 mL cuvette. It was incubated at 37 °C for 3 min and used as a blank. Then, 20 µL 
pyruvate was added and mixed quickly by pipetting. A measurement was started at 
340 nm for 300 seconds. From the absorbance vs time curve, the slope from 0 sec to 
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The experimental parameters were as follows: 
 
Stock solution Final concentration 
PDH buffer (0.5 M KH2PO4, pH 7.5) 50 mM KH2PO4, pH 7.5 
hPDHc (0.5 mg/ml) 1.874 mg/ml (represents 1 
µg of hE1 in original 
protocol) 
0.01 M ThDP + 0.1 M MgCl2 0.2 mM ThDP + 2 mM 
MgCl2 
L-cysteine (200 mM) 4 mM 
CoA (5 mM) 0.156 mM 
NAD+ (20 mM) 2 mM 
Pyruvate (100 mM) 2 mM 
UV/Vis spectrophotometer V-650  
(Jasco GmbH) 
Parameters 
Wavelength 340 nm 
Data pitch 1 sec 
Temperature 37 °C 
Time 300 sec 
 
For steady state kinetics purpose, concentrations of all the constituents in a reaction 
mixture were kept same, except for a substrate being investigated. Variable 
concentrations of pyruvate (6.25, 12.5, 25, 50, 100, 250, 500, 1000 and 2000 µM), 
CoA (5, 10, 25, 50, 100, 250 and 500 µM) and NAD+ (10, 25, 50, 100, 250, 500, 1000 






Where, V = reaction velocity (µM/min) = Aspec * enzyme amount in µg, Vmax = maximum 
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2.2.4. FAD saturation test 
The proportion of FAD bound active site in hE3 protein was estimated for each batch 
of purified protein. First of all, an absorbance spectrum from 300 nm to 700 nm for 1 
mg/ml hE3 in 1 cm quartz cuvette was taken at room temperature. The protein was 
transferred to an Eppendorf tube and heated at 95 °C for 10 min for precipitation, 
releasing bound FAD to solution. The coagulated hE3 was centrifuged at 15000 RPM 
(1420 B, Hettich GmbH & Co. KG), 20 °C for 10 minutes. The yellow supernatant was 
transferred back to cuvette and fresh spectra taken for the same wavelength range. 
The absorbance at 450 nm (A450) which is a λmax for free FAD, was used to calculate 
its concentration ([FAD]free), It must be same to hE3 monomer concentration (19.058 
µM) in case of 100 % saturation, as each monomer can bind to one FAD.  
[FAD]free = A450 / Ɛ450 , where Ɛ450 = 11300 M-1cm-1 is molar extinction coefficient for 
free FAD at 450 nm.  
 
2.2.5. Isothermal titration calorimetry (ITC) 
2.2.5.1. Background 
Within a community of techniques, which can calculate binding constants of 
biomolecular interaction, ITC holds a special place. Till date, it is an only method that 
can provide information on association constant (Ka) and thermodynamic parameters 
such as binding enthalpy (∆H), Gibb’s free energy of binding (∆G) and binding entropy 
(∆S), in a single experiment. Furthermore, by doing measurements at multiple 
temperature, heat capacity of binding (∆Cp) can also be calculated, which aids in 
dissecting the nature of binding interfaces (Falconer, Penkova et al. 2010).  
A receptor solution is kept in a temperature controlled sample cell which is coupled to 
a reference cell, usually filled with water or buffer, by a thermopile/thermocouple 
circuits (Fig. 14). Both of these cells are kept inside an adiabatic jacket. The 
thermopile is sensitive enough to detect tiny changes in temperature (nanojoules) 
between the two cells (Pierce, Raman et al. 1999). A ligand solution is then injected 
to the sample cell in aliquots, which upon binding to receptor molecules, most likely, 
releases or absorbs heat. This will bring a tiny change in temperature in the sample 
cell, which is allowed to equilibrate with the reference cell by using external power. By 
integrating the power with respect to the time required for equilibration of temperature 
between sample and reference cell for a series of injections, ∆H is calculated. As the 
observed heat signal can be treated as an indicator of ligand-receptor complex 
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formation, Ka can be calculated from the plot between heat signal per mole of added 
ligand to the molar ratio between ligand and receptor from the following equation 









1‐ 1 r /2	‐	Xr/2
Xr	 2	‐	2Xr	 1‐r 1 r 2 1/2
 
Where, Xt is total ligand concentration in the volume V, Q is the heat signal, ∆H is the 
enthalpy of binding and Mt is the total receptor concentration. The parameters r and 
Xr are given as 1/r = c = N*Mt*Ka and Xr = Xt/Mt. 
Once the values for ∆H and Ka are known, ∆G and ∆S can be calculated by simply 
using general thermodynamic equations, ∆G = -RTlnKa = ∆H -T ∆S. To the plot of 
dQ/dXt to Xr from experimental data, the above-mentioned equation was fitted, 
assuming 1 ligand binds to only 1 receptor molecule. This resulted in the stoichiometry 
value for the best fitting of obtained data.  
 
 
Fig.14: Schematic of an ITC calorimeter.  
A constant temperature difference is maintained between sample and reference cells during 
the experiment. Upon injection of ligand to the sample cell containing receptor molecules, 
receptor-ligand complexes are formed which might be exothermic or endothermic process, 
thereby subtly changing the temperature of the cell. External power is used to bring back the 
sample cell temperature to original level, which is the raw data. For each injection, the power 
required to maintain the set temperature when integrated with respect to equilibration time, 
yields the heat of interaction for each injection. The plot between heat of interaction per mole 








ITC binding experiments were conducted principally, to investigate CoA and hE3 
binding to hE2/E3BP core. The enzymes to be used were kept inside separate dialysis 
membrane chamber (ZelluTrans/Roth® dialysis membrane, MWCO 3.5 KDa), and 
kept together in a beaker containing 1 L of 50 mM HEPES, 150 mM KCl, pH 7.5, with 
gentle stirring overnight in a cold room. The CoA solution was prepared in the post-
dialysis buffer. An iTC200 Microcalorimeter was kept at 25 °C (hE3-hE2/E3BP) or 30 
°C (CoA-hE2/E3BP) and the sample cell was filled with dialyzed ~ 0.5-2 µM hE2/E3BP 
core solution. A dummy injection of 0.1 µL followed by 24 injections of 1.5 µL of ligands 
i.e. CoA (2 mM) or hE3 (~140-210 µM) were made to the sample cell with constant 
stirring at 500 RPM. A control experiment was also done where sample cell was filled 
with post-dialysis buffer keeping all the parameters and ligand concentration same. 
This control data set containing heat of dilutions was subtracted from the experimental 
one and resulting data set was analyzed further via MicroCal Analysis software for 
base line correction and data fitting.  



















Duration Spacing Filter period 





2.2.6. Small angle X-ray scattering (SAXS) 
SAXS has already been exploited previously for estimation of the size of hPDHc cores 
or sub-complexes in solution (Hiromasa, Fujisawa et al. 2004, Vijayakrishnan, Kelly 
et al. 2010). Similar experiments in an in-house SAXS setup (8 KeV, CuKα radiation 
at 1.54 Å, rotating anode, Pilatus 100k pixel detector) with Kratky camera setup 
(Kratky and Stabinger 1984, Bergmann, Orthaber et al. 2000) at the department of 
Nanoscale Imaging of Cellular Dynamics, Georg-August-University Göttingen (Prof. 
Dr. Sarah Koester) were performed to quantify the possible effect of CoA binding on 
hPDHc cores. Firstly, the purified proteins were dialyzed against their respective 
 
Materials and methods 
69 
 
buffers (refer Section 2.2.5.). Then, ~ 100 µL of post-dialysis buffer (+/- 2 mM CoA) 
was pipetted inside a quartz-glass capillary (Hilgenberg) and sealed using vacuum 
grease before mounting into the setup. Measurements were carried out for 3-4 hours 
in 4 x 10-1 mbar vacuum condition with 1 mm x 400 µm beam size and flux of roughly 
10-7 photons per sec. A separate data set was created every 10 min. Once the 
measurement is done, the buffer (+/- CoA) was removed and a protein sample (800 
nM full length cores or 500 nM truncated cores, +/- CoA) was added to the same 
capillary.  It was again sealed with vacuum grease and the same measurement was 
carried out.   
The preliminary data analysis was done with the help of Dr. Oliva Saldanha 
(Nanoscale Imaging of Cellular Dynamics). First, the raw data containing scattering 
intensities were radially integrated using a homemade MATLAB script. The data from 
buffer (+/- CoA) was subtracted from that of protein sample (+/- CoA). The final 
intensity profile was processed via PRIMUS program (ATSAS package, EMBL, 
Hamburg) to calculate radius of gyration (Rg) and maximum size (Dmax) of the sample 
molecule, using pair-distance distribution function (PDDF) (Petoukhov, Franke et al. 
2012). Additionally, Rg was also estimated by Guinier approximation method to 
validate the quality of sample (Blanchet and Svergun 2013). 
 
2.2.7. Atomic force microscopy (AFM) 
2.2.7.1. Background 
Although, the mechanical investigation of hPDHc by AFM was proposed for more than 
a decade (Zhou, Liao et al. 2001), a dedicated effort is still lacking. Using AFM, we 
attempted complement data on sizes of hPDHc cores from SAXS and force 
spectroscopic experiments to get information on their apparent stiffness. Furthermore, 
we tried to see changes in morphology and mechanical properties of such cores and 
whole complex, upon binding to CoA.     
AFM, in short, is a type of scanning probe microscopy, where a fine tip of a micro 
cantilever is used to raster scans the sample surface (see Fig. 15). A height resolution 
of 1 nm is routinely achievable with this technique. Ideally, a sample (in solution or 
air) is settled on a plain glass surface or other materials with uniform surface like mica. 
The surfaces used, can be chemically modified (add metal ions or spacers) to suit the 
experiment. A laser beam is targeted on the back of a cantilever, which is reflected, 
to a center of a position sensitive photo diode, which acts as a reporter of cantilever 
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deflection. While scanning the surface of a sample at X-Y plane, the cantilever is bent 
because of the non-uniformity in heights of a surface due to sample particles. A piezo 
controller moves the sample surface or cantilever in Z direction so that a set 
distance/force between surface and the tip of the cantilever is maintained (contact 
mode-AFM). Since the piezo movement, which is proportional to the height of the 
sample surface, is recorded throughout scanning, a topographical image of a surface 
can be constructed (Butt, Cappella et al. 2005).  
However, to probe a fragile specimen like a protein complex, contact mode-AFM is 
not suitable, as the tip may destroy the sample (vice-versa) during scanning. To 
circumvent this problem, amplitude modulation (tapping mode) is employed where a 
cantilever is oscillated near its resonance frequency (several KHz) using modulating 
piezo. When a tip comes into close proximity to sample surface, the amplitude of the 
oscillation decreases. Analogous to contact mode, this time, the set amplitude is 
restored by moving cantilever in Z direction and a topographical image is constructed. 
Since, the sample comes into contact of a tip during peaks of the oscillation only, the 
damage to the sample is limited, and this is achieved without compromising on lateral 
resolution (Putman, Vanderwerf et al. 1994).    
 
Fig. 15: Schematic of an AFM set up.  
A laser beam is focused onto a cantilever and the reflected beam is detected by a photo-diode. 
While the tip scans the sample surface, the cantilever bends according to the sample 
topography, changing the laser spot’s position on the photo diode. A signal processor will 
process this information. It then directs Z-peizo to move sample surface, so as to keep the 
force between sample and tip constant. In tapping mode, cantilever oscillates at set amplitude 








Microscope glass cover slips were kept in Teflon rack, placed in a glass container and 
immersed in KOH solution (10 g KOH in 10 ml water and 200 ml ethanol). The 
immersed cover slips were sonicated for 5 minutes. Subsequently, the surfaces were 
rinsed and sonicated in deionized and filtered water three times for 5 minutes. The 
container was refilled with deionized water and 200 µL of N’-(3-[Trimethoxysilyl]-
propyl) diethylenetriamine (DETA) and 20 µL acetic acid were added. After sonication 
for 5 minutes the surfaces were cleaned by three washing steps as described above. 
Finally, the cover slips were dried at 120 °C for about 1 hour and stored until usage 
(max. for one week) (Eghiaian and Schaap 2011). In case of mica, office tape was 
used to remove the top surface of the mica revealing the fresh new surface each time. 
Clean cover slips were fixed on the microscopy slides using vacuum grease. 50-100 
µL protein solutions (hPDHc core or complex, 50-500 pM) was pipetted onto the cover 
slip and the cores were allowed to settle on the surface for 15 min. Finally, the 
microscopy slide was mounted into the AFM instrument before experiment. At 30 min 
interval, 50 µL fresh buffer were added to the sample drop. BL-RC150VB cantilever 
(manufacturing label: spring constant 0.03 N/m and resonant frequency of 37 KHz) 
was used at room temperature in tapping mode for imaging. Usually, a set point of ~ 
150 mV was kept and scanned with a scan size of 1 µM x 1 µM with 256 x 256 lines 
and points at scan rate of 1-2 Hz. The data collected were first analyzed by WSxM 
5.0 software to flatten all the images (Flatten plus tool). Then, height information at 
each pixel for single particle was processed with home written MATLAB script. The 
biggest and smallest 2.5 % heights were ignored to remove artefacts. 
For stiffness measurement, a spring constant (k) of a cantilever was calculated from 
the thermal noise spectrum by fitting Lorentz function to the first peak (Hutter and 
Bechhoefer 1993). In a force curve generated by pressing a tip at non-deformable 
surface like glass, a linear fit of the extension curve represents the sensitivity (nm/V). 
Using Hook’s law (Force, F = kx), the deflection in volt can thus be converted to force. 
Now, the force vs distance curve for the sample can be obtained and also the effective 
spring constant for the sample.  
AFM experiments and their analysis were done at the Third Institute of Physics, 
Georg-August-University Göttingen (Prof. Dr. Iwan Schaap), together by Dr. Mitja 
Platen and myself.  
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2.2.8. Electron microscopy (EM) 
Sample preparation: In a SW 60 rotor tubes, a 10 % - 30 % linear sucrose gradient 
was prepared via Gradient Master 108 according to the manufacturer’s manual 
(BioComp, Canada). For a + CoA condition, 2 mM CoA was added to both the sucrose 
solutions prior to gradient making. For sparse inter molecular crosslinking between 
nearby lysine residues of a sample protein by glutaraldehyde (GraFix), (Kastner, 
Fischer et al. 2008), 0.02 % glutaraldehyde was added to 30 % sucrose solution 
before making gradient. In case of hPDHc and its sub-complexes, NAD+, ThDP and 
MgCl2 was added to a final concentration of 2 mM, 0.2 mM, and 2 mM respectively, 
to both protein mix and sucrose solutions before gradient making. The sucrose 
solutions were prepared in a buffer according to target protein (refer Section 2.2.2.3.). 
Next, 200 µL, 0.25 µM human PDH complex, sub-complex or cores, were loaded onto 
the sucrose gradient and centrifuged at 20000 - 25000 RPM, 4 °C for 16 hr. The 
gradient was then fractionated using a pipette (200 µL fraction size) and dot blot was 
performed as following:   
1 µL from each fraction were pipetted to the nitrocellulose membrane (PROTRAN BA 
83, Whatman GmbH) in a row and allowed to dry. It was then immersed in the Amido 
black stain (0.1 % w/v amido black in 25 % isopropanol, 10 % acetic acid) for 5 min. 
The membrane was then washed with water until the clear blots of protein drops were 
visible. For a homogenous sample, usually most of the proteins would migrate to 
middle of the gradient and thus, the fractions belonging to those region will have 
darker blots. The dot blot was visually inspected and the best fractions from the middle 
of the gradient were chosen for electron microscopy. The excess glutaraldehyde was 
quenched by adding 10 mM aspartate (in the same buffer as sucrose gradient).  
All the electron microscopy measurements were carried out at the Department of 
Structural Dynamics, MPIBPC, Göttingen (Prof. Dr. Holger Stark).  
 
2.2.8.1. Negative staining electron microscopy (neg-EM) 
The protein particles from a chosen fraction were then bound to a thin carbon film for 
30-60 sec. Protein soaked film was transferred to an electron microscopic grid 
covered with a perforated carbon film. Excess liquid was removed from the grid using 
a soft paper. The protein-containing surface of the grid was faced towards saturated 
uranyl formate solution (in water) for staining. After 1 min-2 min staining, excess liquid 
was again removed using a soft paper and air-dried. All these steps were performed 
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over ice. Now, images were recorded at a magnification of 88,000-fold on a 4k x 4k 
CCD camera (TVIPS GmbH) using two-fold pixel binning (2,45 Å/pixel) in a Phillips 
CM200 FEG electron microscope (Philips/FEI) operated at 160 kV acceleration 
voltage. The raw images were edited using Adobe Photoshop CS6 software.   
 
2.2.8.2. Single molecule electron cryo-microscopy (Cryo-EM) 
Good looking samples (checked via neg-staining EM) was buffer exchanged to 
remove sucrose from the GraFix step and vitrified on continuous carbon foil on a 
quantifoil grid (3.5/1) in a FEI Vitrobot mark IV at a blot force of 13 and a blot time of 
8.5 s.   
Roughly 2250 micrographs were recorded on a Titan Krios microscope equipped with 
a Cs corrector at 300kV, 59000x (pixel size: 1.27 A/px) with a dose of 41 e/A². Then, 
212468 particles were selected using the software john Henry (custom written in the 
Stark lab) and an initial model was constructed using angular reconstitution method 
in cow eyes (custom written in Stark lab).  False positively picked particles were 
removed from this initial model by 2D classification. Remaining good particles were 
subjected to 3D classification in Relion (Scheres 2012), imposing icosahedral 
symmetry and the best class was refined. The final map consisted of 29788 particles 
with a resolution of ~ 6.3 Å.  
Model building was performed using Robetta (robetta.bakerlab.org). C-terminal 233 
amino acid residues of hE2 and E3BP were added in the server for structure 
prediction. After few hours, it predicted the secondary structure and a template (PDB 
3B8K). Structure prediction took couple of days, and it calculated 5 structure 
coordinates for each protein sequence in a PDB file format. The monomers were 
assembled in UCSF Chimera and molecular dynamics flexible fitting (MDFF) was 
performed to fit the model to the map. Real space refinement was performed for thus 
obtained final model via Phenix (Afonine, Grosse-Kunstleve et al. 2013).  
The cryo-EM measurements, data analysis and fitting of model into the obtained EM 
density maps were kindly done by Dr. David Haselbach from Department of Structural 
Dynamics, MPIBPC, Göttingen. Visualization of EM density map was done in UCSF 
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2.2.9. Direct stochastic optical reconstruction microscopy (dSTORM) 
2.2.9.1. Background 
Conventional optical microscopy methods are limited to a lateral resolution of roughly 
200 nm as described by Ernst Abbe (d=λ/2nSinθ). Technically, resolution (d) can be 
increased by using smaller wavelength (λ) like X-ray and UV or improving the 
numerical aperture, nSinθ (using immersion oil). But light with lower wavelength show 
lesser contrast, while their prolong exposure causes damage to valuable sample. As 
most of the experiments are carried out in air or buffer/water, the numerical aperture 
term also is difficult to increase after some limit (1.4-1.6).  
Various ingenious ways using photo physics-chemistry of fluorophores have been 
described in past few decades, to cross this diffraction barrier. It can be achieved in 
principle, by discerning the signals from fluorophores at spatial, spectral or time 
domains.  Stochastic optical reconstruction microscopy (STORM) is one of such super 
resolution microscopy techniques. By separating spatially overlapping fluorophores 
temporally, an accurate localization of fluorophore’s with in diffraction-limited region 
is possible in order to reach super resolution (Huang, Bates et al. 2009). Photo 
switchable dyes, which can be activated from dark state to fluorescent state and 
excited to emit fluorescent signal, by light with different wavelengths, are employed in 
this method. An intense excitation light is used to bring all the fluorophore into stable 
but reversible ‘off’ state. Next, cycles of milder activation and excitation light will allow 
only a subset of fluorophores to go to ‘on’ state, emit fluorescent signals and go back 
to ‘off’ state, resolving their respective locations. Data from many cycles when stacked 
together, provides a super resolution image of a sample (van de Linde, Loschberger 
et al. 2011).  The positions of the fluorophores can be laterally resolved up to ~ 20 nm 
via STORM (Rust, Bates et al. 2006). 
In direct-STORM (dSTORM), a photo switchable dye is kept in an oxidizing and 
reducing (ROX) buffer system. When they are excited with a laser of suitable 
wavelength, they enter dark states. As they require oxygen to revert back to 
fluorescent state, ROX buffer system ensures their slow return. Hence, at a time, only 
few fluorophores will stochastically return to fluorescent state, whose signals could be 









Fig. 16: STORM concept.  
(A) A photo switchable dye cycles between ground (1F0) and excited (1F1) singlet states by 
absorbing light of appropriate wavelength and emitting fluorescence photons. Fraction of the 
population of excited state can undergo inter system crossing (ISC) to go to triplet state (3F). 
In the presence of molecular oxygen, it can return to ground state by producing singlet oxygen. 
If a buffer contains oxygen scavenging system and reducing agents like 2-mercaptoethylamine 
(MEA), the triplet state can further hop to radical anion (F*) and completely reduced (FH) 
states. As the intermediary states (3F, F* and FH) takes several seconds to return back to 
ground state, very few fluorophores at a given time will be in a state to give fluorescence signal. 
Figure adapted from (van de Linde, Loschberger et al. 2011).  (B) Reconstruction of an image 
is possible by piling up multiple frames, each with a subset of localized fluorophores. 
 
Mostly, such techniques have been used successfully in cell biology to observe cells 
organelles, cytoskeletons as well as membrane proteins (Rust, Bates et al. 2006). 
However, it remains a challenge to study the biophysical features of single molecule, 
for example protein’s conformational changes. Here, we attempted to observe 
changes in size of eGFP-hE2 core upon binding to coenzyme A using dSTORM in 




2.2.9.2.1. Sample preparation 
Purified eGFP-hE2 core (~ 1000 pmoles) was mixed with anti-GFP-nanobody (~ 3000 
pmoles) labeled with Alexa 647 dye (provided by Dr. Qui Van). The volume was 
brought to 200 µL by adding a buffer (50 mM HEPES, 150 mM KCl, 5 mM DTE, pH 
7.5). In case for + CoA condition, 2 mM CoA was added to both the protein mix and 
the buffer. After 30 min of incubation in a cold room, they were loaded on top of a 10 
% - 30 % linear sucrose gradient (0 % - 0.02 % glutaraldehyde) in a SW 60 rotor tubes 
(the top contained 400 µL cushion of 10 % sucrose without glutaraldehyde), which 
was prepared via Gradient Master 108 according to the manufacturer’s manual 
A B 
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(BioComp, Canada). For a + CoA condition, 2 mM CoA was added to both 10 % and 
30 % sucrose solutions before making a gradient. The ultracentrifugation was 
performed at 20000 RPM, 4 °C for 16 hr. The gradient was then fractionated by pipette 
(200 µL fractions) from the top and dot blot was performed (see 2.2.8). The best two 
fractions were pooled together and 10 mM aspartate (pH adjusted) was added to 
quench excess glutaraldehyde.  
The core-dye complex (50-60 nM) was then mixed with BSA (20 % in PBS) in a v/v 
ratio of 1:2 to 1:5 in total volume of 20-50 µL. This mix was added to 8-well imaging 
chamber (Sarstedt, Nümbrecht) and the droplets were incubated for 10-15 min at 
room temperature to allow the complex to settle on the chamber surface. The droplet 
was then removed gently using pipette and the spot was rinsed with UV-bleached 
PBS. The chamber was finally filled with 500 µL freshly prepared imaging buffer. 
Preparation of imaging buffer: 50 µL enzyme stock + 400 µL glucose stock + 50 µL 
MEA stock (final Volume 500 µL, 100mM MEA final concentration) 
STOCK SOLUTIONS: 
A) Enzyme stock solution (50 mL) contained 100 μL Catalase, 200 μL TCEP (1 M), 
25 mL Glycerine, 22.5 mL water, 1.25 mL KCl (1 M), 1 mL Tris‐HCl pH 7.5 (1 M), 50 
mg Glucose oxidase. Aliquots were stored at ‐20 °C. 
B) Glucose stock solution (50 mL) contained 5 g Glucose, 45 mL water, 5 mL 
Glycerine.    Aliquots were stored at ‐20 °C. 
C) 2-mercaptoethylamine-HCl (MEA) stock solution (1 M)  
 
2.2.9.2.2. dSTORM measurement 
The dSTORM measurement was started at 33% laser power (continuous wave), gain 
200, exposure 20 ms (~1000-5000 frames). Dr. Qui Van and Simon.C. Stein did the 
imaging and data analysis in the lab of Prof. Dr. Jörg Enderlein (Biophysics/complex 
system, III. Institute of Physics, Georg-August-Univertät-Göttingen). 
 
2.2.10. Stimulated emission depletion microscopy (STED) 
STED is also a super resolution microscopy, but unlike dSTORM, high resolution is 
achieved by only allowing fluorophores at small space (less than diffraction limited 
region) to fluoresce. A pulse of excitation laser is followed by a STED pulse (doughnut 
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shaped hollow laser beam) to scan the sample, where all the fluorophores except 
those inside the inner ring of the STED laser are bleached (Klar, Jakobs et al. 2000).   
Purified SNAP-hE2 sample in PBS buffer (10 mM Na2HPO4, 1.8 mM KH2PO4, 137 
NaCl, 2.7 mM KCl, pH 7.4) was labelled with silicon rhodamine (SiR) dye (λexcitation = 
650 nm, λemission = 670 nm). SNAP tag is basically a small protein (a mutant of the 
DNA repair protein O6-alkylguanine-DNA alkyltransferase) of ~ 20 KDa that 
specifically reacts with benzylguanine (BG) derivatives carrying a fluorophore such as 
SiR (Keppler, Gendreizig et al. 2003). This approach was used to label each monomer 
of hE2 core and STED was performed in solution at room temperature.  
Labeling and STED measurements, as well as data analysis for size estimations were 
performed by Dr. Jensen Nickels (Prof. Dr. Stefan Jakobs, Department of 
NanoBiophotonics, MPIBPC, Göttingen).  
 
2.2.11. Mass spectrometry (MS) 
2.2.11.1. MS for protein band identification 
The proteolytically derived truncated versions of hE2 and hE2/E3BP were run in 12 
% SDS-PAGE gels. They were stained and de-stained with fresh staining and 
detaining solutions (refer Section 2.2.2.2.) to avoid contamination. Then, they were 
washed with water to remove de-staining solution. The pure protein bands were cut 
and transferred to fresh Eppendorf tubes and provided to Dr. Oliver Valerius (Mass 
Spectrometry-Yeast group, Georg-August-Universität-Göttingen) who performed 
tryptic digestion and the mass spectrometric analysis of those protein bands 
(Shevchenko, Tomas et al. 2006).   
 
2.2.11.2. Cross-linking mass spectrometry (XL-MS) 
2.2.11.2.1. Sample preparation: 
20 µL hE2/E3BP core (~ 18 mg/mL) or 50 µL hPDHc (3 mg/mL) were incubated on 
ice for 5-10 min with 2 mM CoA. Then, 5 µL BS3 (5 mM) was added to these solutions 
and also to the control (protein without CoA) for crosslinking and incubated for 1 hour 
at 25 °C in a thermomixer operating at 200 RPM. Ethanol precipitation was performed 
for the cross-linked protein samples and the pellet was resuspended in 1% RapiGest 
surfactant (Waters) followed by tryptic digestion according to manufacturer’s protocol 
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(Waters). The peptides were then dried in a speed vacuum and dissolved in 55 µL 30 
% (v/v) acetonitrile (ACN) / 0.1 % (v/v) formic acid solution. Then, the cross-linked 
peptides were separated from non-cross-linked ones, by passing through the gel 
filtration column (Superdex peptide 3.2/300, GE Healthcare). The cross linked 
peptides were eluted via 30 % (v/v) acetonitrile (ACN) / 0.1 % (v/v) formic acid solution 
at a flow rate of 50 µL/min with 50 µL fraction size. The interesting fractions were dried 
using vacuum centrifugation. 
 
2.2.11.2.2. LC-MS 
The dried samples were re-dissolved in 2% (v/v) ACN / 0.05 % TFA solution and were 
separated by nano-flow reversed-phase liquid chromatography (Dionex UltiMate 3000 
RSLC, Thermo scientific). The mobile phases used were mobile phase A: 0.1 % (v/v) 
formic acid and mobile phase B: 80 % (v/v) acetonitrile, 0.08% (v/v) formic acid. Then, 
the peptides were loaded onto a trap column (Reprosil C18, 100 μm I.D., particle size 
5 μm; Dr. Maisch GmbH, prepared in-house) and separated on an analytical C18 
capillary column (Reprosil C18, 75μm I.D., particle size 1.9 μm, 27-28 cm; Dr. Maisch 
GmbH, prepared in-house), with a gradient of 5-90 % (v/v) mobile phase B over 75 
min at flow rate of 300 nL/min. A set up consisted direct elution of thus separated 
peptides into an Orbitrap Fusion Tribrid Mass Spectrometer (Thermo scientific).  
Mass spectrometry was operated in data-dependent mode with following parameters: 
spray voltage: 2.0 kV, capillary temperature: 275°C and normalized collision energy: 
30 % at an activation of q = 0.25 and an activation time of 30 ms. Survey full scan MS 
spectra were acquired in the orbitrap (m/z 350−1550) with a resolution of 120,000 and 
an automatic gain control (AGC) target at 500,000. The top 20 most intense ions were 
selected for HCD MS/MS fragmentation in the orbitrap at an AGC target of 30,000 
and with a first m/z of 110. Previously selected ions within previous 30 s were 
dynamically excluded for 20 s. Ions with charge states 3-8 were only selected. Internal 
calibration of the orbitrap was performed using the lock mass option (lock mass: m/z 
445.120025)(Olsen, de Godoy et al. 2005). 
Raw data files were converted into ‘mgf’ file format using pXtract software tool 
(http://pfind.ict.ac.cn/software.html). By searching against a reduced database 
containing Atg18, potential cross-links were recognized with pLink search engine 
(Yang, Wu et al. 2012),. Search parameters were as follows: fragmentation: HCD, 
enzyme: Trypsin, variable modifications: oxidation (methionine) and 
carbamidomethylation (cysteine) and cross-linker: BS3. Finally, confirmation of 
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spectra of possible crosslinked di-peptides was done manually. Only those crosslinks, 
which have at least one good spectrum, were considered in the final output. 
 
2.2.11.2.3. Quantification of crosslinks  
Quantification of selected crosslinks was performed to find out if the frequency of a 
crosslink changes between presence and absence of CoA.  For every ion intensity 
extracted for crosslink at particular state, an ion chromatogram for the same cross-
link in another state was extracted and the mean value of intensities were calculated 
for both states. 
 
2.2.11.3. Native mass spectrometry (native-MS) 
hPDHc and hE2/E3BP cores in their respective buffers were exchanged against 
200 mM ammonium acetate (pH 7) using Micro Bio-spin 6 columns (Bio Rad). Spectra 
were acquired on a G1 mass spectrometer (Waters) modified especially for high 
masses (Sobott, Hernandez et al. 2002) using in-house prepared gold-coated glass 
capillaries (Hernandez and Robinson 2007). Parameters used for data acquisitions 
are capillary voltage 1.7 kV, cone voltage 150 V, extractor 40 V, trap collision energy 
20 V, transfer collision energy 15 V, source backing pressure 7–10 mbar and trap gas 
0.5 mL/min. Thus obtained spectra were processed and complexes were assigned 
using MassLynx (Waters) and Massign software (Morgner and Robinson 2012). 
Cross-linking and native mass spectrometry experiments and data analysis were 
done by Dr. Carla Schimdt (HALOmem − membrane proteins and dynamics, Martin 
Luther University Halle-Wittenberg) in the lab of Prof. Carol Robinson, University of 






All the results from molecular biology, protein expressions and protein 
purifications are in Appendix A and B, if not described in this section.  
 
3.1. Quality check for hE1, hE2/E3BP and hE3  
DCCPIP assay was performed for hE1 protein to check if it was as active as described 
in the literature. In general, the activity of hE1 depended on the batch of over 
expression and purity. A protein band (near 25 KDa) sometimes contaminated the 
protein (see Fig. 52), whose identity has been established to be E. coli FKBP20 by 
mass spectrometry (PhD thesis of Franziska Seifert). The most active protein batches 
had specific activity of 70-90 mU/mg which is slightly more than reported value of 40-
60 mU/mg (Seifert, Golbik et al. 2006) while other batches had specific activity in the 
reported range or lower. The protein batches with lower specific activity were 
discarded. 
 
Fig. 17: A representative progress curve of DCPIP assay.  
hE1 (Cend = 0.4 mg/ml) was added to a reaction mixture containing 200 µL of 5 x buffer (0.5 M 
KH2PO4, 1.5 M KCl, pH 7.6), 20 µL of 0.01 M ThDP + 0.1 M MgSO4 mix and required volume 
of water to reach 890 µL, in a 1 mL cuvette (path length of 1 cm). It was incubated at room 
temperature for 5 min, then 10 µL DCPIP was added. Time course measurement was started 
immediately at 600 nm at 30 °C. After 600 sec, 100 µL of 0.1 M pyruvate was added, mixed 
rapidly with pipette and depletion of absorbance measured for 400 sec. A slope from 620-650 
sec was used to calculate the specific activity. (Details in section 2.2.3.1.) 
Time (sec)
















For hE3 protein, a fraction of active site bound to FAD cofactor was calculated. By 
heat denaturing the protein, FAD was released to the solution. The concentration of 
released FAD can be calculated, as the molar extinction coefficient of free FAD is 
known (Ɛ450 = 11300 M-1cm-1). In case of 100 % saturation, the concentration of free 
FAD must be twice of the concentration of used hE3 (homodimer), as each monomer 
can bind to one FAD. The purified protein batches generally showed FAD saturation 
of > 80 %, which were deemed good enough for further usage. 
 
Fig. 18: FAD saturation test of hE3.  
A spectrum of 1 mL hE3 (1 mg/mL) was taken from 300-700 nm at room temperature (black). 
The protein was transferred to an Eppendorf tube and heated at 95 °C for 10 min. Denatured 
protein was removed via centrifugation and a spectra of clear supernatant was taken (Red). 
The absorbance at 450 nm for the post-heating spectra was noted and used to calculate 
concentration of free FAD and subsequently, total FAD saturation level as mentioned in 
section 2.2.3.3. 
 
For hE2/E3BP core, it was checked if it could bind to CoA. An ITC-binding experiment 
was performed according to section 2.2.5, where by heat uptake/release upon CoA 










Fig. 19: An ITC-binding experiment between CoA and hE2/E3BP core.  
An ITC data was obtained after titration of 2 mM CoA to ~ 1.5 µM hE2/E3BP core in 50 mM 
HEPES, 150 mM KCl, pH 7.5 at 30 °C with stirring speed of 500 RPM. The upper panel shows 
the heat of binding for each injection. Each peak is integrated, concentration normalized and 
the heat of dilution from control experiment is subtracted to give a plot in a bottom panel, which 
is fitted according to ‘one set of sites’ model fitting in MicroCal Analysis software (refer Section 
2.2.5.). Three independent experiments were performed from two batches of protein 
purification. 
   
The binding of CoA to the core subunits was exothermic in nature. The fitting curve 
was not sigmoidal, probably, due to high dissociation constant (KD) of 88.5 µM (SE = 
14.12 µM). The stoichiometry (N) between CoA and potential binding sites reached 
0.989 (SE = 0.08) if only hE2 was considered to be able to bind CoA. When E3BP 
was also considered to bind CoA, it decreased to 0.66 (SE = 0.05). The concentration 
of binding sites was calculated, considering each core consists of 40 hE2 and 20 
E3BP subunits (refer Section 3.5.)  Since both hE2 and E3BP are considered to 
contain one putative CoA binding site at their respective core forming domains, the 
data on hand suggests E3BP might not bind CoA.   
However, the basis for E3BP not binding CoA needs to be explored further. In the 
crystal structure of E2 from A. vinelandii PDHc, many residues are involved in 





(adenine ring, Ribose-5’phosphate, pyrophosphate and pantetheine arm). When the 
sequence of E2 from A. vinelandii PDHc is compared with human E2 and E3BP, two 
residues Ala534 and Ala585 important for binding to CoA stand out, as they are similar 
in hE2 (Val542, Ser593) but substituted by bulkier residues in E3BP (Lys394, 
Phe445). These residues could be an important discriminant in CoA binding ability 
between E2 and E3BP.  Near C-terminus, further three residues show such 
substitutions, but they are only involved with IN conformation of CoA (Mattevi, 
Obmolova et al. 1993), when the pantetheine arm is in extended form and thus might 




Fig. 20: Sequence alignment of PDHc E2 of Azotobacter vinelandii (AvE2) with hE2 
and E3BP.   
All the amino acyl residues involved in interaction with CoA (IN and OUT conformations) are 
colored, based on the crystal structure of AvE2 complexed with CoA and dihydrolipoamide 
(Mattevi, Obmolova et al. 1993) Among those residues, the ones which are similar between 
the two E2s but significantly different in E3BP are shown in green. Near C-terminus, further 
three residues show such substitutions (shown in blue). Sequence alignment was performed 
with Clustal Omega.  
 
3.2. Proteolysis of hE2 and hE2/E3BP core 
By incubating hE2 and hE2/E3BP cores with thermolysin protease and then 
separating the proteolysed fraction from the stable portion of the protein using sucrose 








Fig. 21: Proteolytic treatment of hPDHc cores with thermolysin.  
Purified hE2 (A) and hE2/E3BP (B) were incubated with thermolysin in a mass ratio of 400:1 
and 100:1, respectively, at 20 °C for 60 min in a thermomixer with shaking at 700 RPM. After 
adding 5 mM EDTA, they were loaded in 10 % - 30 % linear sucrose gradient and centrifuged 
at 25000 RPM, 4 °C for 16 hr. The fractions were collected from the top to bottom manually 
and SDS-PAGE was performed. (Details in section 2.2.2.4.)    
 
Single band for truncated hE2 and two bands for tE2/E3BP, all close to 25 KDa, were 
visible for fractions belonging to the middle of the sucrose gradient. A mass 
spectrometric analysis (refer Section 2.2.11.1.) was carried out for these protein 
bands, which identified them to belong to the core forming inner catalytic domains of 
hE2 and E3BP (see Appendix E). The apparent molecular weight of ~ 25 KDa also 
suggested that all the flexible outer parts (linkers + SBD + lipoyl domains) were 
proteolytically cleaved leaving inner core intact. However, only ~ 1/3rd of the cores 
were recovered. Additionally, brief centrifugation was required every day to remove 







process was only suitable for those experiments that require tiny amount of protein 
like electron microscopy or atomic force microscopy.   
 
3.3. In-vitro reconstitution of hPDHc and sub-complexes 
The purified components of hPDHc (hE2/E3BP core, hE1 and hE3) were mixed and 
10 % - 30 % linear sucrose gradient ultracentrifugation was performed (refer Section 
2.2.2.5.). Most of the reconstituted complex migrated to middle of the gradient and 
could be isolated from excess hE1 and hE3 proteins (see Fig. 22). Only fresh samples 
(< 5 days old) were used for further experiments, since they precipitated with time. At 
least half of the used core concentration could be recovered as whole complex and 











Fig. 22: In-vitro reconstitution of the hPDHc and sub-complexes from their 
component subunits.  
To hE2/E3BP core, hE1 or hE3 or both were added in 3-5 times molar excess of their 
respective binding sites, in reconstitution conditions mentioned in section 2.2.2.5. After 
sucrose gradient ultracentrifugation, whole complex (A), hE1-subcomplex (B) and hE3-
subcomplex (C) were isolated from purer fractions (near middle of the gradient) which were 







3.4. Steady state kinetics of hPDHc 
A steady state kinetics study of in-vitro reconstituted hPDHc was performed with an 
assay explained in section 2.2.3.2. Varying concentrations of its substrates (pyruvate, 
CoA and NAD+) were used and reaction velocities (µM/min) were calculated from a 
slope (0-25 sec) of absorbance vs time plots. A hyperbolic curve (acc. to Michaelis-
Menten equation) was fitted to the plot of reaction velocities to substrate 
concentrations, in order to estimate Vmax and KM, which are listed in Table 4. In 
general, the KM values were comparable to those mentioned for PDHc from eukaryotic 
sources (Lazo and Sols 1980, Kresze and Ronft 1981). But Aspec (5.41 U/mg) was 
lower than reported for hPDHc i.e. 29 U/mg of hE1 (Korotchkina and Patel 2001). If 
we assume that all the binding sites of hE1 are occupied in the reconstituted hPDHc, 
the Aspec will be ~ 10 U/mg of hE1 (i.e. one third of the reported value).  
 
Substrate KM (µM) Vmax (µM/min) Max. Aspec (U/mg) 
Pyruvate 40.9 +/- 10.36 11.4 +/- 0.75  
~ 5.41 +/- 0.55 CoA 7.02 +/- 3.5 10.96 +/- 2.45 
NAD
+
 28.8 +/ 6.27 8.1 +/- 0.6 
 
Table 4: Steady state kinetics parameters of reconstituted hPDHc with associated 
standard errors. 
The affinity of substrates to hPDHc (KM) and the maximum velocity (Vmax) were calculated by 
fitting a hyperbolic function on the plot between substrates concentration and velocity 
according to Michaelis-Menten equation. The hPDHc lost activity gradually (experiments 






Fig. 23: PDHc reaction progress curves (left) and their respective Michaelis-Menten 
plots (right). 
In a standard assay, 1 mL reaction mixture consisted of 50 mM KH2PO4, pH 7.5, 2 mM MgCl2, 
0.2 mM ThDP, 4 mM cysteine, 156 µM CoA, 2 mM pyruvate, 2 mM NAD+ and 1.875 µg hPDHc. 
For studying substrate dependence, assays were performed at 37 °C with varying pyruvate,  
CoA or NAD+ concentrations, keeping concentrations of all the constituents of standard assay 
fixed. The progress of the reaction was monitored spectrophotometrically, with NADH 
production corresponding to increase in absorbance at 340 nm (A340). By fitting a hyperbolic  
function (SigmaPlot 11.0 software) to reaction velocity vs substrate plots, steady state 








3.5. ITC-binding experiment of hE2/E3BP core with hE3  
In an ITC-binding experiment, it could be confirmed that nearly 20 hE3 proteins bind 
to a hE2/E3BP core at full saturation. Two models of different stoichiometry between 
hE2 and E3BP which are in a debate, were tested (refer Section 1.5.). For 40:20 
model (40 hE2 and 20 E3BP), stoichiometry of 1.04 (SE = 0.05) was estimated 
between hE3 dimer and E3BP. Whereas, for 48:12 model, stoichiometry of 1.89 (SE 
= 0.05) was estimated, which is highly unlikely as one E3BP can only bind to one hE3 
dimer (at max.). This means, a hE2/E3BP core consists of nearly 20 E3BP subunits, 
and possibly forms 20 trimers with hE2 in a core with 1:2 stochimetry if distributed 
homogenously. The binding of hE3 to the core was too tight (KD = 4.5 nM, SE = 0.95) 
for accurate estimation.  
 
Fig. 24: An ITC-binding experiment between hE3 and hE2/E3BP core.  
ITC data were obtained after titration of 140-210 µM hE3 to ~ 0.5-1.5 µM hE2/E3BP core in 
50 mM HEPES, 150 mM KCl, pH 7.5 at 25 °C with stirring speed of 500 RPM. The upper panel 
shows the heat of binding for each injection. Each peak is integrated, concentration normalized 
and the heat of dilution from control experiment is subtracted to give the plot in a bottom panel, 
which is fitted according to ‘one set of sites’ model fitting in MicroCal Analysis software (Details 
in 2.2.5.). The concentration of E3BP was calculated considereing 40:20 hE2:E3BP model (in 
this figure) and 48:12 model. Five independent experiments were performed from three 






3.6. Size estimation of hPDHc core and its variants by SAXS 
Previously we observed improved hPDHc core sample quality in the presence of CoA 
(MSc thesis of Sabin Prajapati) during EM study. Thus we performed SAXS with 
hPDHc core variants to see if CoA binding translates into any large conformational 
changes of the cores. Such changes would be then quantified as a change in Rg and 
Dmax values.  
These size estimates obtained for hPDHc cores and its variants are similar to the 
reported values (Hiromasa, Fujisawa et al. 2004, Vijayakrishnan, Kelly et al. 2010). In 
all the measurements, these parameters decreased upon CoA binding (∆ Dmax ~ 4-5 
nm), which suggest the significant compaction of hPDHc cores (see Table 5).  
Interestingly, the change in size is similar to the difference in size between smallest 
and largest yeast PDHc cores during breathing process (Zhou, Liao et al. 2001). 
However, the compaction also might be the result of increased lipoyl arm 
internalization (refer Section 1.4.1.d.).  
 
Fig. 25: A typical SAXS curve of scattering intensity (I) decay over momentum 
transfer (s).  
In general, an addition of CoA to the core, made the data smoother (at higher s). For a big 
particle like hPDHc cores, very few points could be recorded at Guinear region (low s), hence, 
pair distance distribution function was used to calculate both Rg and Dmax. The protein 
concentrations were chosen according to similar experiments published before 
(Vijayakrishnan, Kelly et al. 2010) and CoA concentration was chosen to saturate the core 























hE2/E3BP core (3) 12.8 41.5 11.9 36.7 4.8 
hE2 core (1) 13.1 42 12.8 38 4 
tE2 core (1) 12.3 30.5 10.6 26 4.5 
SNAP-hE2 (1) 12.3 43 12.2 38.5 4.5 
 
Table 5: Radius of gyration (Rg) and maximum diameter (Dmax) estimates for human 
PDH complex cores and its variants.  
The measurements were done in the presence and absence of 2 mM CoA. Upon binding to 
CoA, all the cores showed marked reduction in both Rg and Dmax. As a quantification of size 
reduction, difference in Dmax (∆ Dmax) is used. 
 
3.7. Size and stiffness estimation of hPDHc core and its variants by AFM  
The sizes estimated for all hPDHc and cores by AFM, were significantly lesser (~ 40 
%) than expected. We assume that the PDHc is inherently soft and spreads over solid 
surfaces of glass and mica used in AFM. Even at the low scanning forces, these 
particles showed same tendency, which affected our attempts in understanding the 
effect of CoA binding to the size of these particles. The apparent spring constant 
which is a measure of stiffness were smaller (5-10 times) for all the cores and 
complexes studied here (see Table 7) than normal globular proteins (Zaccai 2000). 
PDHc cores have been predicted to be very soft with apparent spring constant of 
0.015 N/m based on its breathing motion (Kong, Ming et al. 2003). This explains why 












The heights and spring constant of hPDHc and core variants are listed in following 
tables:  
Sample Avg. height (nm) Standard errror Total number (N) 
hE2 core 28.1 0.33 215 
hE2/E3BP core 24.8 0.3 206 
tE2 core 22.6 0.17 70 
SNAP-hE2 core 19.2 0.1 556 
eGFP-hE2 core 25.7 0.21 80 
hPDHc (GraFix) 29.6 0.88 37 
 
Table 6: Heights of human PDH complex and different core variants. 
The sizes of the cores all deviate by ~ 40 % if compared to values obtained by SAXS. The 
truncated cores resisted this tendency but still appear to be ~ 25 % smaller than the expected 
size in solution. Addition of hE1 and hE3 proteins to form reconstituted hDPHc did not seem 
to stop this, as they are also significantly smaller than sizes estimated by electron microscopy 
(see Fig. 35).    
 
Sample App. spring 
constant (N/m) 
Standard error Total number 
(N) 
tE2 core 0.023 0.004 6 
tE2 core + CoA 0.032 0.002 15 
KD-hE2 core 0.035 0.014 6 
KD-hE2 core + CoA 0.012 0.001 11 
hPDHc (GraFix) 0.072 0.02 12 
 
Table 7: Stiffness of human PDH complex and different core variants 
As the hPDHc and its cores drifted a lot while doing force spectroscopy, only few reliable 
measurements could be recorded (reason for low N). Force curves from only those particles 
that did not drift were taken into account. A scanning was performed after taking each force 
curve to see if the particle probed was still there in the previous location. 
 
While scanning the particles, interesting areas were zoomed in, while changing 
scanning rate and number of lines and points per scan. However, the intricate surface 
details of the complex and core (For example: pentagonal holes of the core or lipoyl 






Fig. 26: An example of AFM scans of hPDHc.  
The hPDHc sample that underwent GraFix step, could be scanned as homogenously 
distributed particles (Top row). After raster scanning the protein settled in glass/mica surface 
(top-left), a good-looking area was focused (green arrow). The scan rate was usually 
decreased for scanning selected area (top-right). However, without this step, the complex 
seemed to fall apart into its constituent subunits, with smaller hE1 and hE3 (5 nm), occupying 
majority of the surface (bottom row).  
 
3.8. dSTORM for single molecule analysis  
Although the maximum resolution reported for super resolution fluorescence 
microscopy is only in a range of tens of nanometers, we attempted to observe CoA 
induced size shrinkage of the core (~ 4-5 nm). The idea was to collect dSTORM 
images of many homogenously distributed eGFP-E2 cores which were complexed 
with anti-GFP-nanobody*Alexa 647 dye conjugate. During sample preparation 
optimization, it was very important to remove as much unbound nanobody-dye 
conjugate as possible to reduce the background.  
Our first strategy to achieve this was to use Spin-X® UF concentrator (MWCO 50 
KDa), so that any unbound nanobodies are filtered out. However, this did not prove 
to be successful approach as the background from unbound nanobody-dye conjugate 
could not be reduced by much and also, the complex appeared to aggregate (see Fig. 
27a A). Second strategy was to perform linear sucrose gradient ultracentrifugation so 
that the whole complex migrates to the middle of the gradient leaving excess unbound 





to minimize local aggregation of complex on the surface while imaging. This was 
partially successful because homogenously distributed complex could be observed 
with significantly reduced background. But the signal from the Alexa 647 dye was very 
weak in comparison to eGFP, which could be the result of separation of nanobody-
dye conjugate from eGFP-hE2 core during ultracentrifugation. In a third round of 
optimization, only parameter that was kept different from second strategy was to use 
GraFix (refer Section 2.2.9.2.). This method of fixing protein complexes in a gradient 
of chemical cross-linkers while migrating along a sucrose gradient is used in electron 
microscopy field. It was useful while doing AFM as well (refer Section 3.7.). This time, 
we could observe homogenously distributed complex particles, minimum background 
and good signal from Alexa 647 dye (see Fig. 27a B).  
 
Fig. 27a: dSTORM images of the eGFP-hE2 core bound to Alexa647 coupled anti-
GFP nanobody. 
A) The first strategy to use centrifugation-based concentrator to remove excess dye 
conjugated nanobody did not work, as evident by fluorescence signals from large clusters 
close to each other signaling protein aggregation. B) Post GraFIx and adding BSA to reduce 
unspecific clustering at the coverslip surface, individual cores can be homogenously separated 
(grey - eGFP signal, Red – Alexa 647 signal; signals are not overlapping due to chromatic 
aberration).   
 
Next, the size variation was checked along X and Y-axes, in which we observed the particles 
were larger at Y-axis, suggesting the cores were not radially symmetrical (Fig. 27b A and B). 
Following AFM data, it is most likely that the cores spread over the cover slip surface changing 
its geometry from spherical to ellipsoidal. Another major contributor for this might be drift during 





axis) and principle component 2 (shorter axis) of the particles (Fig. 27a C and D). Here, the 
sizes of the cores at PC1 was slightly smaller for + CoA sample, but, at the given distributions 
and asymmetry of the cores, the observed effect of CoA binding was inconclusive. Possibly, 
the GraFix step improved the integrity of the eGFP-hE2 core, but at the cost of dynamics 




Fig. 27b: Variation in sizes of the eGFP-hE2 core complexed with Alexa 647 coupled 
anti-GFP nanobody. 
A & B) The size variation in standard deviation in pixel is plotted against the number of particles 
(frequency) in presence and absence of 2 mM CoA conditions at X and Y axes, respectively. 
The median of standard deviations in X-axis was 0.171 pixels for both conditions. However, in 
Y-axis it was higher with 0.211 and 0.224 pixels for + and – CoA states, respectively. C & D) 
The size variation in standard deviation in pixel is plotted against the number of particles 
(frequency) in presence and absence of 2 mM CoA conditions at PC1and PC2, respectively. 
In PC1, the median of standard deviations were 0.232 and 0.238 pixels for + and – CoA states, 
respectively. While in PC2, they had similar values of 0.155 and 0.156 pixels. Thus, the 
particles look slightly smaller in + CoA state but due to asymmetry and a broad variation in 
sizes, it is not conclusive. (The figures and the statistical data were kindly provided by Simon 












3.9. Estimation of size variation of hPDHc core by STED  
Another method that was used to observe size variation in hPDHc cores was STED 
microscopy. We used N-terminally SNAP tagged hE2 construct for this experiment. 
Silicon Rhodamine (SiR) dye was self-incorporated into SNAP and the fluorescent 
signals could be detected near 660 nm (Excitation at 645 nm). The lateral size 
variation of the particles was large, although majority lie between 36-65 nm.  Large 
sizes (80-100 nm) were possibly due to inter core oligomerization and thus omitted 
from the final analysis. Overall, the size distribution profile shifts towards smaller size 




Fig. 28: Images obtained by scanning same region by confocal microscope and 
STED microscope and the size variation upon CoA binding.  
A) In an images obtained by STED microscopy, SiR coupled SNAP tagged hE2 cores appear 
smaller than in images obtained by normal confocal microscopy as the attainable resolution is 
better in STED. B) In a size distribution profile of the cores calculated from the STED images, 
upon binding to CoA, the cores appear to be getting smaller. (N = 117 for – CoA and 132 for 
+ CoA condition) 
 
A considerable population of SNAP-hE2 cores at size range beyond 43 nm (Dmax 
calculated via SAXS) indicates the particles collapsed on glass coverslip surface 
during STED microscopy. This effect was also problematic during AFM and dSTORM. 
The increased overall apparent sizes of the cores might be due to increase in size at 
lateral position (XY plane) with complementary decrease in height (Z axis). Finally, 
while these data do complement SAXS in demonstrating the CoA induced PDHc core 






binding shown here with STED should be taken qualitatively only. The shift in size 
distribution upon CoA binding was perhaps visible in STED unlike in dSTORM, since 
the sample did not undergo GraFIx. 
 
3.10. Electron microscopy 
3.10.1. Truncated cores 
Prior to cryo-EM, proteolytically obtained truncated PDHc core samples were tested 
if they were intact and homogeneously distributed by negative staining EM. Typically, 
the samples that did not undergo GraFix step tend to aggregate more with only slight 
improvement when 1-2 mM CoA was added. In contrast, by performing GraFix, these 
particles could be stabilized and homogenously distributed to a level deemed good 
enough to carry out cryo-EM measurements. 
 
Fig. 29: Negative staining EM of proteolytically obtained truncated hE2 cores.  
Without GraFix, these cores either completely aggregated or tend to associate close to each 
other. In the GraFixed sample, the core particles appear to be distributed better, although 
fraction of the population did form aggregates or higher order associations. Same was the 





From the good-looking batch of truncated hE2 cores, cryo-EM was performed in both 
presence and absence of CoA. The maximum resolution that could be achieved with 
these two samples were ~ 7 Å, with no striking differences in density maps (see Fig. 
30). Furthermore, with in the same population, no apparent variation in sizes was 
detected, which meant fixation with glutaraldehyde in GraFix step stopped the 
breathing process. Nevertheless, this endeavor was considered a success, as the EM 
density was better resolved than the best resolution described in literature (~ 9 Å) for 
any human PDH complex core or its variants (Yu, Hiromasa et al. 2008). However, 
we also observed many broken particles in the negative staining EM micrograph, 
which could be the result of proteolysis. Since an unspecific protease ‘thermolysin’ 
was used to cleave flexible lipoyl arms of hPDHc cores, it must have also digested 
parts belonging to core forming domain, at least in few E2 chains.  
 
 
Fig. 30: Cryo-EM density maps of truncated hE2 core in the absence (grey) and 
presence (green) of CoA at their 3 fold axis.  
The EM densities at substrate bound and unbound state of the cores are similar at 7 Å 
resolution. Pseudo-atomic modeling was not done with these densities as the re-inspection of 
the EM micrographs revealed that the core population in a sample was a mixture of intact 
(green arrows) and broken (red arrows) cores. The fraction of the particles in broken states or 
aggregating with other particles was high.  
 
Thus, alternative way of generating core forming IC domain of hE2 was considered. 
One of the option was to clone this domain alone and express and purify as lipoyl arm 
free construct. Fortunately, this construct (KD-hE2) was already available in our lab 





insoluble. Similar problems were also expressed in literatures (Yu, Hiromasa et al. 
2008) sharing a concern that the solubility of the core-forming domain is the real 
bottleneck for crystallization trials. Also, while performing proteolysis of full-length hE2 
and hE2/E3BP, few minutes after addition of thermolysin, the solution would turn 
turbid signifying the insolubility of naked core forming domains at pH 7.5 (buffer for 
hPDHc cores). After performing ThermoFluor assay of thus obtained truncated cores 
to check their stability (see Appendix F), the pH of the buffer was lowered to pH 6-6.5 
which improved the stability. Using this knowledge, 50 mM MES pH 6, 150 mM KCl, 
1 mM DTE was used as a purification buffer for KD-hE2 and indeed it could yield 
sparingly soluble cores (enough for EM investigation). With higher salt and reducing 
agent concentrations to 300 mM KCl and 5 mM DTE and adding 2 mM CoA, these 
KD-hE2 core samples looked homogenously pure and intact, at least in negative 
staining EM.  
 
Fig. 31: Negative staining EM micrograph of KD-hE2 (+ GraFix + 2 mM CoA).  
The core particles looked homogenously distributed and much more intact than proteolytically 
obtained hPDHc cores. Their tendency to associate with each other could be greatly reduced 
by using high salt and high reducing agent concentrations (300 mM KCl, 5 mM DTE in 50 mM 
MES pH 6).  
 
However, in a parallel experiment, we could also obtain high quality sample for full 
length hE2/E3BP cores as well and thus, cryo-EM measurement was performed for it 







3.10.2. hE2/E3BP cores 
The best cryo-EM density map reported for full length human PDHc cores are ~ 15 Å 
for hE2 core (Yu, Hiromasa et al. 2008) and ~ 18 Å for hE2/E3BP core 
(Vijayakrishnan, Kelly et al. 2010). They are bettered only by truncated hE2 core with 
a resolution of ~ 9 Å (Yu, Hiromasa et al. 2008), and a pseudo-atomic model of E2 
core forming domain was reconstructed from this density map. We performed cryo-
EM measurement with full-length hE2/E3BP and could attain a much better resolution 
of 6.3 Å. At this resolution, densities from hE2 and E3BP cannot be differentiated, 
mainly because they share 50 % sequence similarity in their core-forming domain and 
are expected to have similar structure. Nevertheless, atomic models for these 
subunits were calculated from the hybrid EM density map. The initial homology 
models for them were calculated by online Robetta server which used PDB 3B8K as 











Fig. 32: Comparing EM density maps of hE2/E3BP core with truncated E2 core from 
Yu, Hiromasa et al. 2008 and fitting 60 E2 monomers to the hybrid EM map of 
hE2/E3BP core.  
A) Negative staining EM micrograph of hE2/E3BP core (+GraFix+CoA) B) The cryo-EM 
density map of hE2/E3BP core (grey) at 2 fold axis is compared with that from truncated E2 
core (yellow). They look similar, signifying the presence of E3BP in the core do not alter the 
overall shape. The improvement in resolution from 8.8 Å (truncated E2 core) to 6.3 Å 
(hE2/E3BP) meant that at least the densities from helices were much sharper. C) To the EM 
density map of hE2/E3BP, 60 E2 monomers are fitted. It can be done with E3BP as well, since 
the final pseudo atomic models for hE2 and E3BP core forming domains are similar and at 
this resolution, they cannot be differentiated.   
 
The calculated atomic models for hE2 and E3BP core forming domains were 
understandably similar due to their high sequence similarity. Their structures were 
similar to crystal structure of A. vinelandii and E. coli truncated E2 structure but 
showed differences to only reported truncated human E2 model (see Fig. 34). 







unique for human E2 when compared to bacterial versions. Since, we calculated our 
models from the best EM density map for PDHc core, we expect our models to be 
more accurate. Furthermore, recently it was shown via MD simulation that the 
truncated human E2 pseudo atomic model might be unstable and inaccurate 
(Hezaveh, Zeng et al. 2016), and recommended corrections. Taken all together, it 
appears that the core forming domains of human E2 and E3BP are indistinguishable 
from prokaryotic PDHc E2s.  
 
 
Fig. 33: Superposition of atomic models of hE2 and E3BP core forming domains.  
The two opposing views of E2 (red) and E3BP (grey) monomers (upper panel) show that much 
of the secondary structural elements are conserved between the two. Only noticeable 
differences between the two models were in loop regions. The H1 helix and internal hairpin 
loop are the structural elements, which are characteristic surficial and innermost parts of the 
core. In the trimers of hE2 and E3BP (lower panel), S2 and S3 β strands can be seen making 






Our structural model for hE2 was also similar to bacterial E2 at the trimeric level (see 
Fig. 33), which meant the difference between 24meric and 60meric PDHc cores must 
lay at the orientation of inter trimer bridges (refer Section 1.4.1.d.). Keeping in mind 
that these bridges aren’t properly resolved in our EM density map in comparison to 
the crystal structure of bacterial E2 cores (< 3 Å), the direct comparison of the 
orientations of the inter trimer bridges are not carried out here.   
 
 
Fig. 34: Comparing structural model of hE2 with those from bacterial PDHc E2s and 
reported truncated hE2.  
Our hE2 model (red) shows nice similarity to the E2 crystal structure from E. coli (green) and 
A. vinelandii (purple) while the truncated hE2 monomer (blue) deviates from all the other 
models, specifically at three regions (black arrows). A) The arrow shows the H1 helix, which 
has different orientation for truncated hE2 model. B) In a disordered region of the truncated 
hE2 model, both the bacterial E2 structure and our hE2 structure show a beta strand. C) In an 
inner hairpin loop region, bacterial E2s have long beta strands. While our hE2 structure could 
show some ordered region at this part (small beta strand), the truncated hE2 structure appears 
to have only a long loop. All these three differences were reported to be distinctive feature for 
human E2, but our model challenges this notion. D) Furthermore, at a trimeric level also, our 










3.10.3. hPDHc and sub-complexes  
One of the main aim of the thesis was structural investigation of hPDHc and sub-
complexes. This is important because a complete structure of PDH complex from any 
organismal sources have remained elusive. During the present work, these large 
protein assemblies were prepared by in-vitro reconstitution (refer Section 3.3). In the 
negative staining EM, we observed different size distribution of these complexes. 
While hPDHc and hE1-hE2/E3BP were roughly 45 nm, hE3-hE2/E3BP had a size 
variation of ~ 32-37 nm.  
This was unlike sub-complexes from B. stearothermophilus where both E1 and E3 
forms the outer shell near the same space (Milne, Shi et al. 2002, Milne, Wu et al. 
2006), with the annular gap between core and peripheral proteins differing by ~ 1.5 
nm only. Since, the same SBD is used for binding E1 and E3 in bsPDHc, albeit in 
mutually exclusive manner, such observation was not surprising. However, in human 
PDHc, since hE2 and E3BP binds to hE1 and hE3 respectively, it does not need to 
be true.  
 
Fig. 35: Negative staining EM micrograph of hE1-hE2/E3BP, hE3-hE2/E3BP and 
hPDHc.   
The hE3 sub-complex appeared to be much smaller than hE1 sub-complex or hPDHc (by ~ 
10 nm). The sizes were calculated manually by using ruler. The presence or absence of 
cofactors such as CoA, ThDP or NAD+ had no influence in this behavior.   
 
On a closer inspection, hE3 proteins densities had inhomogeneous distribution on the 
core surface (see Fig. 36), forming big patches at few spots while absent in the rest 
of the area of core surface. Even though 20 hE3 proteins could be detected to bind to 
hE2/E3BP core via ITC (refer Section 3.5.) and a high resolution cryo-EM map could 





together and thus, also perhaps E3BP, provides previously unidentified landscape for 
hPDHc. Also the smaller sizes of hE3-subcomplexes could be result of such 
distribution.  
Although, a model for two E3BPs at 2 fold axis of the core binding to one hE3 protein 
exists (Smolle, Prior et al. 2006), it meant that only 10 or 6 hE3 would bind to the core. 
But it has already been disproven using ITC method during this thesis work (refer 
Section 3.5.).  
 
Fig. 36: Negative staining EM micrograph of hE2/E3BP and hE3-hE2/E3BP.   
The hE3 sub-complex is slightly bigger than hE2/E3BP core. Inhomogeneous distribution of 
peripheral densities could be clearly visible in the hE3 sub-complex (marked by red arrows). 
The varying sizes of the sub-complex might be due to presence of extra peripheral densities 
at few orientations of the particles.  
 
 
3.11. Mass spectrometry 
3.11.1. Cross-linking mass spectrometry 
In order to study the dynamics of hPDHc, cross linking MS was employed using BS3 
as a cross-linker. This should give us crosslinks between Cα of lysine residues that 
are roughly 27 Å apart (Rappsilber 2011). As expected, many crosslinks were 
detected between various subunits of hPDHc. They were carefully sorted out to 
remove crosslinks involving linker regions (full set of crosslinks in Appendix H). Unless 
mentioned specifically, the crosslinks described hereafter would only involve hE1 and 






Fig. 37: Crosslinking map of hPDHc.   
All the subunits could make multiple crosslinks with each other, which meant they are at close 
proximity to each other, at least for some time.  The subunits here are shown as rectangular 
bars with their N and C terminus at opposite ends. (This Fig. was kindly provided by Dr. Carla 
Schmidt)    
 
By classifying these crosslinks based on domains where crosslinking partners are 
located, many important details about hPDHc functioning could be revealed and will 
be described in the following sections:   
 
3.11.1.1. Crosslinks within the core-forming domain 
Based on the structure of hE2/E3BP core we obtained, all the lysine residues that are 
C-terminal to residue number 415 for hE2 and 269 for E3BP were considered to 
belong to the core forming domains. In total, we could detect nearly 36 different cross-





spectrum (see Table 8). Out of those, five crosslinks could be identified as inter-hE2 
(K490-K’490 and K604-K’604) or inter-E3BP (K450-K’450, K460-K’460, K488-K’488 
and K491-K’491) chains (see Fig. 38). Except crosslinks between hE2 and E3BP (10 
in total) and aforementioned crosslinks, rest could not be determined as inter or intra 
chain. Hence, precaution was taken to take such crosslinks as both inter and intra 
subunit, such that option yielding a distance near 27 Å or smaller between cross 
linkers, were considered likelier. For all the inter subunit crosslinks, it was considered 
to be both intra trimer and inter trimer. Again, option yielding a distance near 27 Å or 
smaller between crosslinking partners was considered likelier.  
 




partner + CoA 
2ndcrosslinking 
partner - CoA 
462 473, 547, 604 473, 547, 637 
466 473, 637 473, 547, 637 
473 
462, 466, 547, 552, 
637 
462, 466, 547, 552 
490 490 490 
547 462, 473, 552 462, 466, 473, 552 
552 473, 547 473, 547 
604 462, 604 604 
637 466, 473 462, 466 
   
Crosslinks between lysine residues of E3BP IC domain 
289 460  
314 321, 450, 460 450, 460 
321 314, 450, 460 450, 460 
325 394 394 
379 450 460 
394 325 325 
450 
314, 321, 379, 450, 
491 
314, 321, 491 
460 289, 314, 321, 460 314, 321, 379, 460 
488 488  





   
Crosslinks between lysine residues of E3BP and hE2 IC 
domains 
E3BP hE2 + CoA hE2 - CoA 
295 547 440 
314 462 462 
341 473 473 
450 466, 473 473 
460 604 462, 604 
488 462  
491 547  
 
Table 8: All the crosslinks in hE2 and E3BP core forming IC domains in the 
presence and absence of CoA.  
Although crosslinks could be sorted out between inter hE2 and E3BP, those only involving 
either hE2 or E3BP could not be sorted out to occur intra chain or inter chain. Exceptions are 
crosslinks between lysine residues at same positions that ought to be inter chain (red). Still, 








Fig. 38: Inter-chain crosslinks in hE2 and E3BP core forming IC domains.  
hE2 chains (red and grey : upper panel) and E3BP chains (green and grey : lower panel) are 
shown as intra-trimer dimer or inter-trimer dimer with all the crosslinking lysine residues (Cα) 
in orange. Confirmed inter chain crosslinks are highlighted by dashed lines in magenta with 
distance between Cα of crosslink partners given in Angstrom. As an example, crosslink 
between K490-K490’ in hE2 chains is much likelier to be inter trimer where crosslink distance 
will be only 26.2 Å whereas it is 47.5 Å for inter-trimer case.  
 
Most of the crosslinks mentioned in Table 8 have a crosslinking distance of < 35 Å 
when analyzed considering intra or inter chains as well as intra or inter trimer. This 
was deemed acceptable considering protein as well as cross linker’s dynamics. The 
exceptions were K450-K379 (~ 47 Å), K460-K289 (~ 53 Å) and K460-K79 (~ 38 Å) for 
E3BP-E3BP crosslinks and K295-K547 (~ 35 Å) for E3BP- hE2 crosslinks. Among 
them, the first two crosslinking distances are very large and occur between E3BP’s 
surficial residues and inner hairpin loop. Overall, the core forming domains of hE2 and 





E3BP were observed that are possible only if there is a large-scale conformational 
changes. 
 
Fig. 39: Crosslinks between distant lysine residues in E3BP IC domain.  
The two crosslinks K460-K379 and K460-K289 are shown here as both intra and inter chain 
in origin for both intra trimer and inter trimer situations. The two E3BP dimers are shown in 
green and grey monomers for both intra and inter trimer associations. The crosslinks are 
shown as dashed line in magenta with distance between Cα of crosslink partners given in 
Angstrom. All the lysine residues that make at least one crosslink are shown in orange. After 
comparing each possible situation, it seems that these crosslinks are intra chain in origin which 
have the shortest crosslink distances of ~ 47 Å for K460-K379 and ~ 53 Å for K460-K289. 
 
3.11.1.2. Inter lipoyl domain interaction 
One of the key step in PDHc reaction which have never been observed physically but 
have been shown extensively via biochemical and computer simulation studies (refer 
Section 1.4.1.a.) is the interaction between lipoyl domains for acetyl as well as 
reducing equivalent transfer. Luckily, in the crosslinking MS, we did observe 
crosslinking between lipoyl domain of E3BP with those from hE2. The lysine residues 
that are lipoylated cannot make crosslinks with other lysine residues and we did not 
observe it either. Still, there are many other lysine residues at the surface of these 
domains, which should be able to make crosslinks when they come to close proximity 
to each other. Interestingly, we observed crosslinks between K-120 of E3BP lipoyl 
domains with K-114 and K-241 of hE2. We also observed K-120 of E3BP interacting 
with K-78 of another E3BP subunit for which intra chain crosslinking was excluded as 
this lysine is structurally at equivalent position to K-114 and K-241 of LD1 and LD2 of 





domain. Same set of crosslinks were also present in the crosslink MS data from 
hE2/E3BP core (see Appendix I). 
When the structure of LD1 (PDB 2DNE), LD2 (PDB 1FYC) and the homology model 
of lipoyl domain of E3BP (calculated by Robetta online server) was oriented such that 
the lysine residues that are lipoylation sites come close to each other (must happen 
for acetyl or electron pair transfer) as well as the crosslink partners, it appears that 
these lipoyl domains interact with each other at only one orientation (see Fig. 40). 
Other orientations do not look probable, especially because even when there are 
bunch of lysine residues at the back portion of all these lipoyl domains as well as face 
of E3BP lipoyl domain they did not make any crosslinks. As the lipoyl arm is supposed 
to be very flexible and moving around stochastically, this observed restrain in how the 
lipoyl domains would actually come into each other’s contact should challenge the 
notion of unrestrained mobility of lipoyl arms. 
 
    
 
Fig. 40: Crosslinks between lipoyl domains.  
The orientation of lipoyl domains shown here (face of LD2 and head of lipoyl domain of E3BP) 
seems to be the only plausible orientation to explain the observed crosslinks. K-114 and K-
241 of LD1 and LD2 and K-78 of E3BP lipoyl domain are all at equivalent position shown here 
in the purple in the structure of LD2. Other orientations involving back or face of E3BP lipoyl 
domain and back of LD1 and LD2 should have encouraged crosslinks between other lysine 







3.11.1.3. Interactions of lipoyl domains with hE1 and hE3 proteins 
The same lysine residues of lipoyl domains of hE2 and E3BP that were making 
crosslinks with each other were also the ones making crosslinks with hE1 and hE3 
proteins. In the first glance, it appears that all the lipoyl domains of hE2 and E3BP 
can make crosslinks with both the peripheral enzymes (see Table 9). But the numbers 
of different crosslinks they can make with these enzymes are different. The number 
of different crosslinks can also be used as a measure of space explored by these 
lipoyl domains on the surface of hE1 and hE3.  In that regard, the lipoyl domain of 
E3BP seems restricted to explore hE1 (see Fig. 41). The lipoyl domains of hE2 
however can explore the surface of hE3 albeit lesser than lipoyl domain of E3BP. If 
the space explored by these lipoyl domains at hE1 and hE3 is directly related to the 
activity, then it can be assumed that the lipoyl domains of hE2 can participate in hE1 
and hE3 reactions with similar efficiency while the lipoyl domain of E3BP has much 
higher preference for hE3 reaction. 
Crosslinks between hE1 lysine residues with lipoyl domains 
Lipoyl domains hE1 + CoA hE1 - CoA 
E3BP-120 α -40, α-77 α-77 
hE2-114 α-63, α-244, α-321, β-227 α-244, α-336 
hE2-241 
α-77, α-83, α-147, α-244, 
α-321, β-184, β-227, β-
354 
α-40, α-83, α-244, α-321, 
α-336, α-344, β-68, β-
227, β-354 
Crosslinks between hE3 lysine residues with lipoyl domains 
Lipoyl domains hE3 + CoA hE3 - CoA 
E3BP-120 
159, 267, 273, 277, 284, 
410, 430 
159, 267, 277, 410, 430, 
445 
hE2-114 104, 267, 445 104, 445 
hE2-241 104, 267, 445 277, 320 
 
Table 9: All the crosslinks between lipoyl domains of hPDHc with hE1 and hE3.  
Understandably, the variety of crosslinks between lipoyl domains of hE2 with hE1 and lipoyl 
domain of E3BP with hE3 is more as hE1 binds to hE2 and hE3 binds to E3BP, respectively. 
Still, it appears that lipoyl domains of hE2 can make considerable number of crosslinks to hE3 
in comparison to lipoyl domain of E3BP with hE1. Additionally, the pattern did not change 







The dichotomy in relative preferences to visit hE1 and hE3 possibly also has 
functional consequences, especially in regard to responsibility shared by them in 
PDHc reaction. Furthermore, the functional redundancy shown between lipoyl 
domains of prokaryotic PDHc E2 might not have conserved in the lipoyl domains of 
eukaryotic E2 and E3BP during the course of evolution.  
 
Fig. 41: Surface sampling by lipoyl domains of hE2 and E3BP at hE1 and hE3.  
The structure of hE1 (PDB 1ZY8) and hE3 (PDB 1NI4) are shown with all the lysine residues 
that crosslinks with lipoyl domains (entrance for lipoyl moiety shown by black arrows). 
Exclusive crosslinks with hE2-lipoyl domains are in red, exclusive crosslinks with E3BP-lipyol 
domain are in blue and common crosslinks are in grey. Only those lysine residues that are 
close to the lipoyl entrance sites at hE1 and hE3 are labelled.  
 
3.11.1.4. Position of hE3 protein 
Another observation we made with crosslinking MS was the ability of hE1 and hE3 to 
make crosslinks with all the other components of hPDHc and their domains (see Fig. 
37). This was consistent with the negative stain EM results as both of these proteins 
could be seen at peripheral region to the core.  
Interestingly, we also observed few crosslinks between hE3 with inner hairpin loops 
of hE2 and E3BP (see Table 10). As these loops are situated at the inner cavity of the 
dodecahedral hPDHc core, the only way hE3 can make crosslinks with them is if it 
snugs inside the cavity via pentagonal openings of the core. Additionally, one 
crosslink was also observed for hE1 α subunit with inner hairpin loop of hE2, but it 
might be a false positive or a result of degradation/dissociation of hE1, as the full hE1 






Crosslinks between hE3 with inner hairpin loop of  
hE2 and E3BP 




E3BP-460 277 277, 430 
hE2-604 277  
Crosslinks between hE1 with inner hairpin loop of  
hE2 and E3BP 
Inner hairpin loop hE1 + CoA hE1 - CoA 
hE2-604 α -77  
 
Table 10: All the crosslinks between inner hairpin loops with hE1 and hE3. 
In general, high quality MS spectra could be obtained for crosslinks between inner 
hairpin loops of hE2 and E3BP with peripheral proteins in the absence of CoA. While 
only one crosslink was found in the case of hE1 (only α-subunit), several were found 
for hE3, indicating higher probability for hE3 to enter the pentagonal openings of the 
core. 
 
Furthermore, the crosslinking pattern shows that upon binding of CoA to the core, the 
ability of hE3 to enter the inner cavity of the core is reduced. Perhaps, the CoA binding 
affects the breathing such that the pentagonal openings do not stretch to 
accommodate hE3 protein. To validate this pattern, we performed quantification of 
the crosslinks between hE3 and inner hairpin loop in CoA bound and unbound states 
(see Table 11), which further confirmed that these crosslinks are observed more 







Inner hairpin loop hE3 CoA: no CoA no CoA : CoA 
E3BP-450 267 0.85 1.3 
E3BP-450 430 0.81 1.23 
E3BP-450 445 1.04 1.1 
E3BP-460 277 1.21 0.9 
E3BP-460 430 0.69 2 
hE2-604 277 0.54 1.9 
 
Table 11: Quantification of crosslinks between hE3 and inner hairpin loop of hE2 
and E3BP.   
All the crosslinks included lysine residues from inner hairpin loop of E3BP except for one (hE2-
604). All the mentioned crosslinks are provided with the ratio of their respective ion intensities 
during MS in presence and absence of CoA. As an example, the ratio greater than one in 
‘CoA: No CoA’ means the corresponding crosslinks are abundant in the presence of CoA in 
comparison to its absence. 
 
3.11.1.5. Change in lipoyl arm dynamics in CoA bound state 
Another key observation we could make from quantification of crosslinks were that 
the lipoyl domains of E3BP and hE2 visit active site of hE3 more frequently after CoA 
binding (see Table 12). For example, the crosslink between lipoyl domain of E3BP 
and hE3-267, which is a lysine residue, near the lipoyl entrance site of hE3 increased 
by 41 folds in the presence of CoA. Lipoyl domains of hE2 also appear to go near 
lipoyl entrance site of hE3 (< 2 folds) but not as much as lipoyl domain of E3BP. 
Similarly, the cross talk between lipoyl domain of E3BP and LD2 of hE2 increases by 
~ 3 folds.  The approach of hE2 lipoyl domains to the core’s lipoyl entrance site also 
increased by 1.5-2.5 folds but not E3BP lipoyl domains. All of these changes in lipoyl 
domains crosslinking pattern indicate heightened preference to E2 and E3 reactions 
when CoA substrate is present. On the contrary, these lipoyl domains did not show 
large increase in inclination to visit active site of hE1 compared to with hE3, 
suggesting CoA binding has lesser influence on steps happening before its binding in 
the PDHc reaction. The moderate increase in crosslinks of lipoyl domains with E1BD 
and E3BD in the presence of CoA indicates lipoyl domains occupy spaces closer to 











CoA: no CoA no CoA: CoA 
120 114 0.92 1 
120 241 2.94 0.75 
Crosslinks between lipoyl domains and lysine residues near  
lipoyl entrance site at hE1 
Lipoyl domain hE1 CoA: no CoA no CoA: CoA 
hE2-241 β-68 2.24 0.45 
hE2-241 α-83 0.41 2.44 
Crosslinks between lipoyl domains and lysine residues near  
lipoyl entrance site at hE3 
Lipoyl domain hE3 CoA: no CoA no CoA: CoA 
hE2-114 267 1.3 0.77 
hE2-241 104 1.92 0.81 
hE2-241 277 1.1 0.91 
E3BP-120 267 40.77 0.06 
E3BP-120 430 0.83 1.58 
Crosslinks between lipoyl domains and lysine residues near  
lipoyl entrance site at core 
Lipoyl domain core CoA: no CoA no CoA: CoA 
hE2-114 hE2-547 1.03 1.3 
hE2-114 hE2-552 2.48 0.4 
hE2-241 hE2-547 1.54 1.21 
E3BP-120 E3BP-488 1.05 0.95 
Crosslinks between lipoyl domains and subunit binding domains 
 of hE2 and E3BP 





hE2-114 hE2-367 1.5 0.73 
hE2-241 hE2-362 3.23 0.5 
hE2-241 hE2-367 1.24 0.91 
hE2-241 E3BP-194 1.76 0.84 
E3BP-120 hE2-363 1.4 0.78 
E3BP-120 E3BP-194 2.1 1.1 
 
Table 12: Quantification of all the crosslinks of lipoyl domains with SBD and lysine 
residues near the lipoyl entrance site at hE1, hE3 and the core.  
All the mentioned crosslinks are provided with the ratio of their respective ion intensities during 
MS in presence and absence of CoA. As an example, the ratio greater than one in ‘CoA: No 
CoA’ means the corresponding crosslinks are abundant in presence of CoA in comparison to 
its absence. 
 
3.11.2. Native MS of hE2/E3BP cores and hPDHc  
As the stoichiometry between subunits of PDHc from any organismal sources has not 
been accurately estimated, we performed native mass spectrometry in order to 
experimentally demonstrate all the possible ways of inter subunit associations. We 
performed these experiments with hE2/E3BP core and fully reconstituted hPDHc, but 
did not get proper spectra to assign masses to the whole complex or core. However, 
it was possible to assign peaks in the obtained MS spectra to smaller sub-complexes 
and single proteins (see Fig. 42).   
As there might be many different combinations of subunits, which would yield masses 
close to the one assigned to a peak, we used SUMMIT software to discard all the 
combinations that we thought did not make sense.  For example, a combination 
including many subunits of hE1 α subunits alone to give a certain mass will be 
considered highly unlikely if for the similar mass another combination in which both α 
and β subunits are present in equal number. We also gave a window of 500-750 Da 
as a possible error to accommodate as many combinations as possible. Also, the 
lipoyl domain of E3BP was considered to be both lipoylated or un-lipoylated and the 
hE2 chain to be bi-lipoylated, mono-lipoylated and un-lipoylated, with corresponding 
masses of lipoate added to the peptide chain mass, in order to cover whole range of 
possibilities. At the end, the presence or absence of ThDP, Mg2+, FAD, lipoate and 





combinations for each masses assigned to a peak resolved in the native MS spectra 




Fig. 42: Native MS spectra of hE2/E3BP core and hPDHc.  
Relative abundance of charged species are plotted against their respective mass by charge 
ratio, in a typical native mass spectra. The hE2/E3BP core and hPDHc could not be detected 
as an intact unit but rather disintegrated during MS, thereby leaving footprints of their 
corresponding subunits and their oligomers. (These figures were kindly provided by Dr. Carla 






The most striking difference in spectra between the core and the whole complex was 
spotted in the trimer unit formation of the core.  While in the isolated core, a peak for 
a trimer unit could be assigned for 2 hE2 - 1 E3BP, in hPDHc, it was replaced by 2 
E3BP - 1 hE2 type of trimer. As the core of hPDHc consists of 40 hE2 and 20 E3BP 
(refer Section 3.5), in order to balance the stoichiometry, for every 2 E3BP – 1 hE2 
kind of trimer, there must exist one trimer with all hE2 subunits. Since we did not 
detect 3-hE2 type of trimer for hPDHc, it cannot be concluded with absolute certainty 
that the isolated core will only contain a trimer with 2 hE2 - 1 E3BP composition. 
However, it can be predicted that the different trimer arrangements detected in an 
isolated core and reconstituted complex might be dominant species in the 
corresponding system. 
 
hE2/E3BP core Human PDH complex 
Peak (Da) 
Likely candidates 
(+/- 750 Da) 
Peak (Da) 
Likely candidates 
(+/- 500 Da) 
169422 2 hE2 - 1 E3BP 470420 
6 E3BP- 3 hE2 or 4 
E3BP – 2 hE2 – 3 
hE3 
120705 2 hE2 312938 
4 E3BP – 2 hE2 or 2 
E3BP – 1 hE2 – 1 
hE1 
108845 1 hE2 - 1E3BP 263147 
2 E3BP – 1 hE2 – 1 
hE3 
60113 1  hE2 
156157 and 
156447 
2 E3BP – 1 hE2 







Table 13: List of all the possible logical combinations of subunits that have similar 
masses to the one assigned for resolved peaks in the native MS spectra.  
In total, 5 peaks for the hE2/E3BP core and 9 for hPDHc could be assigned masses and their 
logical combinations of subunits are tabulated (SUMMIT software). Some peaks with similar 
masses yielded the same set of combinations. The protein subunits mentioned in the table 
can be both with and without their corresponding cofactors, as it did not change the 






The detection of 1 hE2 - 2 E3BP kind of trimer in at least a reconstituted complex 
means that a population of PDH complex containing E3BPs might be an 
inhomogeneous mixture of cores with different permutations and combinations of 
three types of trimers which are 2 hE2-1 E3BP, 1 hE2 – 2 E3BP and 3 hE2. As now 
there are more ways in which an inter trimer bridge can be constructed between trimer 
units (see Fig. 43), it adds another layer of complexity to the architecture of this 
enzyme complex. Furthermore, two or three such trimers could be detected in a single 
peak, which further supports inhomogeneous distribution of E3BP and hE3 proteins 
in a core surface (refer Section 3.10.3.).  
 
Fig. 43: Examples of some of the inter trimer associations possible in an isolated 
hE2/E3BP core and when it’s reconstituted with hE1 and hE3 proteins.  
Although only one type of trimer between hE2 and E3BP was detected in native MS, each for 
an isolated core and reconstituted hPDHc, the fixed stoichiometry between hE2 and E3BP of 
40:20 means that there must exist trimers with other arrangements between these subunits. 
Trimers containing various combinations of hE2 (blue) and E3BP (green) monomers are 
shown here in making higher order trimer-trimer frameworks. Taken together, as the variation 
in the inter trimer association is already large, if subsequent trimer units are added to any given 






4.1. Structure of hE2/E3BP core and its dynamics 
Pseudo-atomic models for hE2 and E3BP monomers could be calculated from cryo-
EM map of full-length hE2/E3BP core at 6.3 Å (see Fig. 33). They are similar to crystal 
structure of truncated PDHc cores from A. vinelandii and E. coli (Mattevi, Obmolova 
et al. 1992, Wang, Nemeria et al. 2014) (see Fig. 34). However, it showed differences 
with the only available pseudo-atomic model of human tE2 core (Yu, Hiromasa et al. 
2008), exactly at the regions (such as H1 helix and internal hairpin loop) where it 
showed differences to PDHc core from bacterial sources.  
Structurally, both hE2 and E3BP subunit’s core forming IC domains share similar 
architecture (see Fig. 33).  A small β strand at the N-terminus of H1 helix could be 
observed to form anti-parallel beta sheet with S3 and S2 β strands of a neighboring 
monomer in a counter clockwise fashion, which might be important for trimer unit 
formation. This was also observed in crystal structure of E. coli tE2 core but not in A. 
vinelandii tE2 core, where equivalent region has an unstructured loop. In a human tE2 
pseudo atomic model, N-terminus β strand are absent and instead flexible loop is 
present. In a similar manner, our models consist of an internal hairpin loop that is 
much more ordered than human tE2 model (see Fig. 34C). This loop was speculated 
to be disordered compared to E2 from prokaryotic sources, in order to interact 
specifically with equivalent hairpin loop of E3BP. But this hypothesis can be partially 
discredited, as these hairpin loop regions in our hE2 and E3BP models consist a β 
strand that is absent in human tE2 model. But it’s very small compared to long β 
strands present at the same area of prokaryotic PDHc E2 (see Fig. 34B). Consistent 
with this, the H1 helix that forms the outer face of the trimer unit in our models bear 
more resemblance with prokaryotic E2s than human tE2 model, where the orientation 
of this helix is slightly rotated along the core surface (see Fig. 34A).     
Although, in a present work, structures of hE2 and E3BP were calculated from much 
improved EM density map, the discrepancy with the human tE2 model can also be 
due to following two factors: 1) our models were derived from full length hE2/E3BP 
core while human tE2 model was from truncated hE2 core (EM density map at ~ 9 Å) 
and 2) our sample preparation included GraFix step and as well as addition of 2 mM 
CoA, to stabilize the cores. Nevertheless, during the course of this thesis work, 
Hezaveh and colleagues independently showed via MD simulation that the atomic 
model of human tE2 core requires correction as it was deemed unstable and 





atomic models of hE2 and E3BP thus provide experimental back up to the MD 
simulated models and thus, the human tE2 model needs appropriate revision.  
Taken all together, hE2 and E3BP core forming IC domains appear structurally similar 
to that of bacterial PDHc E2, even though they organize into 24meric cube while 
eukaryotic version organizes into 60meric dodecahedron. The difference might lie at 
the inter trimer bridges where it was hypothesized to have subtle differences in 
orientation of C-terminal helices (Izard, Aevarsson et al. 1999). The direct comparison 
of orientations of these bridges in human PDHc core and bacterial versions was 
refrained at the current resolution of cryo-EM map, thus providing scope for improving 
resolution via cryo-EM or X-ray crystallography in the future.     
Nevertheless, the obtained pseudo atomic models of hE2 and E3BP were used to 
visualize cross-links detected in the crosslinking MS of hPDHc, in order to understand 
dynamics with in the core. The crosslinked lysine residues by BS3 cross-linkers 
provided us with maps of conformational fluctuations in the hPDHc core. At priory, we 
expected it to be highly flexible in order to accommodate breathing process. The 
benchmark for distance between crosslinking lysine residues was taken as ~ 27 Å 
between two Cα atoms, based on crystal structure of RNA polymerase II (Rappsilber 
2011). This distance accounts for length of BS3 (11.4 Å), lysine side chain (6-6.5 Å) 
and possible error in crystal structure.  
Four crosslinks were considered to represent large dynamics of the core: K450-K379 
(~ 47 Å), K460-K289 (~ 54 Å) and K460-K79 (~ 38 Å) for E3BP-E3BP crosslinks and 
K295-K547 (~ 35 Å) for E3BP-hE2. The latter two were considered to be normal, as 
small movement of domains could yield such crosslinks while the first two crosslinks 
have very high crosslinking distances, which might be false positives. However, since 
K379 and K289 residues are located near the surface of the core while K450 and 
K460 are at the inner hairpin loop region of E3BP (see Fig. 44), at least a possibility 
of false positive due to the inter hPDHc particle interaction or aggregation can be 
safely ignored. On the contrary, it might be an indicator of a high flexibility of the 
hairpin loop to partially flip upward towards the core surface. Additionally, the 
secondary structural elements to which those surficial lysine residues are part of (For 
e.g. H1 helix - K289), might also move towards the central cavity of the core. This 
provides us a previously unidentified mode of dynamics in the core where at least an 
E3BP monomer could be stretched and compressed along the length of the monomer. 
Equivalent crosslinks in hE2 was not observed primarily because H1 helix of hE2 core 






Fig. 44: Dynamics along the length of E3BP.   
A representative E3BP monomer is focused on a 60meric pentagonal dodecahedral hPDHc 
core, such that surficial part is on the top and the innermost part in the cavity on the bottom. 
K379 and K289 are located at surficial structural elements and K460 is situated at the inner 
hairpin loop. These structural elements can come to close proximity to allow crosslinking. This 
is only possible if these structural elements can fluctuate along the length of the monomer (red 
arrows), which is orthogonal to inter trimer bridge motion (breathing).     
 
These dynamics could also imply that the structural models we generated represent 
only one of the many major conformations of the core. However, its contribution in 
size variation due to breathing would largely depend on pulling and pushing of H1 
helix only, as the flipping of inner hairpin loop at the cavity of dodecahedral hPDHc 
core wont effect its overall size. Furthermore, assigning crosslinks to probe breathing, 
a process of relaxation and contraction of inter trimer bridge was not possible with this 
approach. This is because it’s impossible to credit an inter chain crosslinking to inter 
trimer units as the distance between crosslinking partners were usually smaller when 
crosslinking was considered to occur between two subunits in a same trimer, and thus 
more feasible. Nonetheless, this cannot exclude existence of inter trimer crosslinks 







4.2. Organization of the hPDHc core and its implications on its function 
One of the two models that’s under debate for the stoichiometry between hE2 and 
E3BP subunits in the hPDHc core are 40:20 and 48:12 substitution model. In an 
absence of direct evidences such as structure at atomic resolution or absolute 
quantification MS, the best bet have been to quantify the number of hE3 proteins that 
bind to the core at full saturation. To do this, techniques such as ITC, SAXS and 
analytical ultracentrifugation (AUC) were employed by several groups. But 
interestingly, they arrived at different results.   
To understand this conundrum however, another contradiction needs to be addressed 
first. And it is about the mode of binding of E3BP to hE3 protein. According to the 
crystal structure of hE3 with E3BD, only one E3BD can make contact with a hE3 
dimer, albeit with two different orientations, but never with both in a same complex. 
This means one E3BP will bind to only one hE3 protein, and for the two models in 
question, hPDHc core will bind either 20 or 12 hE3 proteins. Brautigam and 
colleagues showed via ITC and AUC that 20 hE3 proteins binds to hPDHc core 
(Brautigam, Wynn et al. 2009).  Problem arose when other groups used similar 
methods plus SAXS and showed only around 10 or 6 hE3 proteins bind to hPDHc 
core at full occupancy, and argued against the crystal structure (Vijayakrishnan, 
Callow et al. 2011).  According to them, two E3BP subunits can bind to a hE3 protein 
in solution.  Furthermore, recombinantly expressed cores bind to 10 hE3s while native 
cores bind to only 6, possibly showing lesser number of E3BPs present in a native 
system.  
Without scrutinizing the methods used by those authors to purify proteins, especially 
the hPDHc core in those studies, we had observed before that E3BP proteins are 
extremely labile (MSc thesis of Sabin Prajapati). When harsh cell disruption 
techniques like fluidizer or French press are used followed by column chromatography 
(ion exchange and gel filtration), where protein has to spend considerable amount of 
time in a column matrix, the fraction of E3BP proteins leave the core.  It was also 
evident during the follow up negative staining EM that most of the cores obtained such 
way were partially broken. Moreover, native PDHc cores were obtained from native 
bovine PDHc in earlier works by performing discontinuous sucrose gradient 
ultracentrifugation at very high salt concentration of 2 M NaCl, which must have also 
removed fraction of E3BP from the complex along with E1 and E3 proteins 
(Vijayakrishnan, Callow et al. 2011). Possibly, this is the reason why they could only 





In contrast to these, the hPDHc core that was recombinantly expressed during this 
thesis work was purified in a gentler way. Firstly, electric mortar was used to 
mechanically grind E. coli cells (with desired protein overexpressed). Performing PEG 
and protamine sulfate precipitations followed by linear sucrose gradient 
ultracentrifugation, the hPDHc core were purified. The cores obtained this way were 
far more reliable as nearly 20 E3 proteins could bind to the core in at least 3 different 
purification batches, using ITC (see Fig. 24). The binding affinity was very tight (Kd 
<10 nm).  The negative staining EM of these cores showed far lesser number of 
broken particles and also the best ever EM map of any PDHc core could be calculated 
via cryo EM (see Fig. 32).    
The fitness of the hE2/E3BP was judged by its ability to bind CoA, also via ITC. Past 
experiments (in the same lab by Kathrin S. Tittmann and MSc thesis of Sabin 
Prajapati) on an artificial hPDHc core that was devoid of E3BP, showed that such 
cores could bind to nearly 60 CoA molecules, meaning each hE2 subunit binding to 
one CoA molecule. In contrast, the hE2/E3BP cores used in this thesis work, could 
only bind around 40 CoA molecules (see Fig. 19). This is interesting because these 
cores contain 40 hE2 and 20 E3BP subunits, which possibly indicate that E3BP do 
not bind to CoA. Although it is assumed that E3BP do not possess any acetyl 
transferase activity like hE2, principally due to substitution of catalytic histidine with 
serine, its ability to bind substrate ‘CoA‘ has not been investigated before.  Although 
the binding isotherm in ITC is not a desirable sigmoidal but rather hyperbolic (for both 
hE2/E3BP and hE2) which is observed for low affinity system (Kd of ~ 88 µM and 40 
µM respectively for hE2/E3BP and hE2), the calculation of stoichiometry may not be 
as inaccurate as supposed (Turnbull and Daranas 2003). Also, the data obtained for 
stoichiometry between CoA and the cores were highly reproducible.  
As the primary structure of the core forming IC domain of hE2 and E3BP are similar 
(sequence similarity of 50 %), E3BP is supposed to have similar tertiary structure as 
hE2 (Hezaveh, Zeng et al. 2016). At monomeric or trimer level, it was shown that both 
cubic and pentagonal dodecahedral PDHc cores are similar with the slight difference 
in the orientation of the trimer being the key in formation of either the cube or 
pentagonal dodecahedron. This means hE2 and E3BP can be directly compared with 
the available crystal structure of bacterial E2 cores from A. vinelandii and E. coli at 
monomeric or trimeric level.  Doing so, one thing which is quite apparent is that the 
catalytic histidine of hE2 or its substitution serine in E3BP, lie at the active site of 
neighboring monomer in a same trimer (see Fig. 45A). A CoA molecule bind to the 





this catalytic histidine (hE2) or serine in E3BP. If E3BP is unable to bind to CoA, only 
40 sites remain in a core which can bind to CoA. But since, E3BP lacks catalytic 
histidine residue as well, which is situated at the active site of neighboring monomer, 
even if that neighbor is hE2, acetyl transfer reaction cannot occur there.  
Hence, in a trimer containing 3 hE2 subunits like in bacterial PDHc, all the active sites 
for acetyl transfer are operational. Whereas, for eukaryotic PDHc, a trimer containing 
2 hE2 and 1 E3BP has only one functional active site out of three while those 
containing 1 hE2 and 2 E3BP have no functional active sites (see Fig. 45B). 
As there is no experimental report on the distribution of 20 E3BP subunits in a hPDHc 
core, it is not confirmed if all the 20 trimers are same (2 hE2 + 1E3BP type) or a 
mixture of 3 hE2, 2 hE2 + 1 E3BP, 1 hE2 +2 E3BP and 3 E3BP types of trimers. 
Based on negative staining EM of hE3-hE2/E3BP sub-complex (see Fig. 36), it seems 
hE3 proteins are clustered together in few spaces around the core and not uniformly 
distributed. This indicates that corresponding E3BP subunits must also be clustered 
together rather than homogenously distributed in the core.  Separately, via native MS 
(Table 13) it could be shown that 1 hE2 + 2 E3BP type of trimers are present in in-
vitro reconstituted hPDHc but not for isolated hE2/E3BP core. Such trimers could be 
also detected in a group of as much as 2 to 3. It raises the question if the E3BP 
subunits change their distribution in a core once hE3 proteins are around i.e. uniform 













Fig. 45: CoA binding to E2.  
(A) hE2 dimer within same trimer (red and grey as monomers) is superposed to an E3BP 
monomer (pink). A CoA molecule (yellow, coordinates from PDB 1EAD) is bound to grey hE2 
monomer. A catalytic histidine (green) is contributed from a neighboring hE2 monomer (red) 
while at the same position E3BP contributes serine. (B) A cartoon representation of different 
scenarios in a trimer containing different number of E3BP (black cross marks denote 
nonfunctional active site/binding site). When no E3BP is present in a trimer, all the active sites 
of E2 are functional. Adding just one E3BP in a trimer, brings down operational sites to mere 
one, as E3BP neither binds CoA nor contributes catalytic histidine to its neighbor. Adding two 
or more E3BP in a trimer, kills all the potential active sites.  
 
Nevertheless, such clustering behavior of E3BP in a PDH complex might have 
positive functional ramification. As described before, presence of 1 hE2 + 2 E3BP or 
3 E3BP kind of trimers would completely abolish the activity of acetyl transferase site 
in that particular trimer, but the number of such trimers is limited by the copy number 
of E3BP in a core.  It means for every trimer with 1 hE2 + 2 E3BP composition, 
somewhere in a core there must exist a 3 hE2 kind of trimer, so as to balance the 
overall ratio between hE2 and E3BP to 2:1 (40:20).  Similarly, to balance 3 E3BP kind 
of trimer (if it exists), there must exist 2 trimers of 3 hE2 type.  
Hence, in hPDHc, there exists possibility for separate islands dedicated for 
segregating E1/E2 reactions and E3 reaction. A cluster where hE2 is in majority can 
focus mainly on E1 and E2 reaction whereas a cluster where E3BP is in majority can 
perform E3 reaction. This is unlike bacterial PDHc where there is no E3BP and all 
three reactions are to be performed by E2 lipoyl domains. However, a recent study 
on E. coli PDHc suggested a mechanism of inter chain acetyl transfer where by, an 






from neighboring E2 visits this active site after going through E1 reaction, and 
probably third E2 is involved in E3 reaction (Song and Jordan 2012).  Similar 
separation of duties might have been conserved for PDHc from higher organisms that 
have E3BP.  
 
4.3. Functionally nonequivalent lipoyl domains and their mode of 
networking  
Although, lipoyl domain of eukaryotic E3BP is acetylated during PDHc reaction 
(Demarcucci, Hodgson et al. 1986), it might not be its principal responsibility to visit 
catalytic site of E1. Rather, reduced dihydrolipoyl-E2 (after E1 and E2 reaction) might 
exchange the reducing equivalent with lipoyl domain of E3BP. The oxidized lipoyl-E2 
can go back to active site of E1 and reduced lipoyl-E3BP can go to active site of E3 
for re-oxidation. Extensive networking between lipoyl domains for exchanging acetyl 
group and reducing equivalent is the hallmark of multiple random coupling mechanism 
(MRC) model for all PDHc (Stepp, Pettit et al. 1981, Hackert, Oliver et al. 1983, 
Hackert, Oliver et al. 1983).  
During crosslinking mass spectrometry experiment on in-vitro reconstituted hPDHc, 
we observed low number of crosslinks between lipoyl domain of E3BP and hE1. In 
comparison, both the lipoyl domains of hE2 showed extensive crosslinks with hE3. 
And, as expected, the lipoyl domains of hE2 made numerous crosslinks with hE1 and 
lipoyl domain of E3BP did the same with hE3 (see Fig. 41). All in all, the lipoyl domains 
appear redundant if only their capacity to come close to hE1 and hE3 is considered.  
However, the lipoyl domains of hE2 and E3BP show certain dichotomy on how much 
space they can explore on the surface of hE1 and hE3. Based on crosslinking MS 
data, it can be assumed that lipoyl domains of hE2 are free enough to take over the 
function of lipoyl domain of E3BP, but the lipoyl domain of E3BP cannot do reverse 
without compromising the overall activity. In the follow up to previous discussion (refer 
Section 5.2.), this provides another basis for a model where hE2 lipoyl domains focus 
mainly on E1 and E2 reaction while E3BP lipoyl domain focuses on E3 reaction. This 
is very much in line with the two experiments carried out to specifically remove lipoyl 
domains of mammalian PDHc, either from E3BP or E2, at a time.  When a lipoyl 
domain of E3BP was removed, nearly 80 % of the overall activity was retained 
(Neagle and Lindsay 1991). But, when the lipoyl domains from E2 were proteolytically 





We also observed crosslinks between lipoyl domain of E3BP (K-120) with lipoyl 
domains of hE2 (K-114 and K-241). As expected, the lysine residues, which are the 
lipoylation sites, do not make any crosslinks with other lysine residues. When the 
available structure of lipoyl domains of hE2 is compared to the homology model of 
lipoyl domain of E3BP, such that crosslinking lysine residues are near to each other 
while lipoylation sites come to close proximity, it appears that these lipoyl domains 
come into contact with each other at certain orientation only i.e. head of lipoyl-E3BP 
with a face of lipoyl-E2 (see Fig. 40). Any other orientations look less probable as no 
other crosslinks were observed even though multiple lysine residues are present at 
other parts of lipoyl domains. Since, movement of lipoyl arms is assumed to be highly 
random, this provides one of the first ever experiment-derived restraint to this 
randomness. Furthermore, this restraint appear to hold up for lipoyl domains of hE2 
and E3BP even when they are moving around at different active sites , meaning how 
so ever the lipoyl arms move, there is only one dominant orientation for lipoyl domain 
interaction.  
And if a possible dichotomy in responsibility for lipoyl domains of E3BP and hE2 is 
also added to the overall picture, the whole functioning of hPDHc now looks a product 
of careful planning and not chaos. Hence, this demands a further interrogation on 
what else about PDH complex is not random.  
 
4.4. Effect of CoA binding to the hPDHc: a substrate dictates large 
conformational changes    
As already mentioned before, the investigation of CoA binding to hPDHc started after 
observing an increased integrity of hPDHc cores while doing EM and AFM 
experiments (MSc thesis of Sabin Prajapati). As the crystal structure of CoA bound 
E2 core of A. vinelandii PDHc (only available CoA–core complex in literature) do not 
deviate significantly from unbound version (Mattevi, Obmolova et al. 1992, Mattevi, 
Obmolova et al. 1993), the origin of this stability begged explanation. We had two 
hypotheses in the beginning of the investigation. First one was the interference with 
breathing motion of a core by CoA, possibly directing the cores to become more 
compact.  Second one was increased internalization of lipoyl domains based on a 
report of increased affinity of lipoyl domains to the core in the presence of CoA (Kato, 
Wynn et al. 2006).   
The first hypothesis could have been effectively tested if we had achieved good quality 





did not survive until EM step in a good state, especially without CoA (see Fig. 29). 
Since, their stability increased post GraFix, major attention was given to such samples 
and at the end we were successful in obtaining the best ever cryo-EM map for hPDHc 
core at ~ 6 Å. Unfortunately, this was possible at the cost of core dynamics as the 
particles after chemical crosslinking by glutaraldehyde (GraFix) did not show size 
variation as expected for breathing PDHc core.  
Nevertheless, SAXS was performed on hPDHc cores and its variants, in the presence 
and absence of saturating concentration of CoA (2 mM). All the investigated cores 
showed CoA induced compaction in their size by 4-5 nm of Dmax (refer Section 3.6). 
Similar effect was also observed during STED experiments when the CoA binding 
changed the size distribution of SNAP-hE2 cores towards lower size groups (refer 
Section 3.9.).  
If the size of the post-GraFix core (+ CoA) is ~ 25 nm based on neg-staining EM 
micrographs and cryo-EM derived model (only core forming part is visible), and if it’s 
assumed that CoA stops breathing by locking smallest size conformation, the same 
sample in absence of CoA should have ~ 29-30 nm size considering 20 % size 
variation during breathing. This is same as the value obtained for truncated E2 core 
by SAXS (see Table 5) and small angle neutron scattering (SANS) (Vijayakrishnan, 
Kelly et al. 2010). Thus, it looks logical to explain the CoA induced increase in hPDHc 








Fig. 46: CoA induced hPDHc core compaction and comparison with EM.   
A truncated hPDHc core during breathing can be imagined to have a difference in sizes (1.1, 
1 and 0.9) between the largest and the smallest particles of nearly 20 % of the average size. 
For this sample, when SAXS is performed, a Dmax of 1.1 will be calculated. In the presence of 
CoA, if breathing stops and the cores are locked at smallest size conformation, SAXS will 
report Dmax of 0.9, which will make the difference between the Dmax values as 20 % of the 
average size of – CoA state. Adapted from (Zhou, Liao et al. 2001) 
 
As fitting as it seems, this model though lacks one crucial parameter and that is lipoyl 
arm. Since highly flexible lipoyl arms are invisible in EM studies, the size difference 
between largest and smallest core particles during breathing, in afore mentioned 
literature is completely ignoring them. But during SAXS, the size estimate is made out 
of the full-length core and not just core-forming domain alone. Although same level of 
compaction was observed for proteolytically derived truncated E2 core, only single 
data set could be measured and additionally, they were deemed unsuitable for 
structural studies after conducting EM experiments due to overwhelming presence of 
broken particles (see Figure 30 and Table 5). Hence, other techniques were explored 
to see if lipoyl arms are internalized towards cores upon binding to CoA, which should 
also result in core size compaction observed in SAXS.     
Quantification of crosslinks made by all three lipoyl domains of hE2 and E3BP in the 
presence and absence of CoA (see Table 12) detected in crosslinking MS revealed 
that upon binding to CoA, the lipoyl domains of hE2 make as much as 2.5 folds more 
crosslinks with the core forming domain’s residues. This clearly indicates the 





CoA induced size compaction, at least partially. However, the lipoyl domain of E3BP 
does not significantly change its crosslinking to the core. Its interaction with linker 
region between E3BD and E3BP lipoyl domain though increased by 10 folds, possibly 
indicating that E3BP-lipyol arm also folds back when CoA is around.  
Furthermore, inter-lipoyl domain crosslinks also increased by 3 folds, signifying 
increased crosstalk between lipoyl domains upon CoA binding. And the crosslink 
between lipoyl domain of E3BP with K-267 of hE3 (near lipoyl entrance site) amplified 
by 41 folds and hE2-LD2 with K-104 of hE3 (another lysine near lipoyl entrance site) 
increased roughly by 2 times. Similar observations could not be made in regards to 
hE1 protein and lipoyl domains of E3BP, but for hE2-LD2, it was a mixed result as 
crosslinks with lysine residues near active site i.e. α-K-83 increased by 2 folds while 
with β-K-68 decreased by half.  
Summing up these observations, it can be stated that upon binding of CoA to the 
hPDHc core, more lipoyl arms of hE2 folds back towards the inner core, possibly for 
acetyl transfer reaction at hE2 catalytic site. The mobility of lipoyl domain of E3BP 
increases such that they can increase cross talk with hE2-LD2 (for potential exchange 
of reducing equivalent) and also visits E3 active site much more frequently. Thus, it 
appears that the CoA binding to hE2 primes the PDH complex for the subsequent 
events in the PDHc multi-step reaction, which are E2 and E3 reactions. And at least 
from the data on hand, it can be ruled out that CoA binding to the core would change 
hE2-lipoyl domains movement to hE1 as significantly as lipoyl domain of E3BP to hE3 
(Table 12). This is a key finding as for the first time, a substrate of PDHc is observed 
to dictate such a dramatic change in conformational landscape of lipoyl arms with an 






Fig. 47: Net effect of CoA binding to hPDHc.  
The lipoyl domains of hE2 can make more crosslinks (1.5-2.5 folds) with the core forming IC 
domain once the CoA binds, providing alternative explanation to CoA induced core 
compaction. One of the functional consequences of this could be increased mobility of lipoyl 
arm of E3BP, which appears to be now virtually free to move everywhere. In CoA bound state 
of hPDHc, E3BP lipoyl domain significantly makes more contact with hE3 active site region, 
E3-BD, linker between E3BD and LD of E3BP and LD2 of hE2. (Lipoyl domain movement is 
shown with black arrows, domains of hE2 and E3BP and hE1 and hE3 proteins in colored 
solid bodies and the linkers between domains in orange).    
 
So far from SAXS and STED, we observed CoA induced size compaction, which could 
be due to stopping of breathing, internalization of lipoyl arms or both. From mass 
spectrometric analysis, it could be understood that internalization of lipoyl arms of hE2 
will contribute in CoA induced size compaction of hPDHc core, at least partially. 
Although the contribution of breathing on CoA induced size compaction could not be 
conclusively estimated, using dSTORM or related techniques to check the 
fluorescence signal intensity vs radial position in the particle should provide a direct 
glimpse of lipoyl arm internalization. If CoA increases the frequency of lipoyl arm 
internalization, then the fluorescence signals from N-terminal eGFP or organic dye 
bound anti-eGFP nanobody should be significantly higher near the central part of the 
core. But if the intensity remains unchanged after CoA addition, then the observed 
size compaction could be attributed to stopping of breathing.  However, the mixed 
scenario cannot be out ruled. Due to time constraint of the thesis, such analysis could 






4.5. Active site layers in hPDHc 
With the confusion about the position and number of E3BP in hPDHc core, previous 
works have positioned varying number of hE3 proteins at either outside the core or at 
the pentagonal openings (Stoops, Cheng et al. 1997, Zhou, McCarthy et al. 2001, 
Hiromasa, Fujisawa et al. 2004). The position of hE1 protein is however not disputed 
as they have been clearly shown to form a cage from outside the core (Wagenknecht, 
Grassucci et al. 1991, Zhou, McCarthy et al. 2001). In the present work, we observed 
that hE3 protein might not form a regular outer shell like hE1, as the size of 
hE3:hE2/E3BP sub-complex was much smaller than hE1:hE2/E3BP sub-complex or 
hPDHc (refer Section 4.2.). This was in contrast to similar sub-complexes in Bacillus 
Stearothermophilus where both E1 and E3 can form similar outer shells (Milne, Shi et 
al. 2002, Milne, Wu et al. 2006). Furthermore, while comparing electron micrographs 
of hE3:hE2/E3BP sub-complex and hE2/E3BP, we observed hE3’s inhomogeneous 
distribution at the core surface (see Fig. 36).  
Another key finding regarding location of hE3 came from crosslinking mass 
spectrometry. In addition to making crosslinks with the peripheral domains of hE2 and 
E3BP as well as hE1 and surficial core residues, hE3 could also make crosslinks with 
lysine residues of inner hairpin loop of hE2 and E3BP. Even if we take account of high 
flexibility of this hairpin loop to flip upward towards core surface (refer Section 4.1.), 
these crosslinks would only be possible if hE3 protein partially moves inside the core 
via pentagonal openings. The lysine residues of hE3 that makes crosslinks (K267, 
K277, K430 and K445) with the innermost part of core, lie at a same face of hE3 
monomer. As hE3 is a homo dimer, possibly a monomer of hE3 would get inside the 
core with E3BD acting as a hinge (see Fig. 48). The other hE3 monomer could simply 
lie at the core surface.  
The dimension of hE3 dimer is ~ 6 x 9 nm while the widest size of the pentagonal 
openings in hE2/E3BP core model is ~ 6.5 nm. This roughly allows a monomer to 
snug into the pentagonal openings of the core via its smallest edge. However, during 
breathing, the size of the openings can be imagined to increase subtly enabling easier 
accommodation of hE3. This does not appear feasible for hE1 protein (~ 8 x 10 nm), 
which is bulkier than hE3, though a single crosslinking could be identified between 







Fig. 48: Docking of hE3 in a pentagonal opening of hE2/E3BP core.  
A black shadow represents one of the twelve pentagonal openings in hE2/E3BP core. A linker 
connects the core with the E3BD (pink) while another linker connects E3BD to N-terminal lipoyl 
domain (LD). E3BD associates with the hE3 at the dimer interface, such that one monomer 
(green) can enter the pentagonal opening (grey). Inner hairpin loop of hE2 and E3BP core 
forming domains can make crosslinks with four different lysine residues in hE3 (shown in 
orange). The structure of hE3:E3BD is adapted from PDB 1ZY8. 
 
Thus, the observations made with negative staining EM in combination with 
crosslinking MS, reveals that the position of hE3 might not be fixed in space but rather 
dynamic. This accommodates conflicting findings of previously mentioned works and 
in addition, gives an indication of three-dimensional separation of hE1, hE2 and hE3 
catalytic sites. A working model can be thought of where hE1 active sites are located 
at the exterior of a sphere and hE2 active sites at the interior, with hE3 proteins free 
to fluctuate between these layers (see Fig. 49). But it also must be taken into 
consideration that in an hPDHc, E3BP-hE3 and hE2-hE1 forms islands in a core 
where one of the two entities would be in majority (refer Section 4.2). While the 
inhomogeneous distribution of E3BP and hE2 in a core can be explained in context 
of possible separation of E1/E2 reactions with E3 reaction, the need for hE3 to move 
between outer shell and core cavity needs further clarification.  
One possibility could be that after acetyl transfer reaction at the core, the lipoyl 
domains of hE2 will find hE3 immediately for its re-oxidation before going to hE1 for 
fresh round of reaction (see Fig. 1). However, this would make sense only for lipoyl 
domains of hE2 located at islands where hE2 are dominantly distributed. In the islands 





these are the regions where hE3 is at periphery where mainly lipoyl domain of E3BP 




Fig. 49: Radial separation of active sites in hPDHc.  
Active sites of hE1 (green circle) and hE2 (brown circle) are well separated in hPDHc, whereas 
hE3’s position (golden circle) appears to vary between hE1 and hE2 active site layers. The 
presence of hE3 at the core surface might enhance re-oxidation of lipoyl domains of hE2 
whereas distant hE3 might have a role in re-oxidation of lipoyl domain of E3BP. However, 
these situations might not be exclusive as all the lipoyl domains of hE2 and E3BP are able to 
visit all the active sites and they are able to sustain the overall activity in the absence of each 











Our structural models for hE2 and E3BP, which we calculated from the best ever cryo-
EM density map of human PDHc core till date, are similar to those from prokaryotic 
PDHc E2 at monomeric and trimeric levels. These models deviate from the 
observation made regarding differences between human tE2 core pseudo-atomic 
structure with A. vinelandii PDHc E2 crystal structure (Yu, Hiromasa et al. 2008). 
Furthermore, we have now provided experimental backup to the recent MD simulation 
based claims of Hezaveh and colleagues (Hezaveh, Zeng et al. 2016) about 
inaccuracy of human tE2 core structure. In addition to inter trimer breathing motion in 
PDHc core described in 2001 by Zhou and colleagues (Zhou, Liao et al. 2001), we 
have identified another potential mode of dynamics which operates along the length 
of core subunits, at least in E3BP (surfacecavity).  
We have also verified 40:20 stoichiometries between hE2 and E3BP in hPDHc core 
with only hE2 being able to bind CoA. Since, E3BP is catalytically incompetent as 
well, the burden of CoA binding and acetyl transfer reaction lies solely on hE2. During 
native MS experiments, we observed trimers of core subunits in hPDHc consisting of 
1 hE2 and 2 E3BP. This meant that somewhere in the same core, 3 hE2 type of trimer 
should also be present to balance the overall stoichiometry, creating islands where 
either hE2 or E3BP are dominant members. Consistently, in a negative staining EM, 
we observed inhomogeneous distribution of hE3 densities on the core surface. And 
crosslinking MS result showed a population of hE3 proteins entering the cavity of the 
core. Taken altogether, we arrive at a model where the hPDHc is heterogonous in its 
arrangement of hE2 and E3BP. They have distinct patches where E3BP-hE3 or hE2-
hE1 are in majority. Additionally, hE1 and hE3 also appear to be radially separated in 
the hPDHc, with hE1 forming a robust outer shell while hE3 moving between outer 
shell and core cavity. We think this is all nature’s way to segregate E1/E2 reaction 
from E3 reaction. The reduced ability of lipoyl domain of E3BP to sample space on 
hE1 and hE2 further supports this model.  
Although our crosslink MS data backs the multiple random coupling (MRC) model, as 
all the lipoyl domains in principal could visit all the domains of hE2 and E3BP as well 
as peripheral proteins, there is a certain twist. Upon quantification of crosslinks, we 
discovered that once the core binds its substrate ‘CoA’, the lipoyl domains appear to 
concentrate more on subsequent steps of PDHc reaction, which are E2 and E3 
reactions. Thus, PDHc function might not always be the product of random movement 





drives lipoyl domains toward active sites where next catalytic steps are supposed to 
happen.  
The notion of ultra-flexibility of lipoyl arms also needs a minor revision. We observed 
only one orientation for the crosstalk between lipoyl domains (head of E3BP lipoyl 
domain with face of hE2 lipoyl domains). Since all the lipoyl domains also have bunch 
of surficial lysine residues at other parts, many different crosslinks must have been 
detected favoring other orientations, if the lipoyl arms possessed unrestrained 
translational and rotational flexibility. Hence, despite the flexibility required for lipoyl 
arms to visit all three active sites and also to communicate with each other, there must 
be some restrictions in how they move.  It’s also interesting as it implies that lipoyl 
domains should always end up in same orientation regardless of their position in the 
hPDHc (near hE1, hE3, core forming domain or stretched away from all of them). 
From SAXS and STED, we could observe reduction in sizes of all hPDHc cores and 
its variants. The size shrinkage falls in the range of difference between smallest and 
largest size groups during breathing motion of eukaryotic PDHc cores. While it’s 
tempting to attribute CoA induced core shrinkage to the stopping of breathing motion, 
the contribution from lipoyl arms internalization has to be accounted for. Especially 
because lipoyl domains could crosslink with inner components of hPDHc many fold 
higher in the presence of CoA. Perhaps, the information of CoA binding is transduced 
to distant lipoyl arms by changing dynamics of core-forming domain, prompting these 
long appendages to move inward such that lipoyl domains are prepared for E2 and 











One of the main discoveries made during this work was inability of E3BP to bind CoA. 
As this has major functional repercussion in how hPDHc functions (refer Section 4.2.), 
it must be investigated why it cannot bind CoA. The two residues predicted as 
potential discriminant between hE2 and E3BP’s CoA binding abilities (refer Section 
3.1.) should be studied further. Substitutions of amino acids in those positions by the 
equivalent residues found in hE2 should make E3BP able to bind CoA. In the reverse 
way, mutating these residues in hE2 will render it incapable of binding the substrate.  
It will also be an interesting experiment to swap inner linkers between hE2 and E3BP. 
If these linkers play any role for positioning hE1 at distal part while allowing hE3 to 
move between hE1’s outer shell and the core cavity (refer Section 4.5.), the swapping 
will create a reverse situation for these peripheral proteins. Will then the whole 
complex still hold onto its activity? And what if both hE2 and E3BP have same inner 
linker, either of hE2 or E3BP? Will the competition between hE1 and hE3 now to 
occupy similar space compromise the activity in human PDHc? In the case of 
prokaryotic PDHc, where both peripheral proteins bind to the same subunit-binding 
domain of E2, in a mutually exclusive manner, this competition for space does not 
seem to matter. 
Regarding structural study of the PDH complex, next step should be to purify native 
PDHc from mammalian sources (bovine/porcine tissues or HeLa cell) and check if 
they also show inhomogeneous distribution of peripheral proteins. If not, then cryo-
EM should be performed to reach at least moderately resolved density map, as at 
present, there is no structural model for any PDHc. Native MS should be continued 
and aim to fly a larger part of the core and complex in a spectrometer. Perhaps it will 
bring to us other surprises as when it detected 2 E3BP – 1 hE2 kind of trimer in the 
hPDHc. 
As we also discovered that CoA binding changed the preferences of lipoyl domains 
to focus on E2 and E3 reactions, it is only natural to try the similar set of crosslinking 
MS experiments in the presence of pyruvate and its analogs. Perhaps, these lipoyl 
domains would show increased crosslinks with hE1 then. A step ahead would be to 
use quenched flow instrument where holo-PDHc is mixed with pyruvate rapidly and 
the reaction quenched with desired chemical cross-linkers in a time bound manner. It 
will be helpful to understand how this enzyme complex works by tracking movements 





We ventured into a field of super resolution fluorescence microcopy to directly 
demonstrate dynamics in a large protein complex at molecular level. It was partially 
successful as we could observe shift in size distribution of the core in STED and 
dSTORM. Sample preparation part was successfully optimized for dSTORM as we 
could observe homogeneously distributed cores with minimal background. But since 
the hPDHc cores were very soft (refer Section 3.7), they tend to spread over the solid 
surface like glass. To avoid this, new techniques like cryo-STORM is desirable where 
sample can be frozen rapidly in a buffer solution. To make data analysis easier, 
sparse labelling can be done to PDHc cores by using lesser concentrations of dye 
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A. Generation of 6xHis-hE2 and SNAP-hE2 construct 
First of all, a site directed mutagenesis PCR was performed with pET28a-hE2 
(GeneArt, ThermoFisher Scientific) in order to remove a Nde I restriction site in the 




Then using following two primers, a linear sequence for hE2 from pET28a-hE2 
(GeneArt, ThermoFisher Scientific) was generated with Nde I site at its 5’ and Xho I 
site at its 3’ end with STOP codon at immediate 5’ to Xho I site.   
FP_NdeI_polyHIS_hE2: 5’- GCATTAAACATATGGGTTCACTGCCTCCGC – 3’ 
                            Overlap    Nde I   5’-sequence E2 
 
RP_XhoI_polyHIS_hE2: 5’- GGTTACTCGAGTTACAGCAGCAGGTGATCG – 3’ 
                                      Xho I   Stop   end of E2 sequence 
   
Now, Nde I and Xho I restriction endonucleases were used to cleave the obtained 
construct and an empty pET28a vector, and ligated to obtain N-terminally poly 



























Using following two primers, NcoI and NdeI restriction sites were added to start and 
end of SNAP sequence from a plasmid received from the lab of Prof. Steffen Jakobs. 
 
FP_SNAPtag: 5’- CGATGCTCTATAGCCATGGTGAGGTAGGGCG – 3’ 
                            Random sequence      Nco I    SNAP seq. start 
 
RP_SNAPtag: 5’- CGCAGCATATGCTTGTACAGCTCGTCCATGC – 3’ 
                      Random seq  Nde I    SNAP seq end     
 
Using the corresponding restriction sites endonucleases on SNAP tag generated this 
way and pET28a-6xHIs-hE2 construct (sub-cloned using NdeI and XhoI restriction 



































































Fig. 50: SDS-PAGE analysis of overexpression of various proteins used during this 
thesis work.  
hE1 was over expressed using bio fermenter whereas auto-induction method in an incubation 
shaker was used for over expressing all the other proteins. The bands of respective proteins 






Fig. 51: Chromatograms of hE1 and hE3 purifications.  
The hE1 and hE3 proteins both were purified in His-trap columns using gradient of respective 
elution buffers. It was followed by size exclusion chromatography (S75 for hE1 and S200 for 










Fig. 52: SDS-PAGE analysis of the purification of hE1 and hE3 proteins.  
In general, both these proteins were seen to be pure after gel filtration step. The final yield of 
hE1 and hE3 purification are 0.6 mg and 3 mg per 1 g cell pellet used. (CD-cell disruption, 












Fig. 53: SDS-PAGE analysis of the purification of hE2/E3BP core.  
After cell disruption, the lysate underwent 0.1 % protamine sulfate and PEG 6000 (4 %  6 
%) induced precipitations. Post-sucrose gradient ultracentrifugation, the fractions representing 
middle of the bottom gel were selected and pooled. (CD-cell disruption, S.N. - supernatant, 
PS - protamine sulfate, PEG – PEG6000) 
 
 
Fig. 54: SDS-PAGE analysis of the purification of hE2 core.  
After cell disruption, the lysate underwent 0.1 % protamine sulfate and PEG 6000 (4 %  6 
%) induced precipitations. Post-sucrose gradient ultracentrifugation, the fractions representing 
middle of the gel were selected and pooled. (CD-cell disruption, S.N. - supernatant, PS - 








Fig. 55: SDS-PAGE analysis of the purification of KD-hE2 core.  
After cell disruption, the lysate underwent 0.1 % protamine sulfate and PEG 6000 (2 %  4 
%) induced precipitations. Post-sucrose gradient ultracentrifugation, the fractions representing 





Fig. 56: SDS-PAGE analysis of the purification of SNAP-hE2 core.  
After cell disruption, the lysate underwent 0.1 % protamine sulfate and PEG 6000 (4 %  6 
%) induced precipitations. Post-sucrose gradient ultracentrifugation, the fractions representing 
middle of the gel were selected and pooled. (CD-cell disruption, S.N. - supernatant, PS - 










Fig. 57: SDS-PAGE analysis of the purification of eGFP-hE2 core.  
After cell disruption, the lysate underwent 0.1 % protamine sulfate and PEG 6000 (4 %  6 
%) induced precipitations. Post-sucrose gradient ultracentrifugation, the fractions representing 
middle of the gel were selected and pooled. (CD-cell disruption, S.N. - supernatant, PS - 
protamine sulfate, PEG – PEG6000) 
 
C. ITC binding experiment of hE1 with hE2/E3BP core 
 
Fig. 58: An ITC-binding experiment between hE1 and hE2/E3BP core.  
An ITC data was obtained after titration of 147.4 µM hE1 to 1 µM and 3.44 µM hE2/E3BP core 
in 50 mM KH2PO4, 300 mM KCl, pH 7.5 at 25 °C with stirring speed of 500 RPM. The upper 
panel shows the heat of binding for each injection. Since hE1 precipitated severely in this ITC 







D. Intricate surface details of hPDHc cores observed in AFM 
 
 
        
 
Fig. 59: Surficial details of hPDHc cores observed occasionally during AFM study.  
In the top Fig., features resembling three lipoyl arms can be seen. These arm like features had 
higher heights than rest of the particle. In the bottom figures, depressions on KD-hE2 cores 
can be seen when zoomed in (at 5 fold axis only one such hole should be visible, while on 3 
fold or 2 fold axis more than one such holes should be visible). However these observations 












E. Mass spectrometric confirmation of proteolytic processing of full length 
hE2 and E3BP into their IC domains (by Dr. Oliver Valerius) 
 















F. ThermoFluor assay of truncated hPDHc cores  
In order to check the stability of the truncated hPDHc cores generated by proteolysis, 
ThermoFluor assay was performed. In this assay, the protein (5 µM tE2 or tE2/E3BP 
monomers) was kept at different buffer (100 mM) and pH conditions and mixed with 
5 x SYPRO Orange dye. With increasing temperature, the protein gets denatured and 
the hydrophobic regions will be exposed. This dye binds to these exposed 
hydrophobic regions and gives fluorescence signals. Thus, fluorescent signal 
obtained at particular temperature and particular solution condition can be correlated 
with level of protein denaturation and the melting curve is generated.  
Many buffer conditions and pH ranges were screened from 20-95 °C with stepwise 
temperature increment of 1 K / 30 s in a C1000 thermal cycler. The fluorescence 
signals were monitored using CFX96TM Optical Reaction Module (excitation: 515-535, 
detection: 560-580 nm). The assay was performed in the facility of ‘Department of 






MES (pH 4.6-7.4), BisTris (pH 5.2-8.0), Imidazole (pH 5.4-8.2), Phosphate (pH 5.8-
8.6), HEPES (pH 6.0-8.8) and Tris (pH 6.6-9.4) were used for screening with pH-step 
0.4 for each buffer component.   
The proteins were found to be similarly stable at many conditions but the optimum 
buffer and pH was chosen to be best in MES and BisTris 6-6.5. 
 
G. Negative staining electron microscopy of truncated hE2/E3BP cores 
 
Fig. 60: Negative staining EM images of truncated hE2/E3BP.  
Roughly 50 pmoles tE2/E3BP cores were used for GraFix and the best fraction from dot blot 
was used for negative staining EM. The sample containing CoA could be clearly seen 














H. Crosslinks in hPDHc as detected in crosslinking MS 
The numbering of amino acyl residues is based on Uniprot protein database 
(http://www.uniprot.org/). The crosslinks observed in + CoA condition are shown in 
blue whereas - CoA condition is in black. 
 
In the presence of 2 mM CoA In the absence of CoA 
Protein 1 Residue 1 Protein 2 Residue 2 Protein 1 Residue 1 Protein 2 Residue 2
E3BP 120 E3BP 78   
E3BP 120 E3BP 173   
  E3BP 120 E3BP 194 
E3BP 120 E3BP 488   
E3BP 155 E3BP 173   
E3BP 155 E3BP 227   
E3BP 194 E3BP 155   
E3BP 194 E3BP 173   
  E3BP 194 E3BP 194 
E3BP 194 E3BP 213 E3BP 194 E3BP 213 
E3BP 194 E3BP 218   
E3BP 194 E3BP 223 E3BP 194 E3BP 223 
E3BP 194 E3BP 227 E3BP 194 E3BP 227 
  E3BP 194 E3BP 321 
E3BP 194 E3BP 450   
  E3BP 194 E3BP 460 
E3BP 213 E3BP 227   
E3BP 218 E3BP 227 E3BP 218 E3BP 227 
E3BP 227 E3BP 194   
E3BP 227 E3BP 218   
E3BP 314 E3BP 321   
E3BP 314 E3BP 450 E3BP 314 E3BP 450 
E3BP 314 E3BP 460 E3BP 314 E3BP 460 
E3BP 325 E3BP 394 E3BP 325 E3BP 394 
E3BP 341 E3BP 194   
E3BP 450 E3BP 321 E3BP 450 E3BP 321 
E3BP 450 E3BP 379   
E3BP 450 E3BP 450   
E3BP 450 E3BP 491 E3BP 450 E3BP 491 
E3BP 460 E3BP 289   
E3BP 460 E3BP 321 E3BP 460 E3BP 321 
E3BP 460 E3BP 460   
  E3BP 460 E3BP 379 
  E3BP 460 E3BP 460 
E3BP 460 E3BP 488   
E3BP 488 E3BP 488   
  E3BP 491 E3BP 491 
E3BP 120 E1-alpha 40   
E3BP 120 E1-alpha 77 E3BP 120 E1-alpha 77 
E3BP 155 E1-alpha 40   
E3BP 155 E1-alpha 277   
  E3BP 194 E1-alpha 40 
E3BP 194 E1-alpha 77 E3BP 194 E1-alpha 77 
  E3BP 194 E1-alpha 149 
E3BP 194 E1-alpha 244 E3BP 194 E1-alpha 244 
E3BP 194 E1-alpha 277 E3BP 194 E1-alpha 277 
E3BP 194 E1-alpha 336   
  E3BP 218 E1-alpha 277 
E3BP 289 E1-alpha 40   
E3BP 120 E3 159 E3BP 120 E3 159 
E3BP 120 E3 267 E3BP 120 E3 267 
E3BP 120 E3 273   






E3BP 120 E3 284   
E3BP 120 E3 410 E3BP 120 E3 410 
E3BP 120 E3 430 E3BP 120 E3 430 
  E3BP 120 E3 445 
E3BP 155 E3 159 E3BP 155 E3 159 
E3BP 155 E3 277 E3BP 155 E3 277 
E3BP 155 E3 410 E3BP 155 E3 410 
  E3BP 155 E3 430 
E3BP 173 E3 445 E3BP 173 E3 445 
  E3BP 194 E3 159 
  E3BP 194 E3 267 
E3BP 194 E3 277 E3BP 194 E3 277 
  E3BP 194 E3 410 
E3BP 194 E3 430 E3BP 194 E3 430 
E3BP 194 E3 445 E3BP 194 E3 445 
E3BP 194 E3 505 E3BP 194 E3 505 
E3BP 213 E3 445   
  E3BP 218 E3 445 
E3BP 223 E3 445   
E3BP 227 E3 277   
E3BP 227 E3 445   
E3BP 289 E3 267 E3BP 289 E3 267 
E3BP 289 E3 277 E3BP 450 E3 267 
E3BP 295 E3 277   
  E3BP 450 E3 430 
  E3BP 450 E3 445 
E3BP 460 E3 277 E3BP 460 E3 277 
  E3BP 460 E3 430 
E3BP 120 E2 114   
E3BP 120 E2 241 E3BP 120 E2 241 
E3BP 120 E2 363   
E3BP 120 E2 462   
E3BP 155 E2 241   
  E3BP 172 E2 462 
E3BP 194 E2 241 E3BP 194 E2 241 
E3BP 194 E2 362 E3BP 194 E2 362 
E3BP 194 E2 363 E3BP 194 E2 363 
E3BP 194 E2 368   
E3BP 194 E2 376 E3BP 194 E2 376 
E3BP 194 E2 387 E3BP 194 E2 387 
  E3BP 194 E2 462 
E3BP 194 E2 473 E3BP 194 E2 473 
E3BP 194 E2 552 E3BP 194 E2 552 
E3BP 227 E2 241   
E3BP 227 E2 376   
E3BP 289 E2 387 E3BP 289 E2 387 
E3BP 295 E2 362   
E3BP 295 E2 376   
  E3BP 295 E2 440 
E3BP 295 E2 547   
E3BP 314 E2 462 E3BP 314 E2 462 
  E3BP 341 E2 376 
E3BP 341 E2 473 E3BP 341 E2 473 
E3BP 450 E2 387   
E3BP 450 E2 466   
E3BP 450 E2 473 E3BP 450 E2 473 
  E3BP 460 E2 462 
E3BP 460 E2 604 E3BP 460 E2 604 
E3BP 488 E2 363   
E3BP 488 E2 362   
E3BP 488 E2 376   
E3BP 488 E2 462   
E3BP 491 E2 547   
E3BP 194 E1-beta 227 E3BP 194 E1-beta 227 
E3BP 488 E1-beta 229   
E1-alpha 40 E1-alpha 40   






E1-alpha 63 E1-alpha 83   
  E1-alpha 77 E1-alpha 63 
E1-alpha 77 E1-alpha 77 E1-alpha 77 E1-alpha 77 
E1-alpha 77 E1-alpha 83   
E1-alpha 77 E1-alpha 85   
E1-alpha 77 E1-alpha 244 E1-alpha 77 E1-alpha 244 
E1-alpha 77 E1-alpha 313 E1-alpha 77 E1-alpha 313 
E1-alpha 77 E1-alpha 321 E1-alpha 77 E1-alpha 321 
E1-alpha 83 E1-alpha 40   
E1-alpha 83 E1-alpha 142   
E1-alpha 149 E1-alpha 244   
  E1-alpha 158 E1-alpha 77 
E1-alpha 158 E1-alpha 83   
E1-alpha 158 E1-alpha 182   
E1-alpha 158 E1-alpha 277 E1-alpha 158 E1-alpha 277 
E1-alpha 244 E1-alpha 40 E1-alpha 244 E1-alpha 40 
E1-alpha 244 E1-alpha 63   
E1-alpha 244 E1-alpha 142 E1-alpha 244 E1-alpha 142 
E1-alpha 244 E1-alpha 244 E1-alpha 244 E1-alpha 244 
E1-alpha 277 E1-alpha 77 E1-alpha 277 E1-alpha 77 
E1-alpha 277 E1-alpha 83 E1-alpha 277 E1-alpha 83 
E1-alpha 277 E1-alpha 85   
E1-alpha 277 E1-alpha 244 E1-alpha 277 E1-alpha 244 
E1-alpha 277 E1-alpha 277 E1-alpha 277 E1-alpha 277 
E1-alpha 277 E1-alpha 313 E1-alpha 277 E1-alpha 313 
E1-alpha 277 E1-alpha 321 E1-alpha 277 E1-alpha 321 
E1-alpha 321 E1-alpha 40   
E1-alpha 321 E1-alpha 142   
  E1-alpha 336 E1-alpha 40 
E1-alpha 336 E1-alpha 77 E1-alpha 336 E1-alpha 77 
E1-alpha 336 E1-alpha 277 E1-alpha 336 E1-alpha 277 
E1-alpha 336 E1-alpha 313 E1-alpha 336 E1-alpha 313 
E1-alpha 336 E1-alpha 321 E1-alpha 336 E1-alpha 321 
E1-alpha 344 E1-alpha 40   
E1-alpha 344 E1-alpha 77 E1-alpha 344 E1-alpha 77 
E1-alpha 344 E1-alpha 336 E1-alpha 344 E1-alpha 336 
  E1-alpha 40 E3 66 
  E1-alpha 40 E3 284 
E1-alpha 40 E3 277   
E1-alpha 40 E3 320   
E1-alpha 40 E3 445   
E1-alpha 63 E3 430   
  E1-alpha 77 E3 104 
E1-alpha 77 E3 159   
E1-alpha 77 E3 320   
E1-alpha 77 E3 410 E1-alpha 77 E3 410 
E1-alpha 77 E3 445 E1-alpha 77 E3 445 
E1-alpha 83 E3 159   
E1-alpha 83 E3 445   
E1-alpha 158 E3 277   
E1-alpha 244 E3 267   
E1-alpha 244 E3 277   
E1-alpha 244 E3 445   
E1-alpha 277 E3 122   
  E1-alpha 277 E3 211 
  E1-alpha 277 E3 267 
E1-alpha 277 E3 277 E1-alpha 277 E3 277 
  E1-alpha 277 E3 430 
  E1-alpha 313 E3 430 
E1-alpha 321 E3 277   
E1-alpha 321 E3 320   
  E1-alpha 336 E3 267 
E1-alpha 336 E3 430 E1-alpha 336 E3 430 
  E1-alpha 344 E3 277 
  E1-alpha 344 E3 445 
  E1-alpha 40 E2 241 






E1-alpha 40 E2 376   
E1-alpha 40 E2 387   
E1-alpha 40 E2 547 E1-alpha 40 E2 547 
E1-alpha 63 E2 114   
  E1-alpha 63 E2 552 
E1-alpha 77 E2 241   
  E1-alpha 77 E2 362 
E1-alpha 77 E2 376 E1-alpha 77 E2 376 
E1-alpha 77 E2 462   
  E1-alpha 77 E2 473 
E1-alpha 77 E2 552   
E1-alpha 77 E2 604   
E1-alpha 83 E2 241 E1-alpha 83 E2 241 
E1-alpha 147 E2 241   
E1-alpha 244 E2 114 E1-alpha 244 E2 114 
E1-alpha 244 E2 241 E1-alpha 244 E2 241 
E1-alpha 244 E2 363   
E1-alpha 244 E2 462   
E1-alpha 277 E2 376 E1-alpha 277 E2 376 
E1-alpha 277 E2 387   
E1-alpha 277 E2 462   
E1-alpha 277 E2 473 E1-alpha 277 E2 473 
E1-alpha 321 E2 114   
E1-alpha 321 E2 241 E1-alpha 321 E2 241 
  E1-alpha 336 E2 114 
  E1-alpha 336 E2 241 
E1-alpha 336 E2 362   
  E1-alpha 336 E2 363 
E1-alpha 336 E2 376 E1-alpha 336 E2 376 
  E1-alpha 336 E2 462 
E1-alpha 336 E2 473 E1-alpha 336 E2 473 
  E1-alpha 344 E2 241 
E1-alpha 385 E2 387   
E1-alpha 40 E1-beta 227 E1-alpha 40 E1-beta 227 
  E1-alpha 77 E1-beta 227 
E1-alpha 77 E1-beta 229   
E1-alpha 77 E1-beta 258   
E1-alpha 83 E1-beta 68 E1-alpha 83 E1-beta 68 
E1-alpha 83 E1-beta 354   
E1-alpha 85 E1-beta 227   
E1-alpha 85 E1-beta 336   
E1-alpha 244 E1-beta 227 E1-alpha 277 E1-beta 75 
E1-alpha 277 E1-beta 76   
E1-alpha 277 E1-beta 68   
  E1-alpha 277 E1-beta 188 
  E1-alpha 277 E1-beta 227 
  E1-alpha 277 E1-beta 355 
  E1-alpha 321 E1-beta 354 
  E1-alpha 385 E1-beta 227 
  E3 66 E3 430 
E3 66 E3 445   
E3 72 E3 166   
E3 72 E3 320 E3 72 E3 320 
E3 104 E3 122 E3 104 E3 122 
E3 104 E3 267 E3 104 E3 267 
  E3 104 E3 277 
E3 104 E3 284   
E3 104 E3 430 E3 104 E3 430 
E3 122 E3 430 E3 122 E3 430 
E3 132 E3 122   
E3 132 E3 430 E3 132 E3 430 
E3 143 E3 66 E3 143 E3 66 
E3 159 E3 159   
E3 159 E3 267   
E3 159 E3 277 E3 159 E3 277 
E3 159 E3 445   






  E3 215 E3 284 
E3 267 E3 267   
  E3 267 E3 284 
E3 277 E3 211   
E3 277 E3 267   
E3 277 E3 277 E3 277 E3 277 
E3 284 E3 211 E3 284 E3 211 
E3 288 E3 211 E3 288 E3 211 
  E3 288 E3 277 
E3 320 E3 155 E3 320 E3 155 
E3 320 E3 211   
E3 320 E3 277   
E3 346 E3 159 E3 346 E3 159 
  E3 410 E3 277 
E3 410 E3 420 E3 410 E3 420 
  E3 410 E3 430 
E3 410 E3 445 E3 410 E3 445     
E3 417 E3 430   
E3 417 E3 445   
E3 430 E3 122 E3 430 E3 122 
E3 430 E3 267 E3 430 E3 267 
E3 430 E3 277 E3 430 E3 277 
E3 430 E3 430   
E3 430 E3 445   
E3 445 E3 267   
E3 445 E3 273   
E3 445 E3 445   
  E3 66 E2 547 
E3 104 E2 114 E3 104 E2 114 
E3 104 E2 241   
E3 104 E2 462   
E3 159 E2 362   
  E3 159 E2 473 
E3 159 E2 376   
E3 159 E2 552   
E3 267 E2 114   
E3 267 E2 241   
E3 267 E2 362   
E3 267 E2 376 E3 267 E2 376 
  E3 277 E2 241 
E3 277 E2 368 E3 277 E2 368 
E3 277 E2 376 E3 277 E2 376 
E3 277 E2 387 E3 277 E2 387 
E3 277 E2 466   
E3 277 E2 490   
E3 277 E2 552 E3 277 E2 552 
E3 277 E2 604   
E3 284 E2 376   
  E3 320 E2 241 
E3 320 E2 362   
E3 320 E2 376 E3 320 E2 376 
  E3 410 E2 363 
  E3 410 E2 376 
E3 430 E2 368   
E3 445 E2 114 E3 445 E2 114 
E3 445 E2 241   
E3 445 E2 362   
E3 445 E2 363   
E3 445 E2 376 E3 445 E2 376 
E3 445 E2 387   
E3 445 E2 462   
E3 277 E1-beta 80   
  E3 277 E1-beta 184 
  E3 277 E1-beta 188 
E3 277 E1-beta 227   
  E3 284 E1-beta 227 






E3 430 E1-beta 188 E3 430 E1-beta 188 
E2 362 E2 114 E2 362 E2 114 
E2 362 E2 241 E2 362 E2 241 
E2 362 E2 362 E2 362 E2 362 
E2 362 E2 363 E2 362 E2 363 
E2 362 E2 462 E2 362 E2 462 
E2 363 E2 363   
E2 368 E2 362 E2 368 E2 362 
E2 368 E2 387 E2 368 E2 387 
E2 368 E2 473   
E2 376 E2 114 E2 376 E2 114 
E2 376 E2 241 E2 376 E2 241 
E2 376 E2 362   
E2 376 E2 363 E2 376 E2 363 
E2 376 E2 368 E2 376 E2 368 
E2 376 E2 376 E2 376 E2 376 
E2 376 E2 387 E2 376 E2 387 
E2 376 E2 462 E2 376 E2 462 
E2 376 E2 473 E2 376 E2 473 
E2 387 E2 362   
E2 387 E2 363 E2 387 E2 363 
E2 387 E2 387   
  E2 462 E2 637 
E2 466 E2 362   
E2 466 E2 637 E2 466 E2 637 
E2 473 E2 362 E2 473 E2 362 
E2 473 E2 363   
E2 473 E2 387 E2 473 E2 387 
E2 473 E2 462 E2 473 E2 462 
E2 473 E2 466 E2 473 E2 466 
E2 490 E2 376 E2 490 E2 376 
E2 490 E2 490 E2 490 E2 490 
E2 547 E2 114 E2 547 E2 114 
E2 547 E2 241 E2 547 E2 241 
E2 547 E2 363 E2 547 E2 363 
E2 547 E2 368   
E2 547 E2 387 E2 547 E2 387 
E2 547 E2 462 E2 547 E2 462 
  E2 547 E2 466 
E2 547 E2 473 E2 547 E2 473 
  E2 552 E2 114 
E2 552 E2 362   
E2 552 E2 363 E2 552 E2 363 
E2 552 E2 368 E2 552 E2 368 
E2 552 E2 376 E2 552 E2 376 
E2 552 E2 387   
E2 552 E2 473 E2 552 E2 473 
E2 552 E2 547 E2 552 E2 547 
  E2 604 E2 114 
  E2 604 E2 241 
E2 604 E2 462   
E2 604 E2 604 E2 604 E2 604 
E2 637 E2 473   
E2 114 E1-beta 227   
  E2 241 E1-beta 68 
E2 241 E1-beta 184   
E2 241 E1-beta 227 E2 241 E1-beta 227 
E2 241 E1-beta 354 E2 241 E1-beta 354 
E2 363 E1-beta 227 E2 363 E1-beta 227 
E2 363 E1-beta 354   
  E2 376 E1-beta 68 
  E2 376 E1-beta 227 
E2 376 E1-beta 258   
E2 376 E1-beta 354   
E2 376 E1-beta 355 E2 376 E1-beta 355 
E2 387 E1-beta 227 E2 387 E1-beta 227 






E2 462 E1-beta 354   
E2 473 E1-beta 184 E2 473 E1-beta 184 
E2 473 E1-beta 227 E2 473 E1-beta 227 
E2 473 E1-beta 258 E2 473 E1-beta 258 
  E2 552 E1-beta 75 
E2 552 E1-beta 188   
E1-beta 52 E1-beta 80   
E1-beta 68 E1-beta 76   
  E1-beta 76 E1-beta 68 
E1-beta 173 E1-beta 227   
E1-beta 184 E1-beta 227   
  E1-beta 188 E1-beta 227 
E1-beta 227 E1-beta 76   
  E1-beta 227 E1-beta 227 
E1-beta 227 E1-beta 229   
E1-beta 258 E1-beta 354   
E1-beta 354 E1-beta 229   




















I. Crosslinks in hE2/E3BP core as detected in crosslinking MS 
Three different types of crosslinkings were obtained for hE2/E3BP core which 
were inter E2 monomers, inter E3BP monomers and between hE2 and E3BP 
monomers. Spectral counts (number of spectra identified) were used as a way to 
discriminate between presence and absence of CoA states. Although many 
crosslinks were abundant or absent in either of the two states, a coherent effect 
could not be modelled. Thus, they were instead used primarily for proof checking 
some of the interesting crosslinks observed in hPDHc.  
 
E2-E2 with CoA 
spectral counts 
without CoA 
spectral counts Pos1 Pos2
114 114   2 
362 114 4 10 
362 241 15 
362 363 2 
362 462 11 22 
362 637 2 
368 241 10 
368 473 9 
368 362 9 
368 363 2 
368 387 1 
368 473 9 
376 114 16 16 
376 241 21 23 
376 362 12 12 
376 363 9 7 
376 368 3 
376 376 11 16 
376 387 18 16 
376 462 21 
376 466 12 11 
376 473 28 37 
376 641 18 
387 362 9 
387 363 4 
387 387 2   
387 462 6 5 
387 466 2 
396 368 3 
396 376 21 28 
462 363 1 
466 114 5 
466 241 10 
466 362 7 7 
466 363 3 
466 387 1 
466 462 6 
466 637 17 15 
473 362 11 22 
473 387 11 13 
473 462 482 651 
473 466 251 301 
473 473 9 4 
490 637 20 26 






547 241 18 
547 363 2 3 
547 368 6 3 
547 376 29 
547 387 5 5 
547 462 12 7 
547 466 6 
547 473 60 92 
552 241 23 35 
552 363 3 
552 363 3 
552 368 3 
552 376 55 58 
552 387 12 8 
552 466 5 
552 473 17 15 
552 552 3   
552 637 10 15 
604 241 11 
604 376 5 5 
604 462 6 4 
604 473 4 10 
604 552 1 2 
604 604 1   
637 466 37 
637 473 9 
 
E3BP-E3BP with CoA 
spectral counts 
without CoA 
spectral counts Pos1 Pos2
79 194 1 2 
120 120 4 6 
120 173 12 12 
120 213 13 10 
120 227 5 
120 321 5 
120 321 5 
139 120 5 
145 120 9 
145 173 14 2 
145 194 2 
155 173 17 
155 194 4 
155 223 8 
155 321 3 
172 488 4 
173 223 10 8 
173 227 7 6 
194 120 30 
194 145 5 4 
194 155 17 
194 172 13 7 
194 173 26 
194 194 28 30 
194 213 108 147 
194 218 5 
194 223 92 107 
194 227 40 38 
194 321 10 9 
194 325 4 5 
194 334 1 
194 379 10 
194 384 3 
194 394 9 
194 450 20 






194 488 24 
194 491 5 4 
213 173 6 5 
213 223 29 
213 227 3 
213 289 10 
295 120 6 4 
295 173 14 13 
295 194 25 29 
295 213 5 9 
295 223 4 
295 295 1 
295 450 6 
295 460 9 8 
295 491 2 
  7 
314 450 52 59 
314 460 125 161 
321 321 2 
321 173 3 
325 194 4 13 
325 394 90 92 
325 460 4 4 
341 194 8 
341 213 6 6 
341 379 6 
341 384 4 5 
341 460 5 
356 194 2 
379 120 3 4 
379 173 7 7 
379 213 6 5 
379 321 3 
379 491 4 
384 213 3 
394 491 2 
450 120 7 
450 145 1 
450 155 8 12 
450 173 10 14 
450 213 5 11 
450 223 2 3 
450 227 6 3 
450 321 40 31 
450 334 2 
450 379 4 4 
450 394 3 
450 450 4 3 
450 460 11 10 
450 488 56 
450 491 62 66 
460 120 5 7 
460 155 10 11 
460 172 3 
460 173 9 9 
460 213 7 7 
460 223 4 
460 227 5 
460 321 13 16 
460 325 2 
460 379 6 5 
460 384 4 4 
460 394 2 5 
460 460 13 14 
460 488 15 
460 491 6 7 






488 488 7 
491 120 3 
491 213 2 
   
hE2-E3BP with CoA 
spectral counts 
without CoA 
spectral counts hE2 E3BP 
114 155 13 
114 173 5 4 
114 194 22 
114 460 10 
114 488 11 
241 120 18 
241 223 8 6 
241 295 13 
241 314 4 
241 325 6 
241 379 7 
241 394 4 
362 120 6 4 
362 213 4 
362 394 3 
362 450 6 7 
362 460 4 7 
363 120 2 1 
363 173 2 
363 194 10 6 
363 213 2 
363 289 3 
363 295 3 
363 341 1 
363 384 1 
363 460 6 5 
363 488 5 4 
368 120 20 
368 194 5 4 
376 120 15 11 
376 145 2 
376 173 7 
376 194 33 37 
376 213 5 9 
376 223 4 
376 227 6 5 
376 295 9 
376 321 8 4 
376 325 1 6 
376 341 3 5 
376 384 3 
376 394 7 9 
376 460 6 8 
386 488 18 10 
376 491 2 
387 120 7 
387 155 3 
387 173 1 
387 194 7 6 
387 213 3 






387 295 4 2 
387 325 1 
387 341 3 2 
387 394 2 
387 450 9 5 
387 460 9 8 
387 488 11 
440 295 7 6 
462 120 16 14 
462 145 5 7 
462 155 19 14 
462 172 5 2 
462 173 7 11 
462 194 31 37 
462 213 5 7 
462 314 15 
462 341 4 
462 450 10 
462 460 14 9 
466 120 5 6 
466 194 17 16 
466 213 5 2 
466 223 4 
466 450 9 10 
466 460 8 12 
466 488 14 
473 120 5 14 
473 145 2 
473 155 14 14 
473 194 24 50 
473 213 9 
473 223 7 
473 227 5 
473 295 20 4 
473 341 6 6 
473 379 7 2 
473 384 6 
473 394 4 1 
473 450 8 10 
473 460 19 12 
473 491 4 6 
547 173 5 5 
547 194 20 19 
547 491 11 12 
552 173 7 
552 194 28 
552 213 11 
552 223 2 
552 227 4 8 
552 295 5 2 
552 341 3 5 
552 379 5 
552 384 5 
552 450 10 11 
552 460 6 
552 491 5 4 
604 194 5 






604 460 17 38 
637 120 4 6 
637 194 16 
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pyruvate dehydrogenase multi-enzyme complex.” PhD Thesis under supervision of 
Prof. Dr. Kai Tittmann. 
01.10.2012 – 31.03.2013, “Structure and dynamics of the core of human pyruvate 





02.05.2012 - 22.06.2012, “DNA-catalyzed labeling of RNA.” under supervision of Prof. 
Dr. Claudia Höbartner. 
27.02.2012 - 30.04.2012, “Expression, purification and functional analyses of all three 
catalytic subunits of hPDHc.” under supervision of Prof. Dr. Kai Tittmann.  
03.01.2012-24.02.2012, “Screening of alignment media for the residual dipolar 
coupling (RDC) based study of recognition dynamics between ubiquitin and Dsk2.” 
under supervision of Prof. Dr. Christian Griesinger. 
01.05.2009 – 29.10.2009, “Characterization of Choreospondias axillaries (Lapsi) fruit 
protease.” B.Sc. Thesis under supervision of Prof. Dr. Vishwanath P. Agrawal. 
 
Research skills: 
PCR, protein overexpression and purifications, high cell density biofermentation, 
steady state and pre-steady state enzyme kinetics, CD spectroscopy, isothermal 
titration calorimetry, negative staining electron microscopy, nuclear magnetic 
resonance spectroscopy, small angle X-ray scattering and atomic force microscopy,  
Participated in various method courses in the field of biphysics like cryo-EM, X-ray 
crystallography, NMR, EPR, mass spectrometry, FRET, analytical ultracentrifugation 
and in cell biology like RNA-microarray, quantitative PCR, in-situ hybridization in frog 
embryo, mouse fibroblast and embryonic stem cell culture and confocal microscopy. 
 
Contributions in scientific meetings: 
Poster presentation: Why stop breathing? Kyoto winter school (2016), HeKKSaGon, 
Japan 
Talk: Structural studies of the human pyruvate dehydrogenase multi-enzyme complex 
(hPDHc).  SFB 860 retreat (2015) 
Poster presentation and a talk: Understanding the breathing phenomenon observed 
in an icosahedral core of pyruvate dehydrogenase multi-enzyme complex. PhD 
retreat of GGNB Biomolecules program, 2014 (Best poster award) 
